<SEC-DOCUMENT>0000355019-17-000011.txt : 20170510
<SEC-HEADER>0000355019-17-000011.hdr.sgml : 20170510
<ACCEPTANCE-DATETIME>20170510151238
ACCESSION NUMBER:		0000355019-17-000011
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20170331
FILED AS OF DATE:		20170510
DATE AS OF CHANGE:		20170510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		17829898

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fonar10-q_20170331.htm
<DESCRIPTION>FONAR CORPORATION 10-Q
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: justify"></P>

<P STYLE="font: 14pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-variant: normal"><B>FORM
10-Q</B></FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">SECURITIES
AND EXCHANGE COMMISSION</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Washington,
D.C. 20549</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">[X]
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-variant: normal"><B>For
the quarterly period ended MARCH 31, 2017</B></FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Commission
file number 0-10248</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 14pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-variant: normal"><B>FONAR
CORPORATION</B></FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="height: 25; text-align: center; vertical-align: middle">
    <TD STYLE="vertical-align: bottom; width: 48%; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">DELAWARE</FONT></TD>
    <TD STYLE="vertical-align: top; width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 26%; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11-2464137</FONT></TD></TR>
<TR STYLE="height: 25; text-align: center; vertical-align: middle">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(State
                                         or other jurisdiction of</FONT></P>
        <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">incorporation
        or organization)</FONT></P></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(I.R.S.
                                         Employer</FONT></P>
        <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Identification
        No.)</FONT></P></TD></TR>
<TR STYLE="height: 25; text-align: center; vertical-align: middle">
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">110
    Marcus Drive&nbsp;&nbsp;Melville, New York</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11747</FONT></TD></TR>
<TR STYLE="height: 25; text-align: center; vertical-align: middle">
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Zip
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Registrant's
telephone number, including area code: (631) 694-2929</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. YES X NO ___</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding
12 months (or for shorter period that the registrant was required to submit and post such files. YES X NO ___</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definition of accelerated filer, large accelerated filer or smaller reporting company in Rule 12b-2 of
the Exchange Act.(Check one): Large accelerated filer___ Accelerated filer X Non-accelerated filer ___ Smaller reporting company
___</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES NO _X__</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Indicate
the number of shares outstanding of each of the issuer's classes of common stock, as of the close of the latest practicable date.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.2in 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Indicate
the number of shares outstanding of each of the issuer's classes of common stock, as of the close of the latest practicable date.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.2in 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: right; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Outstanding
    at April 30, 2017</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="width: 50%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Common
    Stock, par value $.0001</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 40%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,202,242</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    B Common Stock, par value $.0001</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">146</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    C Common Stock, par value $.0001</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">382,513</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    A Preferred Stock, par value $.0001</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">313,438</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>



    <DIV STYLE="margin-bottom: 6pt; text-align: justify"></DIV>



<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: middle; text-align: center; height: 25"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">INDEX</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.2in 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">PART
    I - FINANCIAL INFORMATION</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Page
    No.</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    1.&nbsp;&nbsp;Financial Statements</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="width: 85%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Condensed
    Consolidated Balance Sheets - March 31, 2017 (Unaudited) and June 30, 2016</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Condensed
    Consolidated Statements of Income for the Three Months Ended March 31, 2017 and March 31, 2016 (Unaudited)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Condensed
    Consolidated Statements of Income for the Nine Months Ended&nbsp;&nbsp;March 31, 2017 and March 31, 2016 (Unaudited)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Condensed
    Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2017 and March 31, 2016 (Unaudited)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Notes
    to Condensed Consolidated Financial Statements&nbsp;&nbsp;(Unaudited)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    2. Management's Discussion and Analysis of Financial Condition and&nbsp;&nbsp;Results of Operations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">24</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    3. Quantitative and Qualitative Disclosures About Market Risk</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">32</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    4. Controls and Procedures</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">32</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">PART
    II - OTHER INFORMATION</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">32</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    1. Legal Proceedings</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">32</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    1A. Risk Factors</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">32</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    2. Unregistered Sales of Equity Securities and Use of Proceeds</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">34</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    3. Defaults Upon Senior Securities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">34</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    4. Mine Safety Disclosures</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">34</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    5. Other Information</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">34</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: rgb(204,238,255); height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
    6. Exhibits</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">35</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="text-align: center; background-color: White; height: 25; vertical-align: middle">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -17.1pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Signatures</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">35</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">CONDENSED
CONSOLIDATED BALANCE SHEETS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">ASSETS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: justify; border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: justify; border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
                                         30,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016
                                         *</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
    and cash equivalents</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,750</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,528</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    receivable - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,614</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,370</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    receivable - related party</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">30</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medical
    receivable - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,332</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">10,127</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees receivable - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">18,480</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,638</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9.6pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees receivable - related medical practices - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,255</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,064</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9.6pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    and estimated earnings in excess of billing on uncompleted contracts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">649</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inventories</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,670</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,074</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Prepaid
    expenses and other current assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,059</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">759</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Current Assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">50,839</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">45,560</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Deferred
    income tax asset</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">14,942</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">13,042</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Property
    and equipment - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,292</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">14,513</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Goodwill</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,322</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,322</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    intangible assets - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,920</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,719</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">509</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">732</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">91,824</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">84,888</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">*Condensed
from audited financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;See
accompanying notes to condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"></P>


<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">CONDENSED
CONSOLIDATED BALANCE SHEETS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;LABILITIES
AND STOCKHOLDERS' EQUITY</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
                                         30,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016
                                         *</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Current
    Liabilities:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Current
    portion of long-term debt and capital leases</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">727</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,448</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    payable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,183</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,254</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    current liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,483</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">10,827</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Unearned
    revenue on service contracts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,987</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,679</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Unearned
    revenue on service contracts - related party</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">28</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Customer
    advances</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,018</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,199</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Billings
    in excess of costs and estimated earnings on uncompleted contracts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">25</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">207</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: 27pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Current Liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">14,451</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">20,614</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Long-Term
    Liabilities:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Deferred
    income tax liability</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">482</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">482</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Due
    to related medical practices</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">228</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">245</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Long-term
    debt and capital leases, less current portion</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">348</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,059</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">890</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">712</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Long-Term Liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,948</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,498</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">16,399</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">24,112</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">*Condensed
from audited financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;See
accompanying notes to condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">CONDENSED
CONSOLIDATED BALANCE SHEETS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">LIABILITIES
AND STOCKHOLDERS' EQUITY (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">STOCKHOLDERS'
    EQUITY:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31, 2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: center; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
                                         30, 2016 *</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    A non-voting preferred stock $.0001 par value; 453 shares authorized at March 31, 2017 and June 30, 2016, 313 issued and outstanding
    at March 31, 2017 and June 30, 2016</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Preferred
    stock $.001 par value; 567 shares authorized at March 31, 2017 and June 30, 2016, issued and outstanding - none</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Common
    Stock $.0001 par value; 8,500 shares authorized at March 31, 2017 and June 30, 2016, 6,214 and 6,062 issued at March 31, 2017
    and June 30, 2016; 6,202 and 6,051 outstanding at March 31, 2017 and June 30, 2016</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    B Common Stock (10 votes per share) $ .0001 par value; 227 shares authorized at March 31, 2017 and June 30, 2016, .146 issued
    and outstanding at March 31, 2017 and June 30, 2016</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    C Common Stock (25 votes per share) $.0001 par value; 567 shares authorized at March 31, 2017 and June 30, 2016, 383 issued
    and outstanding at March 31, 2017 and June 30, 2016</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Paid-in
    capital in excess of par value</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">176,761</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">173,702</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accumulated
    deficit</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(106,911</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(120,624</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Notes
    receivable from employee stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(19</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(24</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Treasury
    stock, at cost - 12 shares of common stock at March 31, 2017 and June 30, 2016</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(675</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(675</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Fonar Corporation Stockholder Equity</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">69,157</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">52,380</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Non
    controlling interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,268</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,396</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Stockholders' Equity</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">75,425</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">60,776</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Liabilities and Stockholders' Equity</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">91,824</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">84,888</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">*Condensed
from audited financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">See
accompanying notes to condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">CONDENSED
CONSOLIDATED STATEMENTS OF INCOME</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FOR
    THE THREE MONTHS ENDED MARCH 31</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">REVENUES</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Product
    sales - net</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">768</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">20</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Service
    and repair fees - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,366</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,406</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Service
    and repair fees - related parties - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">27</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">27</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Patient
    fee revenue, net of contractual allowances and discounts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,028</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,695</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Provision
    for bad debts for patient fee</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(3,979</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(3,830</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,592</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,394</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees - related medical practices - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,206</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,907</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Revenues - Net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">20,008</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">18,619</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">COSTS
    AND EXPENSES</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to product sales</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">364</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">263</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to service and repair fees</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">829</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">552</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to service and repair fees - related parties</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">10</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to patient fee revenue</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,744</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,549</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to management and other fees</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,122</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,649</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to management and other fees - related medical practices</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,122</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,045</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Research
    and development</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">332</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">395</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -13.5pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Selling,
    general and administrative</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,483</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,063</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Costs and Expenses</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">14,006</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">14,522</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Income
    From Operations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,002</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,097</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Interest
    Expense</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(69</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(127</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Investment
    Income</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">47</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">56</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    Income</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Income
    Before Benefit (Provision) for Income Taxes and Non Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,982</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,026</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Benefit
    (Provision) for Income Taxes</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,140</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(145</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,122</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,881</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income - Non Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(1,222</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(876</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income - Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,900</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,005</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,526</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,810</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class A Non-Voting Preferred Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">279</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">145</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class C Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">95</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">50</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.90</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.46</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.88</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.45</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    and Diluted Income Per Share-Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.25</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.13</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic Shares Outstanding - Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,166</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Diluted Shares Outstanding - Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,294</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,178</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic Shares Outstanding - Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Diluted Shares Outstanding - Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">See
accompanying notes to condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">CONDENSED
CONSOLIDATED STATEMENTS OF INCOME</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FOR
    THE NINE MONTHS ENDED MARCH 31,</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">REVENUES</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 66%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Product
    sales - net</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,103</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">780</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Service
    and repair fees - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,074</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,970</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Service
    and repair fees - related parties - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">83</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">83</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Patient
    fee revenue, net of contractual allowances and discounts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">26,509</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">24,596</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Provision
    for bad debts for patient fee</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(11,859</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(10,608</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">28,216</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">27,180</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees - related medical practices - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,020</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,598</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Revenues - Net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">57,146</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">54,599</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 5.4pt"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">COSTS
                                         AND EXPENSES</FONT></P></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to product sales</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">543</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">939</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to service and repair fees</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,168</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,542</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to service and repair fees - related parties</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">25</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">18</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to patient fee revenue</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,481</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,015</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to management and other fees</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,641</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">16,664</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    related to management and other fees - &nbsp;related medical practices</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,202</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,116</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Research
    and development</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,105</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,243</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Selling,
    general and administrative</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">12,617</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">12,125</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: 36.6pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Costs and Expenses</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">41,782</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">42,662</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Income
    From Operations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,364</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,937</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Interest
    Expense</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(244</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(416</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Investment
    Income</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">145</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">164</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    (Expense) Income</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(1</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -18.6pt; padding-left: 18.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Income
    Before Benefit (Provision) for Income Taxes and Non Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,264</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,686</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Benefit
    (Provision) for Income Taxes</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,293</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(235</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">16,557</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,451</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income - Non Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(2,844</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(2,091</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income - Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">13,713</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,360</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">12,842</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,752</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class A Non-Voting Preferred Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">649</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">453</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class C Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">222</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">155</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2.09</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.45</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2.05</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.42</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    and Diluted Income Per Share-Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.58</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.40</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic Shares Outstanding &ndash; Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,143</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Diluted Shares Outstanding &ndash; Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,271</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,178</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">

    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic Shares Outstanding &ndash; Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -18.6pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Diluted Shares Outstanding &ndash; Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">See
accompanying notes to condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FOR
    THE NINE MONTHS ENDED MARCH 31,</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
    Flows from Operating Activities:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -13.5pt; padding-left: 18.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    income</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">16,557</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 3%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,451</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -4.5pt; padding-left: 9.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Adjustments
    to reconcile net income to net cash provided by operating activities:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Depreciation
    and amortization</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,587</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,507</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Deferred
    income tax benefit - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(1,900</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Provision
    for bad debts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(38</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(300</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Stock
    issued for costs and expenses</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,239</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Compensatory
    element of stock issuances</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">27</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Stock
    option exercised</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -36.6pt; padding-left: 36.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Increase)
    decrease in operating assets, net:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts,
    medical and management fee receivable(s)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(4,476</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(3,674</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Notes
    receivable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">12</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">17</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    and estimated earnings in excess of billings on uncompleted contracts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(649</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">403</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inventories</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(596</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(43</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Prepaid
    expenses and other current assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(278</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">223</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(143</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -3.9pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Increase
    (decrease) in operating liabilities, net:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    payable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(72</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(437</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    current liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(4,008</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">576</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Customer
    advances</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(181</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(427</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Billings
    in excess of costs and estimated earnings on completed contracts</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(182</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">112</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">178</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">249</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Due
    to related medical practices</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(17</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    cash provided by operating activities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,428</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">10,300</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 5.4pt"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 0.6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
                                         Flows from Investing Activities:</FONT></P></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Purchases
    of property and equipment</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(1,774</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(534</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cost
    of patents</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(122</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(65</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    cash used in investing activities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(1,896</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(599</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 5.4pt"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 5.1pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
                                         Flows from Financing Activities:</FONT></P></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 27.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Repayment
    of borrowings and capital lease obligations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(3,431</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(1,871</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Distributions
    to non controlling interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(4,972</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(4,138</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Proceeds
    received from acquisition - net</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">88</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 27.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Repayment
    of notes receivable from employee stockholders</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    cash used in financing activities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(8,310</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(6,003</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    (Decrease) Increase in Cash and Cash Equivalents</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(778</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,698</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
    and Cash Equivalents - Beginning of Period</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,528</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,449</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
    and Cash Equivalents - End of Period</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,750</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">13,147</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">See
accompanying notes to condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 21.1pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Description
of Business</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our
business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America
and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America)
to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of
45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management
of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name &ldquo;Health Management
Company of America&rdquo;.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basis
of Presentation</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by accounting principles generally accepted in the United States
of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included. Operating results for the three and nine months ended March 31,
2017, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2017. For further
information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form
10-K filed on September 28, 2016 for the fiscal year ended June 30, 2016.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Principles
of Consolidation</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned
subsidiaries and partnerships (collectively the &ldquo;Company&rdquo;). All significant intercompany accounts and transactions
have been eliminated in consolidation.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Earnings
Per Share</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
earnings per share (&ldquo;EPS&rdquo;) is computed based on weighted average number of shares common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &ldquo;Participating Securities and the Two-Class method&rdquo;,
the Company used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating
diluted earnings per share for the three and nine months ended March 31, 2017 and March 31, 2016.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the
average market price of common shares outstanding during the period. For the three and nine months ended March 31, 2017 and March
31, 2016, diluted EPS for common shareholders includes 128 shares upon conversion of Class C Common.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Earnings
Per Share (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; vertical-align: top">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="11" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Three
                                         months ended</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31, 2017</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="11" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Three
                                         months ended</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31, 2016</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Common
    Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    C Common Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Common
    Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    C Common Stock</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Numerator:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    income available to common stockholders</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,900</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,526</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">95</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,005</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,810</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">50</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Denominator:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    average shares outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,166</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,166</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    income per common share</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.96</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.90</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.25</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.50</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.46</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.13</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><P STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted</FONT></P></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Denominator:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    average shares outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,166</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Convertible
    Class C Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">128</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">128</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    denominator for diluted earnings per share</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,294</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,178</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted
    income per common share</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.88</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.25</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.45</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.13</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; vertical-align: top">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="11" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Nine
                                         months ended</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31, 2017</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="11" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Nine
                                         months ended</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31, 2016</FONT></P></TD></TR>
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Common
    Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    C Common Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Common
    Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Class
    C Common Stock</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Numerator:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    income available to common stockholders</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">13,713</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">12,842</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">222</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,360</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,752</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">155</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Denominator:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    average shares outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,143</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,143</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    income per common share</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2.23</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2.09</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.58</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.55</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.45</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.40</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><P STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted</FONT></P></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Denominator:</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    average shares outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,143</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,050</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Convertible
    Class C Stock</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">128</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">128</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    denominator for diluted earnings per share</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,271</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,178</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted
    income per common share</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2.05</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.58</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.42</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.40</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Recent
Accounting Pronouncements</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
January 2017, the FASB issued Accounting Standards Update (&ldquo;ASU&rdquo;) 2017-04, Intangibles &ndash; Goodwill and Other
(Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment
test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets
and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed
in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill
impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on
our Consolidated Financial Statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments
in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as
acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual
periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting
this guidance on our Consolidated Financial Statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
March 2016, the FASB issued ASU No. 2016-09, &ldquo;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based
Payment Accounting&rdquo;. This update includes provisions intended to simplify various aspects of accounting for share-based
compensation. ASU No. 2016-09 will take effect for public companies for the annual periods beginning after December 15, 2016.
The Company is currently assessing the potential impact of ASU No. 2016-09 on the Company&rsquo;s consolidated condensed financial
statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or
on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability
for all leases with a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less
will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for annual reporting
periods beginning after December 15, 2018, including interim periods within that reporting period and is applied retrospectively.
Early adoption is permitted. The Company is currently in the process of assessing the impact the adoption of this guidance will
have on the Company&rsquo;s consolidated condensed financial statements.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Recent
Accounting Pronouncements (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supercedes the revenue recognition requirements
in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification.
The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an
amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This
ASU is effective for annual reporting periods beginning after December 15, 2017, as deferred including interim periods within
the reporting period and should be applied retrospectively to each prior reporting period presented or retrospectively with the
cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating
the effect that this ASU will have on its condensed consolidated financial statements and related disclosures. The Company has
not yet selected a transition method nor has it determined the effect of the standard on it ongoing financial reporting.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
July 2015, the FASB issued Accounting Standards Update No. 2015-11, &ldquo;Simplifying the Measurement of Inventory&rdquo; (&ldquo;ASU
2015-11&rdquo;). ASU 2015-11 requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable
value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal,
and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (&ldquo;LIFO&rdquo;) or
the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should
be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March
31, 2017 that will become effective in subsequent periods; however, management does not believe that any of those updates would
have significantly affected our financial accounting measures or disclosures had they been in effect during 2017 or 2016, and
it does not believe that any of those pronouncements will have a significant impact on our condensed consolidated financial statements
at the time they become effective.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Reclassifications</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Certain
prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any
effect on reported consolidated net income for any periods presented.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Receivables,
net is comprised of the following at March 31, 2017:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Gross</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Receivable</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Allowance
                                         for</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">doubtful
                                         accounts</FONT></P></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    receivable</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,879</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">265</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,614</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    receivable - related party</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">30</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">30</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medical
    receivable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">31,035</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">19,703</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,332</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees receivable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">31,512</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">13,032</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">18,480</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees receivable - related medical practices ("PC&rsquo;s")</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,648</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">393</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,255</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Receivables,
net is comprised of the following at June 30, 2016:</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Gross</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Receivable</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Allowance
                                         for</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">doubtful
                                         accounts</FONT></P></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    receivable</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,654</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">284</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,370</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
    receivable - related party</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medical
    receivable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">27,579</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">17,452</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">10,127</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees receivable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">29,584</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">13,946</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,638</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 12.6pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    and other fees receivable -&nbsp;&nbsp;related medical practices ("PC&rsquo;s")</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,457</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">393</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,064</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company's customers are concentrated in the healthcare industry.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounts
Receivable</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Credit
risk with respect to the Company&rsquo;s accounts receivable related to product sales and service and repair fees is limited due
to the customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies
are completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing
these services if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from
service and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection
terms. The Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair
fees are provided.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medical
Receivable</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare
programs, patient&rsquo;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing
in Florida. The carrying amount of the medical receivable is reduced by an allowance that reflects management&rsquo;s best estimate
of the amounts that will not be collected. The Company continuously monitors collections from its clients and maintains an allowance
for bad debts based upon the Company&rsquo;s historical collection experience. The Company determines allowances for contractual
adjustments and uncollectible accounts based on specific agings, specific payor collection issues that have been identified and
based on payor classifications and historical experience at each site.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
and Other Fees Receivable</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding
under management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical
reimbursement organizations, principally insurance companies and health management organizations.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Payment
of the management fee receivables from the PC&rsquo;s may be impaired by the inability of the PC&rsquo;s to collect in a timely
manner their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers
compensation claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims.
Approximately 62% and 59% of the PCs&rsquo; net revenues for the three months ended March 31, 2017 and 2016, respectively, were
derived from no-fault and personal injury protection claims. Approximately 62% and 60% of the PCs&rsquo; net revenues for the
nine months ended March 31, 2017 and 2016, respectively, were derived from no-fault and personal injury protection claims. The
Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company
generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables are provided
for in the condensed consolidated financial statements and have historically been within management's expectations.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
and Other Fees Receivable (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
revenues from management and other fees charged to the related PCs accounted for approximately 11.0% and 10.2% of the consolidated
net revenues for the three months ended March 31, 2017 and 2016, respectively. Net revenues from management and other fees charged
to the related PCs accounted for approximately 10.5% and 10.3% of the consolidated net revenues for the nine months ended March
31, 2017 and 2016, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to
the Company, which have arisen under each individual management agreement.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company&rsquo;s patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the three
and nine months ended March 31, 2017 and 2016 are summarized in the following tables.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
                                         the Three Months Ended</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31,</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.1pt; padding-left: 8.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Commercial
    Insurance/ Managed Care</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,228</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,245</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.1pt; padding-left: 8.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medicare/Medicaid</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">351</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">332</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.1pt; padding-left: 8.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Workers'
    Compensation/Personal Injury</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,688</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,453</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,761</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,665</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Patient
    Fee Revenue, net of contractual allowances and discounts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,028</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,695</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.1pt; padding-left: 8.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Provision
    for Bad Debts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(3,979</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(3,830</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.1pt; padding-left: 8.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Patient Fee for Revenue</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,049</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,865</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
                                         the Nine Months Ended</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31,</FONT></P></TD></TR>
<TR STYLE="text-align: center; vertical-align: top">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Commercial
    Insurance/ Managed Care</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,650</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,438</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medicare/Medicaid</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">950</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">874</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Workers'
    Compensation/Personal Injury</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">16,772</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,649</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,137</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,635</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 17.1pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Patient
    Fee Revenue, net of contractual allowances and discounts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">26,509</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">24,596</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Provision
    for Bad Debts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(11,859</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(10,608</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 17.1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Patient Fee for Revenue</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">14,650</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">13,988</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
4 - INVENTORIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inventories
included in the accompanying condensed consolidated balance sheet consist of the following:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; vertical-align: top">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
                                         30,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Purchased
    parts, components and supplies</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,391</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,862</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Work-in-process</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">279</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">212</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Inventories</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,670</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,074</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Information
relating to uncompleted contracts is as follows:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
    31, 2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
    30, 2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    incurred on uncompleted contracts</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,031</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">894</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Estimated
    earnings</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">999</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">491</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Subtotal</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,030</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,385</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Less:
    Billings to date</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,406</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,592</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Costs and estimated earnings in excess of billings on uncompleted contracts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">624</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(207</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Included
in the accompanying condensed consolidated balance sheets under the following captions:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
    31, 2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
    30, 2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
    and estimated earnings in excess of billings on uncompleted contracts</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">649</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Less:
    Billings in excess of costs and estimated earnings on uncompleted contracts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">25</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">207</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Costs and estimated earnings in excess of billings on uncompleted contracts</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">624</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(207</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
6 - OTHER INTANGIBLE ASSETS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheet consist of the following:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
                                         31,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2017</FONT></P></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1pt solid"><P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
                                         30,</FONT></P> <P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2016</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Capitalized
    software development costs</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,005</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,005</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Patents
    and copyrights</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,694</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,571</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Non-compete</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,100</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,100</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Customer
    relationships</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,800</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,800</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Gross
    Other intangible assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">19,599</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">19,476</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Less:
    Accumulated amortization</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">12,679</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,757</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
    Intangible Assets</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,920</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,719</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of patents and copyrights for the three months ended March 31, 2017 and 2016 amounted to $49 and $47, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of capitalized software development costs for the three months ended March 31, 2017 and 2016 amounted to $65 and $65, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of non-compete for the three months ended March 31, 2017 and 2016 amounted to $146 and $146, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of customer relationships for the three months ended March 31, 2017 and 2016 amounted to $48 and $47, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of patents and copyrights for the nine months ended March 31, 2017 and 2016 amounted to $145 and $141, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of capitalized software development costs for the nine months ended March 31, 2017 and 2016 amounted to $195 and $227, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of non-compete for the nine months ended March 31, 2017 and 2016 amounted to $439 and $439, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Amortization
of customer relationships for the nine months ended March 31, 2017 and 2016 amounted to $143 and $142, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
7 - OTHER CURRENT LIABILITIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
current liabilities in the accompanying condensed consolidated balance sheet consist of the following:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="text-align: center; vertical-align: top">
    <TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">March
    31, 2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">June
    30, 2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.95pt; padding-left: 8.95pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accrued
    salaries, commissions and payroll taxes</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">891</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 8%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 12%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,189</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accrued
    interest</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">45</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">45</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Litigation
    accruals</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">245</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">545</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Sales
    tax payable</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,287</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,402</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Legal
    and other professional fees</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">362</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">385</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Accounting
    fees</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">123</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">242</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Self-funded
    health insurance reserve</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">153</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">392</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Interest
    and penalty - sales tax</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,580</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,487</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">797</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,140</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Other Current Liabilities</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,483</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">10,827</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
8 - STOCKHOLDERS EQUITY</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Common
Stock</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the nine months ended March 31, 2017, the Company issued 1 shares of common stock to employees and consultants as compensation
valued at $27 under a stock bonus plan.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the nine months ended March 31, 2017, the Company issued 107 shares of common stock for costs and expenses of $2,239.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the nine months ended March 31, 2017, an option for .2 shares of common stock pursuant to a incentive stock option plan were exercised
for $2.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the nine months ended March 31, 2017, the Company issued 42 shares of common stock valued at $791 for an acquisition (see note
9)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
9 - BUSINESS COMBINATIONS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Acquisitions</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">On
March 20, 2017, the Company purchased 100% interest in Radwell Leasing LLC and Radwell LLC. The consideration and net assets acquired
is as follows:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Consideration</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Stock
    Issued</FONT></TD><TD STYLE="width: 10%; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">791</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Additional
    Cash Consideration(Less: Cash Received)</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(120</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Consideration</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">671</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Assets Acquired</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diagnostic
    Equipment</FONT></TD><TD STYLE="width: 10%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">545</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Leasehold
    Improvements</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">126</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Net Assets Acquired</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">671</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>



<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;On
June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC. The
consideration and net assets acquired is as follows:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
    Paid</FONT></TD><TD STYLE="width: 10%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 18%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,224</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    assets at Fair Value</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,862</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Goodwill</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,555</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
9 - BUSINESS COMBINATIONS (Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Acquisitions
(Continued)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Proforma
                                         Results</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
following unaudited pro forma results of operations for the three and nine months ended March 31, 2016 assumes that the above
acquisitions were made at the beginning of the year prior to acquisition. The unaudited pro forma information does not purport
to be indicative of the results that would have been obtained if the acquisitions had actually occurred at the beginning of the
year prior to acquisition, nor of the results that may be reported in the future.. The result of operations of Radwell Leasing
LLC and Radwell LLC were diminutive and did not affect the pro forma results of operations.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Three
    months ended March 31, 2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Revenues - Net</FONT></TD><TD STYLE="width: 10%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 18%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">18,619</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income - Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,096</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,895</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class A Non-Voting&nbsp;Preferred Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">150</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class C Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">51</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.48</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.47</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    and Diluted Income Per Share - Common C</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.13</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic Shares Outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,051</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Diluted Shares Outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,179</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic and Diluted Shares&nbsp;Outstanding - Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>
<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Nine
    months ended March 31, 2016</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
    Revenues - Net</FONT></TD><TD STYLE="width: 10%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 18%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">54,599</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income - Controlling Interests</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,632</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9,006</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class A Non-Voting&nbsp;&nbsp;&nbsp;Preferred Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">467</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    Income Available to Class C Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">159</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.49</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diluted
    Net Income Per Common Share Available to Common Stockholders</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.46</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Basic
    and Diluted Income Per Share - Common C</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">0.42</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic Shares Outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,051</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Diluted Shares Outstanding</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,179</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Weighted
    Average Basic and Diluted Shares&nbsp;Outstanding - Class C Common</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">383</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
10 - SEGMENT AND RELATED INFORMATION</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic
imaging centers.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies as disclosed
in the Company&rsquo;s 10-K as of June 30, 2017. All inter-segment sales are market-based. The Company evaluates performance based
on income or loss from operations.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Medical
    Equipment</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
    of Diagnostic Imaging Centers</FONT></TD><TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Totals</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
    the three months ended March 31, 2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 46%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    revenues from external customers</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3,162</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">16,846</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="width: 11%; font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">20,008</FONT></TD><TD STYLE="width: 1%; font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inter-segment
    net revenues</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">218</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">218</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Income
    from operations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">104</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5,899</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6,003</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Depreciation
    and amortization</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">81</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">787</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">868</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Capital
    expenditures</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">26</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">267</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">293</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
    the three months ended March 31, 2016</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    revenues from external customers</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,454</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">16,165</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">18,619</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inter-segment
    net revenues</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">546</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">546</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Loss)
    income from operations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(207</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">)</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,304</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4,097</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Depreciation
    and amortization</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">79</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">751</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">830</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Capital
    expenditures</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">31</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">117</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">148</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
    the nine months ended March 31, 2017</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    revenues from external customers</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8,259</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">48,887</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">57,146</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inter-segment
    net revenues</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">981</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">981</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Income
    from operations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">46</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,318</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">15,364</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Depreciation
    and amortization</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">242</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,345</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,587</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Capital
    expenditures</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">122</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,774</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,896</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
    the nine months ended March 31, 2016</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
    revenues from external customers</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7,833</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">46,766</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">54,599</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inter-segment
    net revenues</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,594</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&mdash;&nbsp;&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1,594</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Income
    from operations</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">18</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,919</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">11,937</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Depreciation
    and amortization</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">242</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,265</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2,507</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Capital
    expenditures</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">390</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">209</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">$</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">599</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: normal; font-style: normal; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD><TD STYLE="font-weight: normal; font-style: normal; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
11- SUPPLEMENTAL CASH FLOW INFORMATION</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the nine months ended March 31, 2017 and March 31, 2016, the Company paid $147 and $280 for interest, respectively.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the nine months ended March 31, 2017 and March 31, 2016, the Company paid $740 and $235 for income taxes, respectively.</FONT></P>


<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
12 - COMMITMENTS AND CONTINGENCIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Litigation</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions,
will not have a material adverse effect on the consolidated financial position or results of operations of the Company.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2016 and our form
10Q for the first and second quarters of fiscal 2017.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Other
Matters</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company is also delinquent in filing sales tax returns for certain states, for which the Company has transacted business. As of
March 31, 2017, the Company has recorded tax obligations of approximately $2,287 plus interest and penalties of approximately
$2,580. The Company is in the process of determining the regulatory requirements in order to become compliant.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit
the maximum potential liability for individual claims to $100 per person and for a maximum potential claim liability based on
member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when
estimating its health insurance program liability and related expense. As of March 31, 2017 and June 30, 2016, the Company had
approximately $153 and $377, respectively, in reserve for its self-funded health insurance programs. The reserves are included
in &ldquo;Other current liabilities&rdquo; in the condensed consolidated balance sheets.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to
its reinsurance and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment
is involved in assessing these reserves such as assessing historical paid claims, average lags between the claims&rsquo; incurred
date, reported dates and paid dates, and the frequency and severity of claims. There may be differences between actual settlement
amounts and recorded reserves and any resulting adjustments are included in expense once a probable amount is known. There were
no significant adjustments recorded in the periods covered by this report.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MARCH
31, 2017 and 2016</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Amounts
and shares in thousands, except per share amounts)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(UNAUDITED)</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
13 - INCOME TAXES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position
must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or
expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as
&ldquo;unrecognized benefits&rdquo;. A liability is recognized (or amount of net operating loss carryforward or amount of tax
refundable is reduced) for an unrecognized tax benefit because it represents an enterprise&rsquo;s potential future obligation
to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC topic 740.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable)
and would be classified as &ldquo;Interest expense, net&rdquo;. Penalties if incurred would be recognized as a component of &ldquo;Selling,
general and administrative&rdquo; expenses.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most
instances, the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior
to 2010.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company has recorded a deferred tax asset of $14,942 and a deferred tax liability of $482 as of March 31, 2017, primarily relating
to net operating loss carryforwards of approximately $110,029 available to offset future taxable income through 2031. The net
operating losses begin to expire in 2021 for federal tax purposes and in 2016 for state income tax purposes.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the three and nine months ended March 31, the Company recorded an increase in its deferred tax asset of $1,900 and $800 for 2017
respectively and $0 and $0 for 2016 respectively, in its condensed consolidated balance sheets. During the three months ended
March 31, the Company recorded a net benefit of $1,140 for 2017 and a net provision of $145 for 2016, in its condensed consolidated
statements of income. During the nine months ended March 31, the Company recorded a net benefit of $1,293 ($1,900 benefit offset
by a $607 provision) for 2017 and a net provision of $235 for 2016, in its consolidated statements of income.</FONT></P>



<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which
those temporary differences become deductible. The Company considers projected future taxable income and tax planning strategies
in making this assessment. At present, the Company does have a sufficient history of income and anticipates profitability in the
coming years and has concluded that it is more-likely-than-not that the Company will be able to realize a portion of its tax benefits
in the near future and therefore a valuation allowance was established for the partial value of the deferred tax asset.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the
valuation. Should the Company continue to remain profitable in future periods with supportable trends, the valuation allowance
will be reversed accordingly.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">NOTE
14 - SUBSEQUENT EVENTS</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company has evaluated events that occurred subsequent to March 31, 2017 and through the date the condensed consolidated financial
statements were issued.</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><P STYLE="margin-top: 0; margin-bottom: 0"></P>
                                                 <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
                                         2.</FONT></P></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">MANAGEMENT&rsquo;S
                                         DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</FONT></TD></TR></TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
the nine month period ended March 31, 2017, we reported a net income of $16.6 million on revenues of $57.1 million as compared
to net income of $11.5 million on revenues of $54.6 million for the nine month period ended March 31, 2017. Operating income increased
28.7% from $11.9 million for the nine month period ended March 31, 2016 to $15.4 million for the nine month period ended March
31, 2017.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
the three month period ended March 31, 2017, we reported net income of $7.1 million on revenues of $20.0 million as compared to
net income of $3.9 million of revenues of $18.6 million for the three month period ended March 31, 2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
revenue increase of 4.7%, from $54.6 million for the first nine months of fiscal 2016 to $57.1 million for the first nine months
of fiscal 2017, was primarily due to an increase in patient fee revenue (net of contractual allowances and discounts) from $14.0
million for the first nine months of fiscal 2016 to $14.7 million for the first nine months of fiscal 2017 and increases in net
management fees of $1.4 million, from $32.8 million for the first nine months of fiscal 2016 to $34.2 million for the first nine
months of fiscal 2017. Revenues from product sales increased from the first nine months of fiscal 2016 to the first nine months
of fiscal 2017, by $323,000 from $780,000 for the first nine months of fiscal 2016 to $1.1 million for the first nine months of
fiscal 2017.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">While
our revenues increased, our costs and expenses decreased, resulting in an operating income of $15.4 million for the nine months
ended March 31, 2017, compared to an operating income of $11.9 million for the nine months ended March 31, 2016. In terms of percentages,
costs and expenses decreased 2.1% from $42.7 million for the first nine months of fiscal 2016 to $41.8 million for the first nine
months of fiscal 2017, while revenues increased 4.7%, from $54.6 million for the first nine months of fiscal 2016 to $57.1 million
for the first nine months of fiscal 2017.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Fonar&rsquo;s
wholly-owned subsidiary, Health Management Corporation of America (&ldquo;HMCA&rdquo;), is the controlling, but not sole owner
of two limited liability companies, Imperial Management Services, LLC (&ldquo;Imperial&rdquo;) and Health Diagnostics Management,
LLC (&ldquo;HDM&rdquo;). Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic
imaging centers segment of the business. The reorganization was structured to more completely integrate the operations of HMCA
and HDM. Imperial Management Services LLC contributed all of its assets (which had been utilized in the business of HMCA) to HDM
and received a 24.2% interest in HDM. HMCA retained a direct ownership interest of 45.8% in HDM, and the original investors in
HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of the diagnostic imaging centers business
segment is now being conducted by HDM, operating under the name &ldquo;Health Management Company of America&rdquo;. For the sake
of simplicity, HMCA, Imperial and HDM are referred to as &ldquo;HMCA&rdquo;, unless otherwise indicated.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Forward
Looking Statements</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Certain
statements made in this Quarterly Report on Form 10-Q are &quot;forward-looking statements&quot; (within the meaning of the Private
Securities Litigation Reform Act of 1995) regarding the plans and objectives of Management for future operations. Such statements
involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements
to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties.
Our plans and objectives are based, in part, on assumptions involving the expansion of business. Assumptions relating to the foregoing
involve judgments with respect to, among other things, future economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we
believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate
and, therefore, there can be no assurance that the forward-looking statements included in this Report will prove to be accurate.
In light of the significant uncertainties inherent in the forward-looking statement included herein, the inclusion of such information
should not be regarded as a representation by us or any other person that our objectives and plans will be achieved.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Results
of Operations</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">We
operate in two industry segments: the manufacture and servicing of medical (MRI) equipment, which is conducted by Fonar, and diagnostic
facilities management services, which is conducted through HMCA and its subsidiaries.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Manufacturing
and Service of MRI Equipment</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Revenues
from MRI product sales increased to $1.1 million for the first nine months of fiscal 2017 from $780,000 for the first nine months
of fiscal 2016. Costs related to product sales decreased, from $939,000 for the nine month period ended March 31, 2016 to $543,000
for the nine month period ended March 31, 2017. Management believes this increase in sales revenues although positive, more likely
reflects the volatility resulting from low sales volume. Continuing tight credit and economic uncertainty, together with lower
reimbursement rates for MRI scans, have depressed the market for our MRI scanner products, notwithstanding our scanners&rsquo;
unique technological capabilities (e.g. multi positional scanning).</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Service
revenues increased 1.5% from $7.1 million for the nine month period ended March 31, 2016 to $7.2 million for the nine month period
ended March 31, 2017. Continuing lower sales volumes have been a factor ultimately contributing to the small increase in service
revenues, as the number of older scanners being taken out of service has been greater than the number of new scanners being placed
under service agreements following the expiration of their warranties.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Costs
relating to providing service for the first nine months of fiscal 2017 increased by 40.6% from $1.6 million in the first nine
months of fiscal 2016 to $2.2 million in the first nine months of fiscal 2017. We have been able to control our service costs,
however, because of our ability to monitor the performance of customers&rsquo; scanners from our facilities in Melville, New York
on a daily basis, and to detect and repair any irregularities before more serious problems result.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">There
were approximately $1.2 million in foreign revenues for the first nine months of fiscal 2017 as compared to approximately $440,000
in foreign revenues for the first nine months of fiscal 2016, representing an increase in foreign revenues of 177.63%. We do not
regard this as a material trend, but as part of a normal although sometimes volatile variation resulting from low volumes of foreign
sales.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">We
recognize MRI scanner sales revenues on the &ldquo;percentage of completion&rdquo; basis, which means the revenues are recognized
as the scanner is manufactured. Revenues recognized in a particular quarter do not necessarily reflect new orders or progress
payments made by customers in that quarter. We build the scanner as the customer meets certain benchmarks in its site preparation
in order to minimize the time lag between incurring costs of manufacturing and our receipt of the cash progress payments from
the customer which are due upon delivery. Consequently, there can be a disparity between the revenues recognized in a fiscal period
and the number of product sales. Generally, the revenues from a scanner sale are recognized in a fiscal quarter or quarters following
the quarter in which the sale was made.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Revenues
for the medical equipment segment as a whole increased by 5.5% to $8.3 million for the nine months of fiscal 2017 from $7.8 million
for the first nine months of fiscal 2016. Operating results for our medical equipment segment increased to an operating income
of $46,000 for the first nine months of fiscal 2017 as compared to an operating income of $18,000 for the first nine months of
fiscal 2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Diagnostic
Facilities Management Services</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">HMCA
revenues increased in the first nine months of fiscal 2017 by 4.5% to $48.9 million from $46.8 million for the first nine months
of fiscal 2016. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage
of our revenues derived from our medical equipment segment decreased slightly to 85.5% for the first nine months of fiscal 2017,
from 85.7% for the first nine months of fiscal 2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
increase in HMCA revenues is principally due to HMCA&rsquo;s success in marketing the scanning services of the facilities managed
or owned by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government
programs. The reductions in reimbursement rates are not unique to HMCA or HMCA&rsquo;s clients but are being experienced by the
industry in general.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">HMCA&rsquo;s
efforts are countering the effects of lower reimbursement rates by increasing the scan volume of the facilities it owns or manages.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">As
a result of our vigorous marketing efforts, the number of scans performed at our centers and at our client&rsquo;s centers increased
from 116,226 in the first nine months of fiscal 2016 to 120,462 in the first nine months of fiscal 2017.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">We
manage twenty-six sites, twenty-four of which are equipped with Fonar Upright&reg; MRI scanners (our Upright&reg; MRI Scanners
are also called Stand-Up&reg; MRI Scanners). HMCA experienced an operating income of $15.3 million for the first nine months of
fiscal 2017 compared to operating income of $11.9 million for the first nine months of fiscal 2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">HMCA&rsquo;s
cost of revenues for the first nine months of fiscal 2017 as compared to the first nine months of fiscal 2016 decreased by 5.5%
from $26.8 million to $25.3 million as a result of our continuing cost cutting measures.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Consolidated</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">For
the first nine months of fiscal 2017, our consolidated net revenues increased by 4.7% to $57.1 million from $54.6 million for
the first nine months of fiscal 2016, and total costs and expenses decreased by 2.1% to $41.8 million from $42.7 million for the
first nine months of fiscal 2017 and for the first nine months of fiscal 2016 respectively. As a result, our operating income
increased 28.7% to $15.4 million in the first nine months of fiscal 2017 from $11.9 million in the first nine months of fiscal
2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Selling,
general and administrative expenses increased by 4.1% to $12.6 million in the first nine months of fiscal 2017 from $12.1 million
in the first nine months of fiscal 2016. The compensatory element of stock issuances, which is included in selling, general and
administrative expenses, increased, $26,814 for the first nine months of fiscal 2017 from $0 for the first nine months of fiscal
2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Research
and development expenses decreased by 11.1% to $1.1 million for the first nine months of fiscal 2017 from $1.2 million for the
first nine months of fiscal 2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Interest
expense in the first nine months of fiscal 2017 decreased by 41.3% to $244,000 from $416,000 in the first three months of fiscal
2016. The decrease was due to the repayment of debt.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Inventories
increased to $2.7 million at March 31, 2017 from $2.1 million at June 30, 2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Net
management fee and medical receivables increased by 17.6% to $35.1 million at March 31, 2017 from $29.8 million at June 30, 2016
as a result of slower collections. The slower collections were primarily due to an increase in no-fault and workers&rsquo; compensation
revenue, which typically takes longer to collect.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
results of operations for the first nine months of fiscal 2017 reflect an increase in revenues from management, patient and other
fees, as compared to the first nine months of fiscal 2016 ($48.9 million for the first nine months of fiscal 2017 as compared
to $46.8 million for the first nine months of fiscal 2016), and an increase in MRI equipment segment revenues ($8.3 million as
compared to $7.8 million). Revenues were 14.5% from the MRI equipment segment as compared to 85.5% from HMCA, for the first nine
months of fiscal 2017, as compared to 14.3% from the MRI equipment segment and 85.7% from HMCA for the first nine months of fiscal
2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
implementation of the Patient Protection and Affordable Care Act (PPACA) has had a profound impact on the healthcare industry.
We are experiencing some of the impact of the Act on our business in the reduction of reimbursement rates and fewer sales of our
MRI equipment. Present efforts to repeal and replace the PPACA may result in further significant changes in the healthcare industry
and our business, the likelihood and extent of which we are not able to predict at this time.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">We
are committed to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements.
Nevertheless, factors beyond our control, such as the timing and rate of market growth, economic conditions, the availability
of credit and payor reimbursement rates, or unexpected expenditures and the timing of such expenditures, make it difficult to
forecast future operating results.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">As
mentioned, one of the effects of the PPACA on our business has been the reduction in Medicare reimbursement rates for MRI scans.
This also has resulted in a reduction in the reimbursement rates by commercial insurers and government programs which tie their
reimbursement rates to the Medicare rates. Nevertheless, the increased patient volume of the scanning centers we manage or own
has enabled us to maintain a healthy profitability in spite of these challenges. We believe we are pursuing the correct policies
to cope with these problems and to improve the Company&rsquo;s operating results. However, our future revenues and results of
operations may be adversely impacted by future reductions in reimbursement rates.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Our
Upright&reg; MRI (also referred to as the Stand-Up&reg; MRI), together with our works-in-progress, are intended to significantly
improve our competitive position.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Upright&reg; MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing,
sitting, reclining and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are
visualized in some positions and not others. This enables surgical corrections that heretofore would be unaddressable for lack
of visualizing the symptom causing the pathology and therefore, in general enables the treating physician to achieve a better
treatment outcome for his patient. A floor-recessed elevator brings the patient to the height appropriate for the targeted image
region. A custom-built multi-position adjustable bed will allow patients to sit or lie on their backs, sides or stomachs at any
angle. This allows the MRI technologist to ask the patient to position himself/herself in the exact position that generates his/her
pain so that images of the patient in the position that explicitly generates the patient&rsquo;s pain can be nailed down. Full-range-of-motion
studies of the joints in virtually any direction are possible, a particularly promising feature for sports injuries.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
addition, FONAR has announced the publication of a new book &ldquo;THE CRANIOCERVICAL SYNDROME and MRI&rdquo; that highlights
the unique attributes of FONAR UPRIGHT&reg; MRI Imaging (S. Karger, A.G. based in Basel, Switzerland- www.karger.com/Book/Home/261956)
which has been published by S. Karger, a 125 year old company and an academic publisher of scientific and medical journals and
books. The seven chapter monograph examines the rapid advances in MRI made possible by the FONAR UPRIGHT&reg; Multi-Position MRI
that are transforming the treatment of patients suffering from the craniocervical syndrome (CCS). It is written by leading international
experts in the field to practitioners with a better understanding of the subtle anatomy and MRI appearances at the craniocervical
junction, along with insight into the clinical significance of cerebrospinal fluid (CSF) flow measurements and its potential role
in generating the devastating impairments of the neurodegenerative diseases: Alzheimer&rsquo;s (5.1 million patients in the United
States), childhood and adult Autism (3.0 million), Parkinson&rsquo;s (1.0 million), Multiple Sclerosis (250,000-350,000) and Amyotrophic
Lateral Sclerosis (ALS) (30,000). It calls attention to the revolutionary importance of FONAR&rsquo;s new UPRIGHT&reg; MRI imaging
technology and the prospect of significantly relieving the suffering of the above totaled 9.38 million patients afflicted with
these disorders.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Fonar
also announced a major diagnostic breakthrough in multiple sclerosis achieved with advanced Upright&reg; MRI. Medical researchers
at FONAR published a paper reporting a diagnostic breakthrough in multiple sclerosis (MS), based on observations made possible
by the Company&rsquo;s unique Upright&reg; Multi-Position&trade; MRI scanner. The findings reveal that the cause of multiple sclerosis
may be biomechanical and related to earlier trauma to the neck, which can result in obstruction of the flow of cerebrospinal fluid
(CSF), which is produced and stored in the central anatomic structures of the brain known as the ventricles. Since the ventricles
produce a large net volume of CSF each day (500 cc), the obstruction can result in a build up of pressure within the ventricles,
resulting in leakage of the CSF and the antigenic polypeptides it contains into the surrounding brain tissue. This leakage could
be responsible for generating the brain lesions of multiple sclerosis.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
paper, titled &ldquo;The Possible Role of Cranio-Cervical Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis,&quot;
appears in the of the journal Physiological Chemistry and Physics and Medical NMR (Sept. 20, 2011).</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">This
capability of the Fonar Upright&reg; technology has demonstrated its key value on patients with the Arnold-Chiari syndrome [Cerebellar
Tonsil Extopia (CTE)], which is believed to affect 200,000 to 500,000 Americans. In this syndrome, brain stem compression and
subsequent severe neurological symptoms occur in these patients, because the brain stem descends and is compressed at the base
of the skull in the foramen magnum, which is the circular bony opening at the base of the skull where the spinal cord exits the
skull. Conventional lie-down MRI scanners cannot make an adequate evaluation of this pathology since the patient's pathology is
most visible and the symptoms most acute when the patient is scanned in the upright fully weight-bearing position.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">A
combined study of 1,200 neck pain patients published in &ldquo;Brain Injury&rdquo; (July 2010) by eight university medical centers
reported that cerebellar tonsil ectopia (CTE) of 1mm or greater was found and visualized 2.5 times (250%) more frequently when
patients who had sustained automobile whiplash injuries were scanned upright rather than lying down.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Upright&reg; MRI has also demonstrated its value for patients suffering from scoliosis. Scoliosis patients have been typically
subjected to routine x-ray exams for years and must be imaged upright for an adequate evaluation of their scoliosis. Because the
patient must be standing for a complete evaluation of the extent of the patient&rsquo;s scoliosis, an x-ray machine has been the
only modality that could provide that service. The Upright&reg; MRI is the only MRI scanner which allows the patient to stand
during the MRI exam. Fonar has developed an RF receiver and scanning protocol that for the first time allows scoliosis patients
to obtain diagnostic pictures of their spines without the risks of x-rays. A study by the National Cancer Institute (2000) of
5,466 women with scoliosis reported a 70% increase in breast cancer resulting from 24.7 chest x-rays these patients received on
the average in the course of their scoliosis treatment. The Upright&reg; MRI examination of scoliosis enables the needed imaging
evaluation of the degree of spine scoliosis without exposing the patient to the risk of breast cancer from x-radiation. Currently
scoliosis affects more than 3,000,000 American women.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
addition, the University of California, Los Angeles (UCLA) reported their results of their study of 1,302 patients utilizing the
Fonar Upright&reg; MRI at the 22nd Annual Meeting of the North American Spine Society on October 23, 2007. The UCLA study showed
the superior ability of the Fonar Upright&reg; MRI to detect spine pathology, including spondylolisthesis, disc herniations and
disc degeneration, as compared to visualizations of the spine produced by traditional single position static MRIs.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
UCLA study by MRI of 1,302 back pain patients when they were in the Fonar Upright&reg; MRI and examined in a full range of flexion
and extension positions made possible by Fonar&rsquo;s new Upright&reg; technology established that significant &ldquo;misses&rdquo;
of pathology were occurring with static single position MRI imaging. At L4-5, the vertebral level responsible for 49.8% of lumbar
disc herniations, 35.1% of the spondylolistheses (vertebral instabilities) visualized by the Upright&reg; MRI, were being missed
by static single position MRI (510 patients). Since this vertebral segment is responsible for the majority of all disc herniations,
the finding may reveal a significant cause of failed back surgeries. The UCLA study further showed the &ldquo;miss-rate&rdquo;
of vertebral instabilities by static only MRI was even higher, 38.7%, at the L3-4 vertebral segment. Additionally, the UCLA study
showed that MRI examinations of the cervical spine that did not perform extension images of the neck &ldquo;missed&rdquo; disc
bulges 23.75% of the time (163 patients).</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
UCLA study further reported that they were able to quantitatively measure the dimensions of the central spinal canal with the
&ldquo;highest accuracy&rdquo; using the FONAR Upright&reg; MRI thereby enabling the extent of spinal canal stenosis that existed
in patients to be measured. Spinal canal stenosis gives rise to the symptom complex intermittent neurogenic claudication manifest
as debilitating pain in the back and lower extremities, weakness and difficulties in ambulation and leg paresthesias. Spinal canal
stenosis is a spinal compression syndrome separate and distinct from the more common nerve compression syndrome of the spinal
nerves as they exit the vertebral column through the bony neural foramen.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Fonar Upright&reg; MRI can also be useful for MRI directed emergency neuro-surgical procedures as the surgeon would have unhindered
access to the patient&rsquo;s head when the patient is supine with no restrictions in the vertical direction. This easy-entry,
mid-field-strength scanner could prove ideal for trauma centers where a quick MRI-screening within the first critical hour of
treatment will greatly improve patients&rsquo; chances for survival and optimize the extent of recovery.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Liquidity
and Capital Resources</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
and cash equivalents decreased by 9.1% from $8.5 million at June 30, 2016 to $7.8 million at March 31, 2017, primarily as a result
of the increased purchases of property and equipment.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
provided by operating activities for the first nine months of fiscal 2017 was $9.4 million. Cash provided by operating activities
was attributable principally to net income of $16.6 million and depreciation and amortization of $2.6 million , offset by an increase
in accounts, management fee receivables and medical receivables of $4.5 million and a decrease in other current liabilities of
$4.0 million.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
used in investing activities for the first nine months of fiscal 2017 was $1.9 million. The principal uses of cash used in investing
activities during the first nine months of fiscal 2017 consisted of patent costs of $122,000 and the purchase of property and
equipment of $1.8 million.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Cash
used in financing activities for the first nine months of fiscal 2017 was $8.3 million. The principal uses of cash in financing
activities during the first nine months of fiscal 2017 were the repayment of principal on long-term debt and capital lease obligations
of $3.4 million and distributions to non-controlling interests of $5.0 million.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Total
liabilities decreased by 32.0% to $16.4 million at March 31, 2017 from $24.1 million at June 30, 2016. &ldquo;Other&rdquo; current
liabilities decreased by 30.9% to $7.5 million at March 31, 2017 from $10.8 million at June 30, 2016. Long-term debt and capital
lease obligations decreased from $2.1 million to $348,000. The current portion of our unearned revenue on service contracts decreased
from $4.7 million to $4.0 million. Customer deposits decreased from $1.2 million at June 30, 2016 to $1.0 million at March 31,
2017 as a result of reduced sales.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">As
of March 31, 2017, the total of $7.5 million in &ldquo;other&rdquo; current liabilities included accrued salaries and payroll
taxes of $891,000, and sales taxes of $2.3 million plus accrued interest and penalties of $2.6 million.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Our
working capital increased to $36.4 million at March 31, 2017 from $24.9 million at June 30, 2016. This resulted from an increase
in current assets ($45.6 million at June 30, 2016 as compared to $50.8 million at March 31, 2017), and a decrease in current liabilities
from $20.6 million at June 30, 2016 to $14.5 million at March 31, 2017.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which
those temporary differences become deductible. The Company considers projected future taxable income and tax planning strategies
in making this assessment. A valuation allowance will be maintained until sufficient positive evidence exists to support the reversal
of any portion or all of the valuation allowance. Should the Company continue to remain profitable in the future periods with
supportable trends, the valuation allowance will be reversed accordingly.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">During
the three and nine month periods ended March 31, 2017, the Company recorded an increase in its deferred tax asset of $1.1 million
and $1.9 million respectively compared to no increase for the corresponding periods in the prior years. During the three months
ended March 31, 2017 the Company recorded a net tax benefit of $1.1 million and a tax provision of $145,000 for the three months
ended March 31, 2016, in its condensed consolidated statements of income. During the nine months ended March 31, 2017 the Company
recorded a net tax benefit of $1.3 million ($1.9 million benefit offset by a $607,000 tax provision) and a net tax provision of
$235,000 for the nine months ended March 31, 2016, in its condensed consolidated statements of income.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Fonar
has not committed to making any significant capital expenditures for the remainder of the 2017 fiscal year. A new scanner was
acquired by HMCA and placed in service to a site in Florida managed by HMCA. HMCA also acquired a new facility in White Plains,
New York in March, 2017.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Critical
to our business plan are the improvement and expansion of the MRI facilities managed or owned by HMCA, and increasing the number
of scans performed at those facilities. In addition, our business plan calls for a continuing commitment to providing our customers
with enhanced equipment service and maintenance capabilities and delivering state-of-the-art, innovative and high quality equipment
and upgrades at competitive prices.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">In
furtherance of our business plan, HMCA began managing a twenty-sixth MRI scanning facility located in White Plains, New York,
in the first week of April, 2017.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Management
is seeking to promote wider market recognition of Fonar&rsquo;s scanner products, and to increase demand for Upright&reg; scanning
at the facilities HMCA owns or manages. Given the liquidity and credit constraints in the markets, and the uncertainty resulting
from the Patient Protection and Affordable Care Act or its repeal and replacement, the sale of medical equipment has and may continue
to suffer.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company believes that its business plan has been responsible for the past four consecutive fiscal years and past three fiscal
quarters of profitability (fiscal 2012, fiscal 2013, fiscal 2014, fiscal 2015, fiscal 2016 and the first nine months of fiscal
2017) and that its capital resources will be adequate to support operations at current levels through at least March 31, 2018.
In the past, the Company experienced periods of working capital deficits and prior to fiscal 2011, losses. The future effects
on our business of healthcare legislation, the Deficit Reduction Act, the 2.3% excise tax on sales of medical equipment, reimbursement
rates and the general economic and business climate are not known at the present time. Nevertheless, there is a possibility of
adverse consequences to our business operations from these causes.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
3. Quantitative and Qualitative Disclosures About Market Risk</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">The
Company maintains its funds in liquid accounts. None of our investments are in fixed rate instruments.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">All
of our revenue, expense and capital purchasing activities are transacted in United States dollars.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
4. Controls and Procedures.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Disclosure
Controls and Procedures</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">We
carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer
and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined
in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &lsquo;&lsquo;Exchange Act&rsquo;&rsquo;).
Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required
to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to
the issuer&rsquo;s management, including its principal executive and principal financial officers, or persons performing similar
functions, as appropriate to allow timely decisions regarding required disclosure. Based upon our evaluation, our chief executive
officer and chief financial officer concluded that our disclosure controls and procedures are effective, as of March 31, 2017,
in ensuring that material information that we are required to disclose in reports that we file or submit under the Exchange Act
is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules
and forms.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Changes
in Internal Control over Financial Reporting</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">There
were no changes in our system of internal control over financial reporting during the three months ended March 31, 2017 that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">PART
II &ndash; OTHER INFORMATION</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
1 &ndash; Legal Proceedings: There were no material changes in litigation from that reported in our Form 10-K for the fiscal year
ended June 30, 2016.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
1A &ndash; Risk Factors: An investment in the securities of the Company is subject to various risks, the most significant of which
are summarized below.</FONT></P>



<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">1.
Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. Our scanning
center clients and the Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare, other government
programs and private insurance companies. To date, the impact of these reductions has been countered by increasing scanning volume,
thereby maintaining profitability in this business segment. There is, however, no assurance that we will be able to continue to
do so.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">2.
Demand for MRI Scanners. The reduced reimbursement rates also affects our sales of MRI scanners negatively. With lower revenue
projections, fewer prospective customers will be able to operate, and others are likely to demand lower prices for scanners. Although
the reduced reimbursements may not affect foreign demand, a lower number of sales in the aggregate could reduce economies of scale
and consequently, profit margins.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">3.
Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly greater financial resources,
production capacity, and other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips.
Although Fonar is the only company which can manufacture and sell the unique Stand-Up&reg; (Upright&reg;) MRI scanner, potential
customers must be convinced that the purchase of a Fonar scanner is their best choice. We believe that with time, that objective
will be reached, particularly with customers scanning patients having neck, back, knee and various orthopedic issues who would
benefit from being scanned in weight-bearing positions.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">4.
Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic
imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians and other third
parties to the facilities we manage or own for the MRI scanning services performed. If these physicians and other third parties
were to reduce the number of patients they refer or discontinue referring patients, scan volumes could decrease, which would have
the effect of reducing our net revenue, from both management and scanning fees, and operating margins.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">5.
Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider
organizations is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required
to refer diagnostic imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition,
managed care contracting has become very competitive. The expansion of health maintenance organizations, preferred provider organizations
and other managed care organizations within New York or Florida could have a negative impact on the utilization and pricing of
services performed at the facilities HMCA manages or owns to the extent these organizations exert control over patients&rsquo;
access to diagnostic imaging services, selections of the provider of such services and reimbursement rates for those services.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">6.
Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities we manage or own
compete for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists,
established hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">7.
Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare through private employers, the
number of patients who are uninsured or participate in governmental programs may increase. Healthcare legislation may increase
the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage,
subject to any changes which may result from efforts to repeal and replace the PPACA. A shift in payor mix from managed care and
other private payors to government payors or an increase in the number of uninsured patients may result in a reduction in the
rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding decrease in net
revenue. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions on
whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs
and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could
increase patient financial responsibility, resulting in a greater risk of uncollectible receivables. These factors and events
could have a material adverse effect on our business, financial condition, and results of operations.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">8.
A proposal was published by the New York State Workers&rsquo; Compensation Board (&ldquo;NYSWCB&rdquo;) in 2014 to change the
fee schedule for Workers&rsquo; Compensation payments. Initially, the fees proposed would be set at approximately 130% of the
Medicare fees. This would reduce fees for the most commonly billed radiology procedures by approximately 60%. Further, since the
Workers&rsquo; Compensation fees are coupled with the New York State No Fault Program, radiology providers would suffer similar
reductions for No-Fault fees. Although we and the HMCA clients wrote to the NYSWCB to argue against this proposal, and other affected
parties commented as well, there can be no assurance that the NYSWCB will withdraw or modify this proposal, or if they elect to
do so, the extent to which the NYSWCB would modify their proposal. No further action, however, has been taken by the NYSWCB to
advance this proposal for approximately two years. A significant reduction in Workers&rsquo; Compensation and No-Fault fees could
have a material adverse impact on our business.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">9.
Federal and state privacy and information security laws. We must comply with numerous federal and state laws and regulations governing
the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security
regulations, as amended by the federal HITECH Act and collectively referred to as HIPAA. If we fail to comply with applicable
privacy and security laws, regulations and standards, properly maintain the integrity of our data, protect our proprietary rights
to our systems, or defend against cybersecurity attacks, our business, reputation, results of operations, financial position and
cash flows could be materially and adversely affected.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Information
security risks have significantly increased in recent years in part because of the proliferation of new technologies, the use
of the internet and telecommunications technologies to conduct our operations, and the increased sophistication and activities
of organized crime, hackers, terrorists and other external parties, including foreign state agents. Our operations rely on the
secure processing, transmission and storage of confidential, proprietary and other information in our computer systems and networks.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">10.
Changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic
and global economic conditions, including recession or economic slowdown and disruption of credit markets. Turbulence and uncertainty
in the United States and international markets and economies may adversely affect our liquidity, financial condition, revenues,
profitability and business operations generally.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
2 &ndash; Unregistered Sales of Equity Securities and Use of Proceeds: In March, 2017, the Company issued 42,884 shares of its
unregistered Common Stock in connection with the acquisition of an MRI facility in White Plains, New York.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
3 - Defaults Upon Senior Securities: None</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
4 - Mine Safety Disclosure: Not Applicable</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
5 - Other Information: None</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION AND SUBSIDIARIES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Item
6 - Exhibits and Reports on Form 8-K:</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">a)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit 31.1 Certification. See Exhibits</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit
32.1 Certification. See Exhibits</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Report
on Form 8-K filed on February 10, 2017, Item 2.02: Results of Operations and</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 40pt; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Financial
Condition for the fiscal quarter ended December 31, 2016.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">SIGNATURES</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">FONAR
CORPORATION</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">(Registrant)</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">By:
/s/ Timothy Damadian</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Timothy
Damadian</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">President
and Principal Executive Officer</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">/s/
Raymond V. Damadian</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Raymond
V. Damadian</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Chairman
of the Board, Treasurer and</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 3.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Acting
Principal Financial Officer</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">Dated:&#9;May
10, 2017</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: normal 10pt Arial, Helvetica, Sans-Serif; text-decoration: none"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal">&nbsp;</FONT></P>



<P STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>



<P STYLE="margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 31.1</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">CERTIFICATION</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Timothy Damadian, and Raymond V. Damadian
each certify that:</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have reviewed this report on Form 10-Q of Fonar Corporation;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented
in this report;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f) for the registrant
and have:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">designed such disclosure controls and procedures or caused such disclosure controls over procedures
to be designed under my supervision to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being
prepared;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">designed such internal control over financial reporting, or caused such internal control over financial
reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented
in this report my conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered
by this report; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting
that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case
of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors
and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">all significant deficiencies and material weaknesses in the design or operation of internal control
over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize
and report financial information; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">Any fraud, whether or not material, that involves management or other employees who have a significant
role in the registrant&rsquo;s internal control over financial reporting.</TD></TR></TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Date: May 10, 2017</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">/s/ Timothy Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Timothy Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">President and Principal Executive Officer</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">/s/ Raymond V. Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Raymond V. Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Chairman of the Board, Treasurer and</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Acting Principal Financial Officer</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Exhibit 32.1</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">CERTIFICATION PURSUANT TO</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">18 U.S.C. SECTION 1350,</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">AS ADOPTED PURSUANT TO</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">In connection with the Quarterly Report
of FONAR Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10Q for the fiscal quarter ended March 31, 2017, as filed
with the Securities and Exchange Commission on the date hereof (the &ldquo;Report&rdquo;), I, Timothy Damadian, President and Chief
Executive Officer, and I, Raymond V. Damadian, Chairman of the Board, Treasurer and Chief Financial Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Report fully complies with the requirements
of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">The information contained in the Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">/s/Timothy Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">----------------------------------</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Timothy Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">President and Chief Executive Officer</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">/s/ Raymond V. Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">-----------------------------------</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Raymond V. Damadian</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Chairman of the Board, Treasurer and</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">Chief Financial Officer</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">May 10, 2017</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">A signed original of this written statement
required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar Corporation and furnished to the Securities
and Exchange Commission or its staff upon request.</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>4
<FILENAME>fonr-20160930.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: xfr%2D3Qf17%2Dfinal.xfr; Date: 2017%2D05%2D10T18:49:42Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x802C0000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:FONR="http://fonar.com/20160930">
    <link:schemaRef xlink:href="fonr-20160930.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2017-04-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-30_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AllowanceForDoubtfulAccountsCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AllowanceForDoubtfulAccountsCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-06-30_custom_TK2EquipmentManagemenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:TK2EquipmentManagemenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_PreferredStockClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:PreferredStockClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-07-01to2017-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-07-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">FONR:Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-07-01</xbrli:startDate>
        <xbrli:endDate>2016-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-03-20">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-03-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">7750000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">8528000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">2670000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">2074000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">1059000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">759000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">50839000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">45560000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">15292000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">14513000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssets contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">509000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">732000</us-gaap:OtherAssets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">727000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">2448000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">1183000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">1254000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">7483000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">10827000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">3987000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">4679000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CustomerAdvancesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">1018000</us-gaap:CustomerAdvancesCurrent>
    <us-gaap:CustomerAdvancesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">1199000</us-gaap:CustomerAdvancesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">14451000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">20614000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">348000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">2059000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">1948000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">3498000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">16399000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">24112000</us-gaap:Liabilities>
    <us-gaap:OtherDeferredCreditsCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">28000</us-gaap:OtherDeferredCreditsCurrent>
    <us-gaap:OtherDeferredCreditsCurrent contextRef="AsOf2016-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-03-31_us-gaap_PreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2016-06-30_us-gaap_PreferredStockMember" unitRef="USDPShares" decimals="INF">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-06-30_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-03-31_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-06-30_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2016-06-30_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:Goodwill contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">3322000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">3322000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2016-06-30_custom_TK2EquipmentManagemenMember" unitRef="USD" decimals="-3">1555000</us-gaap:Goodwill>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">228000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">245000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">20000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">1103000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">780000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:SalesRevenueGoodsNet contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">768000</us-gaap:SalesRevenueGoodsNet>
    <us-gaap:MaintenanceRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">2406000</us-gaap:MaintenanceRevenue>
    <us-gaap:MaintenanceRevenue contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">7074000</us-gaap:MaintenanceRevenue>
    <us-gaap:MaintenanceRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">6970000</us-gaap:MaintenanceRevenue>
    <us-gaap:MaintenanceRevenue contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">2366000</us-gaap:MaintenanceRevenue>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">27000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">83000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">83000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">27000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <us-gaap:ManagementFeesRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">9394000</us-gaap:ManagementFeesRevenue>
    <us-gaap:ManagementFeesRevenue contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">28216000</us-gaap:ManagementFeesRevenue>
    <us-gaap:ManagementFeesRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">27180000</us-gaap:ManagementFeesRevenue>
    <us-gaap:ManagementFeesRevenue contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">9592000</us-gaap:ManagementFeesRevenue>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">1907000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">6020000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">5598000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">2206000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:CostOfGoodsSold contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">263000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">543000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">939000</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">364000</us-gaap:CostOfGoodsSold>
    <us-gaap:MaintenanceCosts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">552000</us-gaap:MaintenanceCosts>
    <us-gaap:MaintenanceCosts contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">2168000</us-gaap:MaintenanceCosts>
    <us-gaap:MaintenanceCosts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1542000</us-gaap:MaintenanceCosts>
    <us-gaap:MaintenanceCosts contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">829000</us-gaap:MaintenanceCosts>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">6000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">25000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">18000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">10000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <us-gaap:ServiceManagementCosts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">5649000</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">15641000</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">16664000</us-gaap:ServiceManagementCosts>
    <us-gaap:ServiceManagementCosts contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">5122000</us-gaap:ServiceManagementCosts>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">1045000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">3202000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">3116000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">1122000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">395000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">1105000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1243000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">332000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4063000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">12617000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">12125000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">4483000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">14522000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">41782000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">42662000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">14006000</us-gaap:CostsAndExpenses>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-876000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-2844000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-2091000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">-1222000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">3005000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">5526000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">8752000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">145000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">279000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">50000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">95000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">13713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">9360000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">12842000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">2810000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">649000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31_custom_PreferredStockClassAMember" unitRef="USD" decimals="-3">453000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2016-07-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">222000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">155000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">5900000</us-gaap:NetIncomeLoss>
    <us-gaap:AssetsNet contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">91824000</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">84888000</us-gaap:AssetsNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">18619000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">57146000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">54599000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2017-01-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">3162000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">8259000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2017-01-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">16846000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-07-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">48887000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">7833000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">46766000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">20008000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">2454000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">16165000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="USD" decimals="-3">18619000</us-gaap:SalesRevenueNet>
    <us-gaap:SalesRevenueNet contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="USD" decimals="-3">54599000</us-gaap:SalesRevenueNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">148000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">1896000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">599000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2017-01-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">26000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-07-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">122000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2017-01-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">267000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-07-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">1774000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">390000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">209000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">293000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">31000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">117000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">830000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">2587000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">2507000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2017-01-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">81000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-07-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">242000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2017-01-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">787000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-07-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">2345000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">242000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">2265000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">868000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">79000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">751000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4097000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">15364000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11937000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2017-01-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">104000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-07-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">46000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2017-01-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">5899000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-07-01to2017-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">15318000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">18000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2015-07-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">11919000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">6003000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">-207000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations contextRef="From2016-01-01to2016-03-31_custom_ManagementOfDiagnosticImagingCentersMember" unitRef="USD" decimals="-3">4304000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">546000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">981000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1594000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-01-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">218000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-07-01to2017-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">981000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-07-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">1594000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">218000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2016-01-01to2016-03-31_custom_MedicalEquipmentMember" unitRef="USD" decimals="-3">546000</us-gaap:Revenues>
    <us-gaap:ProfitLoss contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">3881000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">16557000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11451000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">7122000</us-gaap:ProfitLoss>
    <us-gaap:CustomerAdvancesAndDeposits contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">1406000</us-gaap:CustomerAdvancesAndDeposits>
    <us-gaap:CustomerAdvancesAndDeposits contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">1592000</us-gaap:CustomerAdvancesAndDeposits>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">12679000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">11757000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">6920000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">7719000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">2549000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">6481000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">7015000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">1744000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2016-01-01to2016-03-31" unitRef="Pure" decimals="INF">.59</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2016-07-01to2017-03-31" unitRef="Pure" decimals="INF">0.62</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2015-07-01to2016-03-31" unitRef="Pure" decimals="INF">0.6</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims contextRef="From2017-01-01to2017-03-31" unitRef="Pure" decimals="INF">0.62</FONR:NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2016-01-01to2016-03-31" unitRef="Pure" decimals="INF">-0.102</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2016-07-01to2017-03-31" unitRef="Pure" decimals="INF">-0.105</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2015-07-01to2016-03-31" unitRef="Pure" decimals="INF">-0.103</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs contextRef="From2017-01-01to2017-03-31" unitRef="Pure" decimals="INF">-0.11</FONR:NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs>
    <us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">2287000</us-gaap:SalesAndExciseTaxPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">2580000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">176761000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">173702000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">-19000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">-24000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:TreasuryStockValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">-675000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">-675000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">69157000</us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital>
    <us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">52380000</us-gaap:StockholdersEquityAttributableToParentNotAllowableForNetCapital>
    <us-gaap:MinorityInterest contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">6268000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">8396000</us-gaap:MinorityInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">91824000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">84888000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-06-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2016-06-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6214000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6062000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-06-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2016-06-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6202000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6051000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-03-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-06-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2016-06-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-03-31_us-gaap_PreferredStockMember" unitRef="Shares" decimals="0">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2016-06-30_us-gaap_PreferredStockMember" unitRef="Shares" decimals="0">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2016-06-30_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-03-31_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-06-30_custom_ClassANonVotingPreferredStockMember" unitRef="Shares" decimals="0">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2016-06-30_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-04-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6202242</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-04-30_us-gaap_CommonClassBMember" unitRef="Shares" decimals="0">146</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-04-30_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">382513</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2017-04-30_custom_PreferredStockClassAMember" unitRef="Shares" decimals="0">313438</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2016-01-01to2016-03-31" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2017-01-01to2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2016-07-01to2017-03-31" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2016-07-01to2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:InterestPaid contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">147000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">280000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">740000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">235000</us-gaap:IncomeTaxesPaid>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">153000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">392000</us-gaap:SelfInsuranceReserve>
    <FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">100000</FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance>
    <FONR:MedicalReceivable contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">11332000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">10127000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2016-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">27579000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2016-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">17452000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2017-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">31035000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2017-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">19703000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">18480000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">15638000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2016-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">29584000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2016-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">13946000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2017-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">31512000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2017-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">13032000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">30000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2017-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">30000</FONR:AccountsReceivableNetRelatedParty>
    <us-gaap:CommonStockValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">1000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">1000</us-gaap:CommonStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">75425000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">60776000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">14942000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">13042000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">482000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">482000</us-gaap:DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent>
    <us-gaap:BillingsInExcessOfCostCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">25000</us-gaap:BillingsInExcessOfCostCurrent>
    <us-gaap:BillingsInExcessOfCostCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">207000</us-gaap:BillingsInExcessOfCostCurrent>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">8695000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">26509000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">24596000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-07-01to2017-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">3650000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">3438000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2017-01-01to2017-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">1228000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_CommercialInsuranceManagedCareMember" unitRef="USD" decimals="-3">1245000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2017-01-01to2017-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">351000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">332000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-07-01to2017-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">950000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_MedicareMedicaidMember" unitRef="USD" decimals="-3">874000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2017-01-01to2017-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">5688000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">5453000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">15649000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-07-01to2017-03-31_custom_WorkersCompensationPersonalInjuryMember" unitRef="USD" decimals="-3">16772000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-07-01to2017-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">5137000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2015-07-01to2016-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">4635000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2016-01-01to2016-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">1665000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2017-01-01to2017-03-31_custom_OtherRevenueSourceMember" unitRef="USD" decimals="-3">1761000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:HealthCareOrganizationPatientServiceRevenue contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">9028000</us-gaap:HealthCareOrganizationPatientServiceRevenue>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-145000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">1293000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-235000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">1140000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-778000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">3698000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-8310000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-6003000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:RepaymentsOfOtherDebt contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">5000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:RepaymentsOfOtherDebt contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">6000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-4972000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-4138000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-3431000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-1871000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-1896000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-599000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-122000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-65000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-1774000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-534000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-17000</us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">178000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">249000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-181000</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInCustomerAdvances contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-427000</us-gaap:IncreaseDecreaseInCustomerAdvances>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-4008000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">576000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-72000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-437000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">223000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-143000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-278000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">9000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-596000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-43000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">12000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">17000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-4476000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-3674000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:DepreciationAndAmortization contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">2587000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">2507000</us-gaap:DepreciationAndAmortization>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-01-01to2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6166000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-01-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-07-01to2017-03-31" unitRef="Shares" decimals="0">6143000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-07-01to2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6143000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6050000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-07-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-01-01to2017-03-31" unitRef="Shares" decimals="0">6166000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="Shares" decimals="INF">6051000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="Shares" decimals="INF">6051000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="Shares" decimals="INF">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="Shares" decimals="INF">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">1031000</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:CostsIncurredOnUncompletedContracts contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">894000</FONR:CostsIncurredOnUncompletedContracts>
    <FONR:EstimatedEarnings contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">999000</FONR:EstimatedEarnings>
    <FONR:EstimatedEarnings contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">491000</FONR:EstimatedEarnings>
    <FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">2030000</FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts>
    <FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">1385000</FONR:SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">891000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">3189000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">245000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">545000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">2287000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">2402000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">362000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">385000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">123000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">242000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">2580000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">2487000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">797000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">1140000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-3830000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-11859000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-10608000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">-3979000</us-gaap:HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">5255000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">4064000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2016-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">4457000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2016-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">393000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2017-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">5648000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2017-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">393000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">624000</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">-207000</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear>
    <us-gaap:OtherLiabilities contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">890000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">712000</us-gaap:OtherLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">9428000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">10300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">3614000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">4370000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2016-06-30_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">4654000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2016-06-30_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">284000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2017-03-31_us-gaap_AccountsReceivableMember" unitRef="USD" decimals="-3">3879000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2017-03-31_us-gaap_AllowanceForDoubtfulAccountsCurrentMember" unitRef="USD" decimals="-3">265000</FONR:AccountsReceivableServiceAndRepairFees>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31" unitRef="USDPShares" decimals="INF">0.5</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-01-01to2017-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.9</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.45</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-01-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.25</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-07-01to2017-03-31" unitRef="USDPShares" decimals="INF">2.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31" unitRef="USDPShares" decimals="INF">1.55</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-07-01to2017-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-07-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.4</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-01-01to2017-03-31" unitRef="USDPShares" decimals="INF">0.96</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.49</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.42</us-gaap:EarningsPerShareBasic>
    <FONR:ProvisionForBadDebts contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-38000</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-300000</FONR:ProvisionForBadDebts>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent contextRef="AsOf2015-07-01" unitRef="Pure" decimals="INF">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4026000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">15264000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11686000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">5982000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:InvestmentIncomeNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">56000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">145000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">164000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">47000</us-gaap:InvestmentIncomeNet>
    <us-gaap:EarningsPerShareDiluted contextRef="From2017-01-01to2017-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.88</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2017-01-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.25</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-07-01to2017-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">2.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.45</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-07-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.58</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.4</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember" unitRef="USDPShares" decimals="INF">1.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="USDPShares" decimals="INF">0.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">7750000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">8528000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-06-30" unitRef="USD" decimals="-3">9449000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2016-03-31" unitRef="USD" decimals="-3">13147000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">2239000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-01-01to2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6294000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6178000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-01-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-07-01to2017-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6271000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="0">6178000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-07-01to2017-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2016-03-31_us-gaap_CommonClassCMember" unitRef="Shares" decimals="0">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="Shares" decimals="INF">6179000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="Shares" decimals="INF">6179000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="Shares" decimals="INF">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="Shares" decimals="INF">383000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">279000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">212000</us-gaap:InventoryWorkInProcess>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">2391000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">1862000</us-gaap:OtherInventorySupplies>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">19599000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">19476000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">4571000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">4100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2016-06-30_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">3800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2017-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2017-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">4694000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2017-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">4100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2017-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">3800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent contextRef="AsOf2015-07-01" unitRef="Pure" decimals="INF">0.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent contextRef="AsOf2015-07-01" unitRef="Pure" decimals="INF">0.3</FONR:OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">47000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-07-01to2017-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">145000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2017-01-01to2017-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">49000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_custom_PatentsAndCopyrightsMember" unitRef="USD" decimals="-3">141000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2017-01-01to2017-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">65000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-07-01to2017-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">195000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">65000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="USD" decimals="-3">227000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2017-01-01to2017-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">146000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-07-01to2017-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">439000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">146000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_us-gaap_NoncompeteAgreementsMember" unitRef="USD" decimals="-3">439000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2017-01-01to2017-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">48000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-07-01to2017-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">143000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2016-01-01to2016-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">47000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="From2015-07-01to2016-03-31_us-gaap_CustomerRelationshipsMember" unitRef="USD" decimals="-3">142000</us-gaap:AmortizationOfIntangibleAssets>
    <dei:EntityRegistrantName contextRef="From2016-07-01to2017-03-31">Fonar Corporation</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2016-07-01to2017-03-31">0000355019</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2016-07-01to2017-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2016-07-01to2017-03-31">2017-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2016-07-01to2017-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2016-07-01to2017-03-31">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2016-07-01to2017-03-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2016-07-01to2017-03-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2016-07-01to2017-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityFilerCategory contextRef="From2016-07-01to2017-03-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2016-07-01to2017-03-31">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2016-07-01to2017-03-31">2017</dei:DocumentFiscalYearFocus>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">45000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">45000</us-gaap:InterestPayableCurrent>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4097000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">15364000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">11937000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">6002000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:InterestExpense contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">-127000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-244000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">-416000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">-69000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-1000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">1000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">2000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">4865000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">14650000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">13988000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
    <us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">5049000</us-gaap:HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">27000</us-gaap:StockIssuedDuringPeriodValueEmployeeBenefitPlan>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">-106911000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2016-06-30" unitRef="USD" decimals="-3">-120624000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">649000</us-gaap:CostsInExcessOfBillingsOnUncompletedContractsOrPrograms>
    <FONR:SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares. contextRef="From2016-07-01to2017-03-31" unitRef="Shares" decimals="0">107000</FONR:SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares.>
    <FONR:ValueOfSharesIssuedToEmployeesAsCompensationValue. contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">27000</FONR:ValueOfSharesIssuedToEmployeesAsCompensationValue.>
    <FONR:ValueOfSharesIssuedInSettlementOfLiabilitiesValue. contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">2239000</FONR:ValueOfSharesIssuedInSettlementOfLiabilitiesValue.>
    <FONR:NetAssetsAtFairValue contextRef="AsOf2016-06-30_custom_TK2EquipmentManagemenMember" unitRef="USD" decimals="-3">2862000</FONR:NetAssetsAtFairValue>
    <FONR:CashPaid contextRef="AsOf2016-06-30_custom_TK2EquipmentManagemenMember" unitRef="USD" decimals="-3">4224000</FONR:CashPaid>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Description&#13;of Business&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Effective&#13;July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our&#13;business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America&#13;and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America)&#13;to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of&#13;45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management&#13;of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name &amp;#8220;Health Management&#13;Company of America&amp;#8221;.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basis&#13;of Presentation&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting&#13;principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly,&#13;they do not include all of the information and footnotes required by accounting principles generally accepted in the United States&#13;of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals)&#13;considered necessary for a fair presentation have been included. Operating results for the three and nine months ended March 31,&#13;2017, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2017. For further&#13;information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form&#13;10-K filed on September 28, 2016 for the fiscal year ended June 30, 2016.&lt;/font&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;MARCH 31, 2017 and 2016&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(Amounts and shares in thousands, except per&#13;share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Principles&#13;of Consolidation&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned&#13;subsidiaries and partnerships (collectively the &amp;#8220;Company&amp;#8221;). All significant intercompany accounts and transactions&#13;have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings&#13;Per Share&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&#13;earnings per share (&amp;#8220;EPS&amp;#8221;) is computed based on weighted average number of shares common stock and stock equivalents&#13;outstanding, net of common stock. In accordance with ASC topic 260-10, &amp;#8220;Participating Securities and the Two-Class method&amp;#8221;,&#13;the Company used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating&#13;diluted earnings per share for the three and nine months ended March 31, 2017 and March 31, 2016.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&#13;EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the&#13;average market price of common shares outstanding during the period. For the three and nine months ended March 31, 2017 and March&#13;31, 2016, diluted EPS for common shareholders includes 128 shares upon conversion of Class C Common.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Numerator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,900&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,526&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;95&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;3,005&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2,810&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;50&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.96&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.25&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.46&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;p style="font-weight: normal; font-style: normal"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,294&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.88&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.25&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Numerator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,713&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;12,842&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;222&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;9,360&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;8,752&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;p style="font-weight: normal; font-style: normal"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,271&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.05&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Recent&#13;Accounting Pronouncements&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;January 2017, the FASB issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2017-04, Intangibles &amp;#8211; Goodwill and Other&#13;(Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment&#13;test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets&#13;and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed&#13;in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill&#13;impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on&#13;our Consolidated Financial Statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments&#13;in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as&#13;acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual&#13;periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting&#13;this guidance on our Consolidated Financial Statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;March 2016, the FASB issued ASU No. 2016-09, &amp;#8220;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based&#13;Payment Accounting&amp;#8221;. This update includes provisions intended to simplify various aspects of accounting for share-based&#13;compensation. ASU No. 2016-09 will take effect for public companies for the annual periods beginning after December 15, 2016.&#13;The Company is currently assessing the potential impact of ASU No. 2016-09 on the Company&amp;#8217;s consolidated condensed financial&#13;statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying&#13;leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase&#13;by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or&#13;on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability&#13;for all leases with a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less&#13;will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for annual reporting&#13;periods beginning after December 15, 2018, including interim periods within that reporting period and is applied retrospectively.&#13;Early adoption is permitted. The Company is currently in the process of assessing the impact the adoption of this guidance will&#13;have on the Company&amp;#8217;s consolidated condensed financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supercedes the revenue recognition requirements&#13;in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification.&#13;The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an&#13;amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This&#13;ASU is effective for annual reporting periods beginning after December 15, 2017, as deferred including interim periods within&#13;the reporting period and should be applied retrospectively to each prior reporting period presented or retrospectively with the&#13;cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating&#13;the effect that this ASU will have on its condensed consolidated financial statements and related disclosures. The Company has&#13;not yet selected a transition method nor has it determined the effect of the standard on it ongoing financial reporting.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;July 2015, the FASB issued Accounting Standards Update No. 2015-11, &amp;#8220;Simplifying the Measurement of Inventory&amp;#8221; (&amp;#8220;ASU&#13;2015-11&amp;#8221;). ASU 2015-11 requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable&#13;value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal,&#13;and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (&amp;#8220;LIFO&amp;#8221;) or&#13;the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should&#13;be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FASB,&#13;the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March&#13;31, 2017 that will become effective in subsequent periods; however, management does not believe that any of those updates would&#13;have significantly affected our financial accounting measures or disclosures had they been in effect during 2017 or 2016, and&#13;it does not believe that any of those pronouncements will have a significant impact on our condensed consolidated financial statements&#13;at the time they become effective.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Reclassifications&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Certain&#13;prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any&#13;effect on reported consolidated net income for any periods presented.&lt;/font&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivables,&#13;net is comprised of the following at March 31, 2017:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance for&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;doubtful accounts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;3,879&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;265&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;3,614&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Medical receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;31,035&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;19,703&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;11,332&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;31,512&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,032&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;18,480&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable - related medical practices ("PC&amp;#8217;s")&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,648&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;393&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,255&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivables,&#13;net is comprised of the following at June 30, 2016:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance for&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;doubtful accounts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,654&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;284&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,370&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Medical receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;27,579&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;17,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;10,127&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;29,584&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,946&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;15,638&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable -&amp;#160;&amp;#160;related medical practices ("PC&amp;#8217;s")&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,457&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;393&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,064&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company's customers are concentrated in the healthcare industry.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts&#13;Receivable&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Credit&#13;risk with respect to the Company&amp;#8217;s accounts receivable related to product sales and service and repair fees is limited due&#13;to the customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies&#13;are completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing&#13;these services if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from&#13;service and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection&#13;terms. The Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair&#13;fees are provided.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical&#13;Receivable&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical&#13;receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare&#13;programs, patient&amp;#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing&#13;in Florida. The carrying amount of the medical receivable is reduced by an allowance that reflects management&amp;#8217;s best estimate&#13;of the amounts that will not be collected. The Company continuously monitors collections from its clients and maintains an allowance&#13;for bad debts based upon the Company&amp;#8217;s historical collection experience. The Company determines allowances for contractual&#13;adjustments and uncollectible accounts based on specific agings, specific payor collection issues that have been identified and&#13;based on payor classifications and historical experience at each site.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management&#13;and Other Fees Receivable&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding&#13;under management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical&#13;reimbursement organizations, principally insurance companies and health management organizations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Payment&#13;of the management fee receivables from the PC&amp;#8217;s may be impaired by the inability of the PC&amp;#8217;s to collect in a timely&#13;manner their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers&#13;compensation claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims.&#13;Approximately 62% and 59% of the PCs&amp;#8217; net revenues for the three months ended March 31, 2017 and 2016, respectively, were&#13;derived from no-fault and personal injury protection claims. Approximately 62% and 60% of the PCs&amp;#8217; net revenues for the&#13;nine months ended March 31, 2017 and 2016, respectively, were derived from no-fault and personal injury protection claims. The&#13;Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company&#13;generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables are provided&#13;for in the condensed consolidated financial statements and have historically been within management's expectations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&#13;revenues from management and other fees charged to the related PCs accounted for approximately 11.0% and 10.2% of the consolidated&#13;net revenues for the three months ended March 31, 2017 and 2016, respectively. Net revenues from management and other fees charged&#13;to the related PCs accounted for approximately 10.5% and 10.3% of the consolidated net revenues for the nine months ended March&#13;31, 2017 and 2016, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Tallahassee&#13;Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;#38; Diagnostic Center, PA (all related medical&#13;practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to&#13;the Company, which have arisen under each individual management agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company&amp;#8217;s patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the three&#13;and nine months ended March 31, 2017 and 2016 are summarized in the following tables.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the Three Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,228&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,245&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;351&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;332&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;5,688&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;5,453&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Other&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,761&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,665&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;9,028&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;8,695&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(3,979&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(3,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,049&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the Nine Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;3,650&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;3,438&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;950&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;874&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;16,772&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;15,649&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Other&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;5,137&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;4,635&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;26,509&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;24,596&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(11,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(10,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;14,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,988&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;4 - INVENTORIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inventories&#13;included in the accompanying condensed consolidated balance sheet consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June 30,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Purchased parts, components and supplies&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;2,391&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,862&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;212&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Inventories&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2,670&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <FONR:CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;MARCH 31, 2017 and 2016&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(Amounts and shares in thousands, except per&#13;share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Information&#13;relating to uncompleted contracts is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;June 30, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Costs incurred on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,031&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;894&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;Estimated earnings&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;999&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Subtotal&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,030&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,385&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;Less: Billings to date&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,406&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,592&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;624&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Included&#13;in the accompanying condensed consolidated balance sheets under the following captions:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;June 30, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;649&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Less: Billings in excess of costs and estimated earnings on uncompleted contracts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;25&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;624&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;</FONR:CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;6 - OTHER INTANGIBLE ASSETS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&#13;intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheet consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June 30,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Capitalized software development costs&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Patents and copyrights&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,694&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,571&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Non-compete&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,100&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,100&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Gross Other intangible assets&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;19,599&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;19,476&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;12,679&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;11,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 8.85pt"&gt;Other Intangible Assets&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;7,719&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of patents and copyrights for the three months ended March 31, 2017 and 2016 amounted to $49 and $47, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of capitalized software development costs for the three months ended March 31, 2017 and 2016 amounted to $65 and $65, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of non-compete for the three months ended March 31, 2017 and 2016 amounted to $146 and $146, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of customer relationships for the three months ended March 31, 2017 and 2016 amounted to $48 and $47, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of patents and copyrights for the nine months ended March 31, 2017 and 2016 amounted to $145 and $141, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of capitalized software development costs for the nine months ended March 31, 2017 and 2016 amounted to $195 and $227, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of non-compete for the nine months ended March 31, 2017 and 2016 amounted to $439 and $439, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization&#13;of customer relationships for the nine months ended March 31, 2017 and 2016 amounted to $143 and $142, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;7 - OTHER CURRENT LIABILITIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&#13;current liabilities in the accompanying condensed consolidated balance sheet consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;June 30, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.95pt; padding-left: 8.95pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;891&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;3,189&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;45&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;45&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Litigation accruals&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;245&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;545&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Sales tax payable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,402&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Legal and other professional fees&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;362&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;385&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Accounting fees&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;123&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;242&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Self-funded health insurance reserve&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;153&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;392&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Interest and penalty - sales tax&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,580&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,487&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Other Current Liabilities&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;7,483&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;10,827&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;MARCH 31, 2017 and 2016&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(Amounts and shares in thousands, except per&#13;share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;8 - STOCKHOLDERS EQUITY&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common&#13;Stock&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;the nine months ended March 31, 2017, the Company issued 1 shares of common stock to employees and consultants as compensation&#13;valued at $27 under a stock bonus plan.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;the nine months ended March 31, 2017, the Company issued 107 shares of common stock for costs and expenses of $2,239.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;the nine months ended March 31, 2017, an option for .2 shares of common stock pursuant to a incentive stock option plan were exercised&#13;for $2.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;the nine months ended March 31, 2017, the Company issued 42 shares of common stock valued at $791 for an acquisition (see note&#13;9)&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;9 - BUSINESS COMBINATIONS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Acquisitions&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;On&#13;March 20, 2017, the Company purchased 100% interest in Radwell Leasing LLC and Radwell LLC. The consideration and net assets acquired&#13;is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: top"&gt;Consideration&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Stock Issued&lt;/td&gt;&lt;td style="width: 10%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;791&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Additional Cash Consideration(Less: Cash Received)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(120&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total Consideration&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;671&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center; vertical-align: top; border-bottom: Black 1pt solid"&gt;Net Assets Acquired&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; text-align: left; padding-left: 5.4pt"&gt;Diagnostic Equipment&lt;/td&gt;&lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;545&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Leasehold Improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total Net Assets Acquired&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;671&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;On&#13;June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC. The&#13;consideration and net assets acquired is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Cash Paid&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;4,224&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net assets at Fair Value&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,862&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Goodwill&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,555&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Pro&#13;forma Results&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;following unaudited pro forma results of operations for the three and nine months ended March 31, 2016 assumes that the above&#13;acquisitions were made at the beginning of the year prior to acquisition. The unaudited pro forma information does not purport&#13;to be indicative of the results that would have been obtained if the acquisitions had actually occurred at the beginning of the&#13;year prior to acquisition, nor of the results that may be reported in the future.. The result of operations of Radwell Leasing&#13;LLC and Radwell LLC were diminutive and did not affect the pro forma results of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Three months ended March 31, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Total Revenues - Net&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;18,619&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income - Controlling Interests&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;3,096&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,895&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class A Non-Voting&amp;#160;Preferred Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;150&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class C Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;51&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.48&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.47&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic and Diluted Income Per Share - Common C&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,051&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Diluted Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,179&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic and Diluted Shares&amp;#160;Outstanding - Class C Common&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Nine months ended March 31, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Total Revenues - Net&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;54,599&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income - Controlling Interests&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;9,632&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;9,006&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class A Non-Voting&amp;#160;&amp;#160;&amp;#160;Preferred Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;467&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class C Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;159&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1.49&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1.46&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic and Diluted Income Per Share - Common C&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.42&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,051&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Diluted Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,179&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic and Diluted Shares&amp;#160;Outstanding - Class C Common&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;10 - SEGMENT AND RELATED INFORMATION&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic&#13;imaging centers.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;accounting policies of the segments are the same as those described in the summary of significant accounting policies as disclosed&#13;in the Company&amp;#8217;s 10-K as of June 30, 2017. All inter-segment sales are market-based. The Company evaluates performance based&#13;on income or loss from operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Summarized&#13;financial information concerning the Company's reportable segments is shown in the following table:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;Medical Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;Management of Diagnostic Imaging Centers&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;Totals&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the three months ended March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"&gt;3,162&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"&gt;16,846&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"&gt;20,008&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;218&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;218&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;104&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;5,899&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,003&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;81&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;787&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;868&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;26&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;267&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;293&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the three months ended March 31, 2016&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,454&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;16,165&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;18,619&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;546&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;546&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;(Loss) income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,304&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,097&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;79&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;751&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;830&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;31&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;117&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;148&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the nine months ended March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;8,259&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;48,887&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;57,146&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;981&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;981&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;46&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;15,318&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;15,364&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;242&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,345&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,587&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;122&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,774&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,896&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the nine months ended March 31, 2016&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;7,833&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;46,766&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;54,599&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,594&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,594&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;18&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;11,919&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;11,937&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;242&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,265&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,507&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;390&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;209&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;599&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;11-  SUPPLEMENTAL CASH FLOW INFORMATION&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;the nine months ended March 31, 2017 and March 31, 2016, the Company paid $147 and $280 for interest, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;the nine months ended March 31, 2017 and March 31, 2016, the Company paid $740 and $235 for income taxes, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;MARCH 31, 2017 and 2016&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(Amounts and shares in thousands, except per&#13;share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;12 - COMMITMENTS AND CONTINGENCIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Litigation&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury,&#13;customer contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions,&#13;will not have a material adverse effect on the consolidated financial position or results of operations of the Company.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;There&#13;were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2016 and our form&#13;10Q for the first and second quarters of fiscal 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&#13;Matters&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company is also delinquent in filing sales tax returns for certain states, for which the Company has transacted business. As of&#13;March 31, 2017, the Company has recorded tax obligations of approximately $2,287 plus interest and penalties of approximately&#13;$2,580. The Company is in the process of determining the regulatory requirements in order to become compliant.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit&#13;the maximum potential liability for individual claims to $100 per person and for a maximum potential claim liability based on&#13;member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when&#13;estimating its health insurance program liability and related expense. As of March 31, 2017 and June 30, 2016, the Company had&#13;approximately $153 and $392, respectively, in reserve for its self-funded health insurance programs. The reserves are included&#13;in &amp;#8220;Other current liabilities&amp;#8221; in the condensed consolidated balance sheets.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to&#13;its reinsurance and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment&#13;is involved in assessing these reserves such as assessing historical paid claims, average lags between the claims&amp;#8217; incurred&#13;date, reported dates and paid dates, and the frequency and severity of claims. There may be differences between actual settlement&#13;amounts and recorded reserves and any resulting adjustments are included in expense once a probable amount is known. There were&#13;no significant adjustments recorded in the periods covered by this report.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FONAR&#13;CORPORATION AND SUBSIDIARIES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTES&#13;TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;MARCH&#13;31, 2017 and 2016&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Amounts&#13;and shares in thousands, except per share amounts)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(UNAUDITED)&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;13 - INCOME TAXES&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;ASC&#13;topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement&#13;of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position&#13;must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or&#13;expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as&#13;&amp;#8220;unrecognized benefits&amp;#8221;. A liability is recognized (or amount of net operating loss carryforward or amount of tax&#13;refundable is reduced) for an unrecognized tax benefit because it represents an enterprise&amp;#8217;s potential future obligation&#13;to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC topic 740.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable)&#13;and would be classified as &amp;#8220;Interest expense, net&amp;#8221;. Penalties if incurred would be recognized as a component of &amp;#8220;Selling,&#13;general and administrative&amp;#8221; expenses.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most&#13;instances, the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior&#13;to 2010.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company has recorded a deferred tax asset of $14,942 and a deferred tax liability of $482 as of March 31, 2017, primarily relating&#13;to net operating loss carryforwards of approximately $110,029 available to offset future taxable income through 2031. The net&#13;operating losses begin to expire in 2021 for federal tax purposes and in 2016 for state income tax purposes.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;the three and nine months ended March 31, the Company recorded an increase in its deferred tax asset of $1,900 and $800 for 2017&#13;respectively and $0 and $0 for 2016 respectively, in its condensed consolidated balance sheets. During the three months ended&#13;March 31, the Company recorded a net benefit of $1,140 for 2017 and a net provision of $145 for 2016, in its condensed consolidated&#13;statements of income. During the nine months ended March 31, the Company recorded a net benefit of $1,293 ($1,900 benefit offset&#13;by a $607 provision) for 2017 and a net provision of $235 for 2016, in its consolidated statements of income.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which&#13;those temporary di&lt;/font&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;fferences&#13;become deductible. The Company considers projected future taxable income and tax planning strategies in making this assessment.&#13;At present, the Company does have a sufficient history of income and anticipates profitability in the coming years and has concluded&#13;that it is more-likely-than-not that the Company will be able to realize a portion of its tax benefits in the near future and&#13;therefore a valuation allowance was established for the partial value of the deferred tax asset.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;A&#13;valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the&#13;valuation. Should the Company continue to remain profitable in future periods with supportable trends, the valuation allowance&#13;will be reversed accordingly.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;FONAR CORPORATION AND SUBSIDIARIES&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;MARCH 31, 2017 and 2016&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(Amounts and shares in thousands, except per&#13;share amounts)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;(UNAUDITED)&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE&#13;14 - SUBSEQUENT EVENTS&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company has evaluated events that occurred subsequent to March 31, 2017 and through the date the condensed consolidated financial&#13;statements were issued.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Principles&#13;of Consolidation&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned&#13;subsidiaries and partnerships (collectively the &amp;#8220;Company&amp;#8221;). All significant intercompany accounts and transactions&#13;have been eliminated in consolidation.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings&#13;Per Share&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&#13;earnings per share (&amp;#8220;EPS&amp;#8221;) is computed based on weighted average number of shares common stock and stock equivalents&#13;outstanding, net of common stock. In accordance with ASC topic 260-10, &amp;#8220;Participating Securities and the Two-Class method&amp;#8221;,&#13;the Company used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating&#13;diluted earnings per share for the three and nine months ended March 31, 2017 and March 31, 2016.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&#13;EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the&#13;average market price of common shares outstanding during the period. For the three and nine months ended March 31, 2017 and March&#13;31, 2016, diluted EPS for common shareholders includes 128 shares upon conversion of Class C Common.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Numerator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,900&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,526&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;95&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;3,005&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2,810&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;50&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.96&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.25&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.46&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;p style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;u&gt;Diluted&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,294&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.88&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.25&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Numerator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,713&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;12,842&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;222&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;9,360&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;8,752&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;p style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,271&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.05&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Recent&#13;Accounting Pronouncements&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;January 2017, the FASB issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2017-04, Intangibles &amp;#8211; Goodwill and Other&#13;(Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment&#13;test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets&#13;and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed&#13;in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill&#13;impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on&#13;our Consolidated Financial Statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments&#13;in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as&#13;acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual&#13;periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting&#13;this guidance on our Consolidated Financial Statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;March 2016, the FASB issued ASU No. 2016-09, &amp;#8220;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based&#13;Payment Accounting&amp;#8221;. This update includes provisions intended to simplify various aspects of accounting for share-based&#13;compensation. ASU No. 2016-09 will take effect for public companies for the annual periods beginning after December 15, 2016.&#13;The Company is currently assessing the potential impact of ASU No. 2016-09 on the Company&amp;#8217;s consolidated condensed financial&#13;statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During&#13;February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying&#13;leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase&#13;by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or&#13;on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability&#13;for all leases with a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less&#13;will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for annual reporting&#13;periods beginning after December 15, 2018, including interim periods within that reporting period and is applied retrospectively.&#13;Early adoption is permitted. The Company is currently in the process of assessing the impact the adoption of this guidance will&#13;have on the Company&amp;#8217;s consolidated condensed financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supercedes the revenue recognition requirements&#13;in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification.&#13;The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an&#13;amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This&#13;ASU is effective for annual reporting periods beginning after December 15, 2017, as deferred including interim periods within&#13;the reporting period and should be applied retrospectively to each prior reporting period presented or retrospectively with the&#13;cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating&#13;the effect that this ASU will have on its condensed consolidated financial statements and related disclosures. The Company has&#13;not yet selected a transition method nor has it determined the effect of the standard on it ongoing financial reporting.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In&#13;July 2015, the FASB issued Accounting Standards Update No. 2015-11, &amp;#8220;Simplifying the Measurement of Inventory&amp;#8221; (&amp;#8220;ASU&#13;2015-11&amp;#8221;). ASU 2015-11 requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable&#13;value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal,&#13;and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (&amp;#8220;LIFO&amp;#8221;) or&#13;the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should&#13;be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FASB,&#13;the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March&#13;31, 2017 that will become effective in subsequent periods; however, management does not believe that any of those updates would&#13;have significantly affected our financial accounting measures or disclosures had they been in effect during 2017 or 2016, and&#13;it does not believe that any of those pronouncements will have a significant impact on our condensed consolidated financial statements&#13;at the time they become effective.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Reclassifications&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Certain&#13;prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any&#13;effect on reported consolidated net income for any periods presented.&lt;/font&gt;&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 14pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;Earnings&#13;Per Share&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Numerator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,900&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,526&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;95&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;3,005&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2,810&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;50&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.96&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.90&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.25&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.50&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.46&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;p style="font-weight: normal; font-style: normal"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,166&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,294&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.88&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.25&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="11" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Nine months ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31, 2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;u&gt;Basic&lt;/u&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Class C Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Total&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Common Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Class C Common Stock&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Numerator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Net income available to common stockholders&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,713&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;12,842&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;222&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;9,360&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;8,752&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;155&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Basic income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.23&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.09&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.55&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.45&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"&gt;&lt;p style="font-weight: normal; font-style: normal"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid"&gt;Denominator:&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Weighted average shares outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,143&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,050&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Convertible Class C Stock&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;128&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom"&gt;Total denominator for diluted earnings per share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,271&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,178&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt"&gt;Diluted income per common share&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2.05&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.58&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;1.42&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;0.40&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivables,&#13;net is comprised of the following at March 31, 2017:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance for&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;doubtful accounts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;3,879&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;265&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;3,614&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;30&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Medical receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;31,035&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;19,703&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;11,332&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;31,512&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,032&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;18,480&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable - related medical practices ("PC&amp;#8217;s")&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,648&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;393&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,255&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivables,&#13;net is comprised of the following at June 30, 2016:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivable&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance for&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;doubtful accounts&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;Net&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%"&gt;Accounts receivable&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,654&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;284&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,370&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Accounts receivable - related party&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Medical receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;27,579&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;17,452&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;10,127&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;29,584&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,946&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;15,638&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Management and other fees receivable -&amp;#160;&amp;#160;related medical practices ("PC&amp;#8217;s")&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,457&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;393&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,064&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock>
    <us-gaap:ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;Company&amp;#8217;s patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the three&#13;and nine months ended March 31, 2017 and 2016 are summarized in the following tables.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the Three Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,228&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,245&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;351&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;332&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;5,688&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;5,453&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Other&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,761&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,665&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;9,028&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;8,695&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(3,979&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(3,830&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;5,049&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;4,865&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For the Nine Months Ended&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%"&gt;Commercial Insurance/ Managed Care&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;3,650&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;3,438&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.1pt; padding-left: 8.1pt"&gt;Medicare/Medicaid&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;950&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;874&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Workers' Compensation/Personal Injury&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;16,772&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;15,649&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Other&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;5,137&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;4,635&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Patient Fee Revenue, net of contractual allowances and discounts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.1pt; padding-left: 8.1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;26,509&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;24,596&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Provision for Bad Debts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(11,859&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;(10,608&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom"&gt;Net Patient Fee for Revenue&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;14,650&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;13,988&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inventories&#13;included in the accompanying condensed consolidated balance sheet consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June 30,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Purchased parts, components and supplies&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;2,391&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,862&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Work-in-process&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;279&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;212&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Inventories&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2,670&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;2,074&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <FONR:CustomerAdvancesTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Information&#13;relating to uncompleted contracts is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;June 30, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Costs incurred on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;1,031&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;894&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;Estimated earnings&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;999&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;491&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt"&gt;Subtotal&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,030&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,385&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt"&gt;Less: Billings to date&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,406&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,592&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;624&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</FONR:CustomerAdvancesTableTextBlock>
    <FONR:IncludedInAccompanyingCondensedConsolidatedBalanceSheets contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Included&#13;in the accompanying condensed consolidated balance sheets under the following captions:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top"&gt;June 30, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;649&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Less: Billings in excess of costs and estimated earnings on uncompleted contracts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;25&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;207&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom"&gt;Total Costs and estimated earnings in excess of billings on uncompleted contracts&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;624&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</FONR:IncludedInAccompanyingCondensedConsolidatedBalanceSheets>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&#13;intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheet consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;March 31,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2017&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June 30,&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2016&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Capitalized software development costs&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;7,005&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Patents and copyrights&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,694&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,571&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Non-compete&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,100&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,100&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt"&gt;Customer relationships&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;3,800&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt"&gt;Gross Other intangible assets&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;19,599&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;19,476&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt"&gt;Less: Accumulated amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;12,679&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;11,757&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 8.85pt"&gt;Other Intangible Assets&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;6,920&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;7,719&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&#13;current liabilities in the accompanying condensed consolidated balance sheet consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="text-align: center; vertical-align: top"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid"&gt;June 30, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.95pt; padding-left: 8.95pt"&gt;Accrued salaries, commissions and payroll taxes&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;891&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 8%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-weight: normal; font-style: normal; text-align: right"&gt;3,189&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Accrued interest&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;45&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;45&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Litigation accruals&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;245&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;545&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Sales tax payable&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,287&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,402&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Legal and other professional fees&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;362&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;385&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Accounting fees&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;123&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;242&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Self-funded health insurance reserve&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;153&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;392&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Interest and penalty - sales tax&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,580&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,487&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Other&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;797&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right"&gt;1,140&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;Total Other Current Liabilities&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;7,483&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right"&gt;10,827&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0.9pt 0 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Pro&#13;forma Results&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The&#13;following unaudited pro forma results of operations for the three and nine months ended March 31, 2016 assumes that the above&#13;acquisitions were made at the beginning of the year prior to acquisition. The unaudited pro forma information does not purport&#13;to be indicative of the results that would have been obtained if the acquisitions had actually occurred at the beginning of the&#13;year prior to acquisition, nor of the results that may be reported in the future.. The result of operations of Radwell Leasing&#13;LLC and Radwell LLC were diminutive and did not affect the pro forma results of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Three months ended March 31, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Total Revenues - Net&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;18,619&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income - Controlling Interests&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;3,096&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,895&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class A Non-Voting&amp;#160;Preferred Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;150&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class C Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;51&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.48&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.47&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic and Diluted Income Per Share - Common C&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,051&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Diluted Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,179&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic and Diluted Shares&amp;#160;Outstanding - Class C Common&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom"&gt;Nine months ended March 31, 2016&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Total Revenues - Net&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;54,599&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income - Controlling Interests&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;9,632&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;9,006&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class A Non-Voting&amp;#160;&amp;#160;&amp;#160;Preferred Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;467&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Net Income Available to Class C Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;159&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1.49&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Diluted Net Income Per Common Share Available to Common Stockholders&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1.46&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Basic and Diluted Income Per Share - Common C&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;0.42&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,051&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Diluted Shares Outstanding&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,179&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt"&gt;Weighted Average Basic and Diluted Shares&amp;#160;Outstanding - Class C Common&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;383&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&amp;#160;&lt;/p&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Summarized&#13;financial information concerning the Company's reportable segments is shown in the following table:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;Medical Equipment&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;Management of Diagnostic Imaging Centers&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center; border-bottom: Black 1pt solid"&gt;Totals&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the three months ended March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 46%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"&gt;3,162&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"&gt;16,846&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 5%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font-weight: normal; font-style: normal; text-align: right"&gt;20,008&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;218&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;218&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;104&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;5,899&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;6,003&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;81&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;787&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;868&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;26&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;267&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;293&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the three months ended March 31, 2016&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,454&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;16,165&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;18,619&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;546&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;546&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;(Loss) income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;(207&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,304&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;4,097&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;79&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;751&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;830&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;31&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;117&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;148&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the nine months ended March 31, 2017&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;8,259&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;48,887&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;57,146&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;981&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;981&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;46&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;15,318&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;15,364&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;242&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,345&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,587&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;122&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,774&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,896&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt"&gt;For the nine months ended March 31, 2016&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net revenues from external customers&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;7,833&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;46,766&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;54,599&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Inter-segment net revenues&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,594&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;&amp;#8212;&amp;#160;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,594&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Income from operations&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;18&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;11,919&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;11,937&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Depreciation and amortization&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;242&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,265&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,507&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Capital expenditures&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;390&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;209&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;599&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="From2016-07-01to2017-03-31" unitRef="Shares" decimals="0">2</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-1900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="From2016-07-01to2017-03-31" unitRef="Shares" decimals="0">1000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan>
    <FONR:NetIncome contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="USD" decimals="-3">3096000</FONR:NetIncome>
    <FONR:NetIncome contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" unitRef="USD" decimals="-3">9632000</FONR:NetIncome>
    <FONR:NetIncome contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">2895000</FONR:NetIncome>
    <FONR:NetIncome contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonStockMember" unitRef="USD" decimals="-3">9006000</FONR:NetIncome>
    <FONR:NetIncome contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_custom_ClassANonVotingPreferredStockMember" unitRef="USD" decimals="-3">150000</FONR:NetIncome>
    <FONR:NetIncome contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_custom_ClassANonVotingPreferredStockMember" unitRef="USD" decimals="-3">467000</FONR:NetIncome>
    <FONR:NetIncome contextRef="From2016-01-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">51000</FONR:NetIncome>
    <FONR:NetIncome contextRef="From2015-07-01to2016-03-31_custom_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_us-gaap_CommonClassCMember" unitRef="USD" decimals="-3">159000</FONR:NetIncome>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross contextRef="From2016-07-01to2017-03-31" unitRef="Shares" decimals="0">200</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationGross>
    <FONR:SharesOfCommonStockIssuedForAcquisitionShares contextRef="From2016-07-01to2017-03-31" unitRef="Shares" decimals="0">42000</FONR:SharesOfCommonStockIssuedForAcquisitionShares>
    <FONR:ValueOfSharesIssuedForAcquisitionValue. contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">791000</FONR:ValueOfSharesIssuedForAcquisitionValue.>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2017-03-31" unitRef="USD" decimals="-3">110029000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">1900000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">145000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">1293000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">1140000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="From2016-01-01to2016-03-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">1900000</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredOtherTaxExpenseBenefit>
    <us-gaap:DeferredOtherTaxExpenseBenefit contextRef="From2017-01-01to2017-03-31" unitRef="USD" decimals="-3">0</us-gaap:DeferredOtherTaxExpenseBenefit>
    <FONR:ProceedsReceivedFromAcquisitionNet contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">88000</FONR:ProceedsReceivedFromAcquisitionNet>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock contextRef="From2016-07-01to2017-03-31">&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Acquisitions&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;On&#13;March 20, 2017, the Company purchased 100% interest in Radwell Leasing LLC and Radwell LLC. The consideration and net assets acquired&#13;is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: top"&gt;Consideration&lt;/td&gt;&lt;td style="font-size: 10pt; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Stock Issued&lt;/td&gt;&lt;td style="width: 10%; padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;791&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Additional Cash Consideration(Less: Cash Received)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(120&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Total Consideration&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;671&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center; vertical-align: top; border-bottom: Black 1pt solid"&gt;Net Assets Acquired&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="font-size: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; text-align: left; padding-left: 5.4pt"&gt;Diagnostic Equipment&lt;/td&gt;&lt;td style="width: 10%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;545&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"&gt;Leasehold Improvements&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;126&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-left: 5.4pt"&gt;Total Net Assets Acquired&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;671&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&amp;#160;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;On&#13;June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC. The&#13;consideration and net assets acquired is as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"&gt;(Amounts and shares in thousands, except per share amounts)&#13;(UNAUDITED)&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Cash Paid&lt;/td&gt;&lt;td style="width: 10%; font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; font-weight: normal; font-style: normal; text-align: right"&gt;4,224&lt;/td&gt;&lt;td style="width: 1%; font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Net assets at Fair Value&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;2,862&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt"&gt;Goodwill&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: right"&gt;1,555&lt;/td&gt;&lt;td style="font-weight: normal; font-style: normal; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-649000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">403000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2016-07-01to2017-03-31" unitRef="USD" decimals="-3">-182000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="From2015-07-01to2016-03-31" unitRef="USD" decimals="-3">112000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts contextRef="AsOf2017-03-20" unitRef="USD" decimals="-3">671000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized contextRef="AsOf2017-03-20" unitRef="USD" decimals="-3">671000</us-gaap:BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized>
    <FONR:StockIssued contextRef="AsOf2017-03-20" unitRef="USD" decimals="-3">791000</FONR:StockIssued>
    <FONR:AdditionalCashConsiderationlessCashReceived contextRef="AsOf2017-03-20" unitRef="USD" decimals="-3">-120000</FONR:AdditionalCashConsiderationlessCashReceived>
    <FONR:DiagnosticEquipment contextRef="AsOf2017-03-20" unitRef="USD" decimals="-3">545000</FONR:DiagnosticEquipment>
    <FONR:LeaseholdImprovements contextRef="AsOf2017-03-20" unitRef="USD" decimals="-3">126000</FONR:LeaseholdImprovements>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>fonr-20160930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: xfr%2D3Qf17%2Dfinal.xfr; Date: 2017%2D05%2D10T18:49:42Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x802C0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/DocumentAndEntityInformation" xlink:href="fonr-20160930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheets" xlink:href="fonr-20160930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheetsParenthetical" xlink:href="fonr-20160930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfIncome" xlink:href="fonr-20160930.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfCashFlows" xlink:href="fonr-20160930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:href="fonr-20160930.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-Inventories" xlink:href="fonr-20160930.xsd#Note4-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-StockholdersEquity" xlink:href="fonr-20160930.xsd#Note8-StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation" xlink:href="fonr-20160930.xsd#Note11-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies" xlink:href="fonr-20160930.xsd#Note12-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-IncomeTaxes" xlink:href="fonr-20160930.xsd#Note13-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-SubsequentEvents" xlink:href="fonr-20160930.xsd#Note14-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesTables" xlink:href="fonr-20160930.xsd#Note4-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinationsTables" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformationTables" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesDetails" xlink:href="fonr-20160930.xsd#Note4-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-ProformaResultsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note8-StockholdersEquity-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note13-IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNet" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="loc_us-gaapOtherDeferredCreditsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherDeferredCreditsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:label="loc_us-gaapCustomerAdvancesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapCustomerAdvancesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:label="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaapMaintenanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapMaintenanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="loc_us-gaapServiceManagementCosts" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapServiceManagementCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Statements of Cash Flows" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:title="00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:title="00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:title="00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-Inventories" xlink:title="00000009 - Disclosure - NOTE 4 - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:title="00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:title="00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-StockholdersEquity" xlink:title="00000013 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations" xlink:title="00000014 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-IncomeTaxes" xlink:title="00000018 - Disclosure - NOTE 13 - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-SubsequentEvents" xlink:title="00000019 - Disclosure - NOTE 14 - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:title="00000022 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesTables" xlink:title="00000023 - Disclosure - NOTE 4 - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:title="00000024 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinationsTables" xlink:title="00000027 - Disclosure - NOTE 9 - Business Combinations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformationTables" xlink:title="00000028 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:title="00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:title="00000030 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:title="00000031 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesDetails" xlink:title="00000032 - Disclosure - NOTE 4 - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:title="00000033 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:label="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesAndDeposits" xlink:label="loc_us-gaapCustomerAdvancesAndDeposits" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_us-gaapCustomerAdvancesAndDeposits" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:title="00000034 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:title="00000035 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:title="00000036 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:title="00000037 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - Radwell (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:title="00000038 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - TK2 + Turnkey - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails" xlink:title="00000039 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Proforma Results (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:title="00000040 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:title="00000041 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:title="00000042 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:title="00000043 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:title="00000044 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative" xlink:title="00000045 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:title="00000046 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:title="00000047 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative" xlink:title="00000048 - Disclosure - NOTE 13 - INCOME TAXES - (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>fonr-20160930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: xfr%2D3Qf17%2Dfinal.xfr; Date: 2017%2D05%2D10T18:49:42Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x802C0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/DocumentAndEntityInformation" xlink:href="fonr-20160930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheets" xlink:href="fonr-20160930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheetsParenthetical" xlink:href="fonr-20160930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfIncome" xlink:href="fonr-20160930.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfCashFlows" xlink:href="fonr-20160930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:href="fonr-20160930.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-Inventories" xlink:href="fonr-20160930.xsd#Note4-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-StockholdersEquity" xlink:href="fonr-20160930.xsd#Note8-StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation" xlink:href="fonr-20160930.xsd#Note11-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies" xlink:href="fonr-20160930.xsd#Note12-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-IncomeTaxes" xlink:href="fonr-20160930.xsd#Note13-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-SubsequentEvents" xlink:href="fonr-20160930.xsd#Note14-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesTables" xlink:href="fonr-20160930.xsd#Note4-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinationsTables" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformationTables" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesDetails" xlink:href="fonr-20160930.xsd#Note4-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-ProformaResultsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note8-StockholdersEquity-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note13-IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_110" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapSalesRevenueGoodsNet_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceRevenue" xlink:label="loc_us-gaapMaintenanceRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapMaintenanceRevenue_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ManagementFeesRevenue" xlink:label="loc_us-gaapManagementFeesRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapManagementFeesRevenue_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_170" xlink:to="loc_us-gaapSalesRevenueNet_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapCostOfGoodsSold_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaapMaintenanceCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapMaintenanceCosts_170" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_170" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_170" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="loc_us-gaapServiceManagementCosts_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapServiceManagementCosts_170" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_170" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_170" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_170" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_170" xlink:to="loc_us-gaapCostsAndExpenses_170" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="loc_us-gaapOtherIncomeAbstract_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherIncomeAbstract_170" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_170" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapInterestExpense_170" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapInvestmentIncomeNet_170" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapNonoperatingIncomeExpense_170" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_170" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_170" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapProfitLoss_170" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_170" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapNetIncomeLoss_170" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapEarningsPerShareBasic_170" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapEarningsPerShareDiluted_170" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_170" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOtherIncomeAbstract_170" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_170" xlink:type="arc" order="36" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:title="00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:title="00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:title="00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-Inventories" xlink:title="00000009 - Disclosure - NOTE 4 - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:title="00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:title="00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-StockholdersEquity" xlink:title="00000013 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations" xlink:title="00000014 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-IncomeTaxes" xlink:title="00000018 - Disclosure - NOTE 13 - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-SubsequentEvents" xlink:title="00000019 - Disclosure - NOTE 14 - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:title="00000022 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesTables" xlink:title="00000023 - Disclosure - NOTE 4 - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:title="00000024 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinationsTables" xlink:title="00000027 - Disclosure - NOTE 9 - Business Combinations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformationTables" xlink:title="00000028 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:title="00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_130" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:title="00000030 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRMedicalReceivable_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:title="00000031 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue_210" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_210" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_210" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesDetails" xlink:title="00000032 - Disclosure - NOTE 4 - INVENTORIES (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:title="00000033 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:title="00000034 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:title="00000035 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:title="00000036 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:title="00000037 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - Radwell (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:title="00000038 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - TK2 + Turnkey - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_TK2EquipmentManagemenMember" xlink:label="loc_FONRTK2EquipmentManagemenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRTK2EquipmentManagemenMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CashPaid" xlink:label="loc_FONRCashPaid_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCashPaid_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetAssetsAtFairValue" xlink:label="loc_FONRNetAssetsAtFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetAssetsAtFairValue_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_20" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails" xlink:title="00000039 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Proforma Results (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" xlink:label="loc_FONRRadwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRadwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:label="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" xlink:to="loc_us-gaapSalesRevenueNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetIncome" xlink:label="loc_FONRNetIncome_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" xlink:to="loc_FONRNetIncome_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_90" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:title="00000040 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_130" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:title="00000041 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:title="00000042 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock_50" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:title="00000043 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:title="00000044 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_170" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative" xlink:title="00000045 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:title="00000046 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:title="00000047 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative" xlink:title="00000048 - Disclosure - NOTE 13 - INCOME TAXES - (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>fonr-20160930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: xfr%2D3Qf17%2Dfinal.xfr; Date: 2017%2D05%2D10T18:49:42Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x802C0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Class B Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Class C Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PreferredStockClassAMember" xlink:label="FONR_PreferredStockClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PreferredStockClassAMember" xlink:to="FONR_PreferredStockClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PreferredStockClassAMember_lbl" xml:lang="en-US">Preferred Stock Class A</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non-Voting Preferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">AccountsNotesLoansAndFinancingReceivableByReceivableType [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Gross Receivabe</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:label="us-gaap_AllowanceForDoubtfulAccountsCurrentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:to="us-gaap_AllowanceForDoubtfulAccountsCurrentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsCurrentMember_lbl" xml:lang="en-US">Allowance for Doubtful Accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Capitalized software development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Non-compete</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer relationships</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_TK2EquipmentManagemenMember" xlink:label="FONR_TK2EquipmentManagemenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TK2EquipmentManagemenMember" xlink:to="FONR_TK2EquipmentManagemenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TK2EquipmentManagemenMember_lbl" xml:lang="en-US">TK2 Equipment Management</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance / Managed Care</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare/Medicaid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation/Personal Injury</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Statement, Operating Activities Segment [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalEquipmentMember" xlink:label="FONR_MedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalEquipmentMember_lbl" xml:lang="en-US">Medical Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" xlink:label="FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" xlink:to="FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember_lbl" xml:lang="en-US">Radwell LLC. and Radwell Leasing LLC. acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Is Entity a Well-known Seasoned Issuer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Is Entity a Voluntary Filer?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Is Entity's Reporting Status Current?</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">Accounts receivable - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="FONR_AccountsReceivableNetRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetRelatedParty_lbl" xml:lang="en-US">Accounts receivable - Related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">Medical receivables -net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xml:lang="en-US">Management and other fees receivable -net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable - related medical practices -net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:to="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms_lbl" xml:lang="en-US">Costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsNet" xlink:label="us-gaap_AssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNet_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of long-term debt and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="us-gaap_OtherDeferredCreditsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDeferredCreditsCurrent" xlink:to="us-gaap_OtherDeferredCreditsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDeferredCreditsCurrent_lbl" xml:lang="en-US">Unearned revenue on service contracts - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:label="us-gaap_CustomerAdvancesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerAdvancesCurrent" xlink:to="us-gaap_CustomerAdvancesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerAdvancesCurrent_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="us-gaap_BillingsInExcessOfCostCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BillingsInExcessOfCostCurrent" xlink:to="us-gaap_BillingsInExcessOfCostCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BillingsInExcessOfCostCurrent_lbl" xml:lang="en-US">Billings in excess of costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent_lbl" xml:lang="en-US">Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US">Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure" xlink:label="us-gaap_NotesReceivableFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableFairValueDisclosure" xlink:to="us-gaap_NotesReceivableFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesReceivableFairValueDisclosure_lbl" xml:lang="en-US">Notes receivable from employee stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost - 12 shares of common stock at March 31, 2017 and June 30, 2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:label="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:to="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_lbl" xml:lang="en-US">Total Fonar Corporation Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">Non controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_lbl" xml:lang="en-US">Total Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par Value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="us-gaap_SalesRevenueGoodsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueGoodsNet" xlink:to="us-gaap_SalesRevenueGoodsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueGoodsNet_lbl" xml:lang="en-US">Product sales - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceRevenue" xlink:label="us-gaap_MaintenanceRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaintenanceRevenue" xlink:to="us-gaap_MaintenanceRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaintenanceRevenue_lbl" xml:lang="en-US">Service and repair fees - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees - related parties - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenue_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_lbl" xml:lang="en-US">Provision for bad debts and bad debt expense for patient fee</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ManagementFeesRevenue" xlink:label="us-gaap_ManagementFeesRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementFeesRevenue" xlink:to="us-gaap_ManagementFeesRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ManagementFeesRevenue_lbl" xml:lang="en-US">Management and other fees - net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees - related medical practices - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Total Revenues - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="us-gaap_CostOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsSold_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="us-gaap_MaintenanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaintenanceCosts" xlink:to="us-gaap_MaintenanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaintenanceCosts_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="us-gaap_ServiceManagementCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ServiceManagementCosts" xlink:to="us-gaap_ServiceManagementCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ServiceManagementCosts_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees - related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="us-gaap_OtherIncomeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAbstract" xlink:to="us-gaap_OtherIncomeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAbstract_lbl" xml:lang="en-US">INCOME</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income From Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Other (Expense) Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income Before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Benefit/(Provision) for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income - Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income - Controlling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted Average Basic Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax benefit- net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock issued for costs and expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan_lbl" xml:lang="en-US">Compensatory element of stock issuances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_lbl" xml:lang="en-US">Stock option exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivable(s)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US">Costs and estimated earnings in excess of Billings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances_lbl" xml:lang="en-US">Customer advances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US">Billings in excess of costs and estimated earnings on completed contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_lbl" xml:lang="en-US">Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ProceedsReceivedFromAcquisitionNet" xlink:label="FONR_ProceedsReceivedFromAcquisitionNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProceedsReceivedFromAcquisitionNet" xlink:to="FONR_ProceedsReceivedFromAcquisitionNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProceedsReceivedFromAcquisitionNet_lbl" xml:lang="en-US">Proceeds received from acquisition - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="us-gaap_RepaymentsOfOtherDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherDebt" xlink:to="us-gaap_RepaymentsOfOtherDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfOtherDebt_lbl" xml:lang="en-US">Repayment of notes receivable from employee stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net (Decrease) Increase in Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and Cash Equivalents - Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and Cash Equivalents - End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 3 - ACCOUNTS RECEIVABLE. MEDICAL RECEIVABLES AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 4 - INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="FONR_NotesToFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NotesToFinancialStatementsAbstract" xlink:to="FONR_NotesToFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NotesToFinancialStatementsAbstract_lbl" xml:lang="en-US">Notes to Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_lbl" xml:lang="en-US">NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 6 - OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">NOTE 7 - OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 8 - STOCKHOLDERS EQUITY</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 9 - BUSINESS COMBINATIONS</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 10 - SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 12 - COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">NOTE 13 - INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">NOTE 14 - SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:label="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract_lbl" xml:lang="en-US">Note 2 - Summary Of Significant Accounting Policies Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_lbl" xml:lang="en-US">Receivables - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock_lbl" xml:lang="en-US">Patient fee revenue - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CustomerAdvancesTableTextBlock" xlink:label="FONR_CustomerAdvancesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesTableTextBlock" xlink:to="FONR_CustomerAdvancesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerAdvancesTableTextBlock_lbl" xml:lang="en-US">Information relating to uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:label="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:to="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_lbl" xml:lang="en-US">Included in the accompanying condensed consolidated balance sheets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Other intangible assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_lbl" xml:lang="en-US">Consideration and Net Assets for TK2 Equip. Mgmt, Turnkey Service Of NY &amp; Radwell Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">Pro Forma Results Of Operations For Radwell Leasing LLC and Radwell LLC Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xml:lang="en-US">Segment information</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Basic Numerator: Net income available to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic Denominator: Weighted average shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareBasic_2_lbl" xml:lang="en-US">Basic Income Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Convertible Class C Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Total Denominator for diluted earnings per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareDiluted_2_lbl" xml:lang="en-US">Diluted Income Per Share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_MedicalReceivable_2_lbl" xml:lang="en-US">Medical Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_2_lbl" xml:lang="en-US">Management and other fees receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xml:lang="en-US">Management and other fees receivable from related medical practices ("PC's")</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts_2_lbl" xml:lang="en-US">Provision for bad debts for patient fee and bad debt expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_lbl" xml:lang="en-US">Net patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Total inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="FONR_CostsIncurredOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsIncurredOnUncompletedContracts_lbl" xml:lang="en-US">Costs incurred on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_EstimatedEarnings" xlink:label="FONR_EstimatedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EstimatedEarnings_lbl" xml:lang="en-US">Estimated earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_lbl" xml:lang="en-US">Subtotal</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesAndDeposits" xlink:label="us-gaap_CustomerAdvancesAndDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerAdvancesAndDeposits" xlink:to="us-gaap_CustomerAdvancesAndDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerAdvancesAndDeposits_lbl" xml:lang="en-US">Less: Billings to date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_lbl" xml:lang="en-US">Total Costs and estimated earnings in excess of billings on uncompleted contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BillingsInExcessOfCostCurrent" xlink:to="us-gaap_BillingsInExcessOfCostCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BillingsInExcessOfCostCurrent_2_lbl" xml:lang="en-US">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross Other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other Intangible Assets - net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="us-gaap_InterestPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrent" xlink:to="us-gaap_InterestPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Litigation accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Interest and penalty - sales tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_BusinessCombinationsAcquisitionRadwellDetailsAbstract" xlink:label="FONR_BusinessCombinationsAcquisitionRadwellDetailsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_BusinessCombinationsAcquisitionRadwellDetailsAbstract" xlink:to="FONR_BusinessCombinationsAcquisitionRadwellDetailsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_BusinessCombinationsAcquisitionRadwellDetailsAbstract_lbl" xml:lang="en-US">Note 9 - Business Combinations - Acquisition - Radwell Details</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract_lbl" xml:lang="en-US">Consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_StockIssued" xlink:label="FONR_StockIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockIssued" xlink:to="FONR_StockIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StockIssued_lbl" xml:lang="en-US">Stock Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AdditionalCashConsiderationlessCashReceived" xlink:label="FONR_AdditionalCashConsiderationlessCashReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AdditionalCashConsiderationlessCashReceived" xlink:to="FONR_AdditionalCashConsiderationlessCashReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AdditionalCashConsiderationlessCashReceived_lbl" xml:lang="en-US">Additional Cash Consideration(Less: Cash Received)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_lbl" xml:lang="en-US">Total Consideration</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US">Net Assets Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_DiagnosticEquipment" xlink:label="FONR_DiagnosticEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipment" xlink:to="FONR_DiagnosticEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DiagnosticEquipment_lbl" xml:lang="en-US">Diagnostic Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_LeaseholdImprovements" xlink:label="FONR_LeaseholdImprovements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LeaseholdImprovements" xlink:to="FONR_LeaseholdImprovements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LeaseholdImprovements_lbl" xml:lang="en-US">Leasehold Improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:label="us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_lbl" xml:lang="en-US">Total Net Assets Acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CashPaid" xlink:label="FONR_CashPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CashPaid" xlink:to="FONR_CashPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CashPaid_lbl" xml:lang="en-US">Cash Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetAssetsAtFairValue" xlink:label="FONR_NetAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetAssetsAtFairValue" xlink:to="FONR_NetAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetAssetsAtFairValue_lbl" xml:lang="en-US">Net assets at Fair Value</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:label="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_lbl" xml:lang="en-US">Pro forma results of operations for Radwell Leasing, LLC and Radwell LLC acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_2_lbl" xml:lang="en-US">Total Revenues - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetIncome" xlink:label="FONR_NetIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncome" xlink:to="FONR_NetIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetIncome_lbl" xml:lang="en-US">Net Income (Proforma)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xml:lang="en-US">Weighted Average Shares Outstanding - Basic</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3_lbl" xml:lang="en-US">Weighted Average Shares Outstanding - Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_2_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SalesRevenueNet_3_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:label="FONR_Note9ControllingAndNoncontrollingInterestsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:to="FONR_Note9ControllingAndNoncontrollingInterestsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Note9ControllingAndNoncontrollingInterestsAbstract_lbl" xml:lang="en-US">Note 1 - Description Of Business And Basis Of Presentation - Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM (percent).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM (percent).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM after reorganization of newly expanded HDM (percent).</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_2_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common to calculate a diluted EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:label="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:to="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract_lbl" xml:lang="en-US">Note 3 - Accounts Receivable Medical Receivable And Management And Other Fees Receivable - Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Net revenues derived from no-fault and personal injury protection claims</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:to="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_lbl" xml:lang="en-US">Net revenues from management and other fees charged to related PCs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract_lbl" xml:lang="en-US">Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_lbl" xml:lang="en-US">Shares of common stock issued to employees as compensation (shares).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue." xlink:label="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue." />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue." xlink:to="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue._lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue._lbl" xml:lang="en-US">Value of Shares Issued to employees as compensation (value).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." xlink:label="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." xlink:to="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares._lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares._lbl" xml:lang="en-US">Shares of common stock issued in settlement of liabilities (shares).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue." xlink:label="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue." />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue." xlink:to="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue._lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue._lbl" xml:lang="en-US">Value of Shares Issued in Settlement of Liabilities (value).</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xml:lang="en-US">Shares issued pursuant to incentive stock option plan (shares).</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan_lbl" xml:lang="en-US">Value of shares issued pursuant to incentive stock option plan (value).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SharesOfCommonStockIssuedForAcquisitionShares" xlink:label="FONR_SharesOfCommonStockIssuedForAcquisitionShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesOfCommonStockIssuedForAcquisitionShares" xlink:to="FONR_SharesOfCommonStockIssuedForAcquisitionShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SharesOfCommonStockIssuedForAcquisitionShares_lbl" xml:lang="en-US">Shares of common stock issued for acquisition (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ValueOfSharesIssuedForAcquisitionValue." xlink:label="FONR_ValueOfSharesIssuedForAcquisitionValue." />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ValueOfSharesIssuedForAcquisitionValue." xlink:to="FONR_ValueOfSharesIssuedForAcquisitionValue._lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ValueOfSharesIssuedForAcquisitionValue._lbl" xml:lang="en-US">Value of shares issued for acquisition (value).</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:label="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:to="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract_lbl" xml:lang="en-US">Note 11 - Supplemental Cash Flow Information - Details Narrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income Taxes Paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Recorded tax obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_lbl" xml:lang="en-US">Tax interest and penalties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xml:lang="en-US">Maximum limit for individual claims under stop-loss umbrella policy for health insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Net deferred operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xml:lang="en-US">Increase in deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Deferred tax asset net benefit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOtherTaxExpenseBenefit" xlink:to="us-gaap_DeferredOtherTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredOtherTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred tax benefit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetRelatedParty_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A NonVoting Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:to="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock_doc" xml:lang="en-US">Costs And EstimatedEarningsOn Uncompleted Contracts And Customer Advances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsIncurredOnUncompletedContracts" xlink:to="FONR_CostsIncurredOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsIncurredOnUncompletedContracts_doc" xml:lang="en-US">Costs incurred on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_doc" xml:lang="en-US">Costs related to the management and other fees - related medical practices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_doc" xml:lang="en-US">Costs incurred and are directly related to generatingmaintenance revenues. Also includes costs of maintenance on client contracts - for related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerAdvancesTableTextBlock" xlink:to="FONR_CustomerAdvancesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CustomerAdvancesTableTextBlock_doc" xml:lang="en-US">Table of total customer advances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EstimatedEarnings" xlink:to="FONR_EstimatedEarnings_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EstimatedEarnings_doc" xml:lang="en-US">Estimated earnings.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:to="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets_doc" xml:lang="en-US">Table of balance sheet items</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_doc" xml:lang="en-US">Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations - for related medical practices - net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xml:lang="en-US">Management of, and other fees receivable from MRI Centers owned by non-related parties, - net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management of Diagnostic Imaging Centers - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_doc" xml:lang="en-US">Management of, and other fees receivable from MRI Centers owned by related medical practices - net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xml:lang="en-US">The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalEquipmentMember_doc" xml:lang="en-US">Medical equipment - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalReceivable_doc" xml:lang="en-US">Medical receivable from management of specific centers - net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Approximate per cent ofthePCs net revenues derived from no-fault and personal injury protection claims</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:to="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_doc" xml:lang="en-US">Net revenues from Management and other fees charged to related PCs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PreferredStockClassAMember" xlink:to="FONR_PreferredStockClassAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PreferredStockClassAMember_doc" xml:lang="en-US">Preferred stock class A - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProvisionForBadDebts_doc" xml:lang="en-US">Provision for bad debts used for calculationof cash flow statements.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_doc" xml:lang="en-US">Revenue derived from maintenance services provided under contracts or arrangements with clients for related parties - net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_doc" xml:lang="en-US">The calculation of the subtotal of costs, estimated earnings, and billings on uncompleted contracts plus costs incurred on uncompleted contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TK2EquipmentManagemenMember" xlink:to="FONR_TK2EquipmentManagemenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_TK2EquipmentManagemenMember_doc" xml:lang="en-US">TK2 Equipment Management, LLC proforma results</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CashPaid" xlink:to="FONR_CashPaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CashPaid_doc" xml:lang="en-US">On June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetAssetsAtFairValue" xlink:to="FONR_NetAssetsAtFairValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetAssetsAtFairValue_doc" xml:lang="en-US">On June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetIncome" xlink:to="FONR_NetIncome_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetIncome_doc" xml:lang="en-US">The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition_doc" xml:lang="en-US">The following unaudited pro forma results of operations for the three and nine months ended March 31, 2016 assumes that the above acquisitions were made at the beginning of the year prior to acquisition. The unaudited pro forma information does not purport to be indicative of the results that would have been obtained if the acquisitions had actually occurred at the beginning of the year prior to acquisition, nor of the results that may be reported in the future. The result of operations of Radwell Leasing LLC and Radwell LLC were diminutive and did not affect the pro forma results of operations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." xlink:to="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares._doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares._doc" xml:lang="en-US">During the six months ended December 31, 2016, the Company issued 107,000 shares of common stock for costs and expenses valued at $2,239,000.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue." xlink:to="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue._doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue._doc" xml:lang="en-US">During the six months ended December 31, 2016, the Company issued 1,000 shares of common stock to employees and consultants as compensation valued at $27,000 under a stock bonus plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue." xlink:to="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue._doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue._doc" xml:lang="en-US">During the six months ended December 31, 2016, the Company issued 107,000 shares of common stock for costs and expenses valued at $2,239,000.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SharesOfCommonStockIssuedForAcquisitionShares" xlink:to="FONR_SharesOfCommonStockIssuedForAcquisitionShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_SharesOfCommonStockIssuedForAcquisitionShares_doc" xml:lang="en-US">During the nine months ended March 31, 2017, the Company issued 42,000 shares of common stock valued at $791,000 for an acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ValueOfSharesIssuedForAcquisitionValue." xlink:to="FONR_ValueOfSharesIssuedForAcquisitionValue._doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ValueOfSharesIssuedForAcquisitionValue._doc" xml:lang="en-US">During the nine months ended March 31, 2017, the Company issued 42,000 shares of common stock valued at $791,000 for an acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProceedsReceivedFromAcquisitionNet" xlink:to="FONR_ProceedsReceivedFromAcquisitionNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ProceedsReceivedFromAcquisitionNet_doc" xml:lang="en-US">Additional cash consideration received by Company during purchase from Radwell Leasing, LLC.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StockIssued" xlink:to="FONR_StockIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StockIssued_doc" xml:lang="en-US">On March 20, 2017, the Company issued 42,000 shares of common stock valued at $791,000 for an acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AdditionalCashConsiderationlessCashReceived" xlink:to="FONR_AdditionalCashConsiderationlessCashReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AdditionalCashConsiderationlessCashReceived_doc" xml:lang="en-US">Cash received as result of acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DiagnosticEquipment" xlink:to="FONR_DiagnosticEquipment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_DiagnosticEquipment_doc" xml:lang="en-US">MRI scanner.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LeaseholdImprovements" xlink:to="FONR_LeaseholdImprovements_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_LeaseholdImprovements_doc" xml:lang="en-US">Leasehold improvements acquired as part of acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNet" xlink:to="us-gaap_AssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNet_2_lbl" xml:lang="en-US">Net Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:to="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent, Not Allowable for Net Capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1_2_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:to="us-gaap_IncreaseDecreaseInCustomerAdvances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInCustomerAdvances_2_lbl" xml:lang="en-US">Increase (Decrease) in Customer Advances</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_2_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:to="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts_2_lbl" xml:lang="en-US">Health Care Organization, Patient Service Revenue Less Provision for Bad Debts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:to="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts_3_lbl" xml:lang="en-US">SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:to="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear_2_lbl" xml:lang="en-US">Costs in Excess of Billings, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_2_lbl" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized_2_lbl" xml:lang="en-US">Business Combination, Assets and Liabilities Arising from Contingencies, Amount Recognized, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:to="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs_3_lbl" xml:lang="en-US">NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>fonr-20160930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: xfr%2D3Qf17%2Dfinal.xfr; Date: 2017%2D05%2D10T18:49:42Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x802C0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/DocumentAndEntityInformation" xlink:href="fonr-20160930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheets" xlink:href="fonr-20160930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/BalanceSheetsParenthetical" xlink:href="fonr-20160930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfIncome" xlink:href="fonr-20160930.xsd#StatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/StatementsOfCashFlows" xlink:href="fonr-20160930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:href="fonr-20160930.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-Inventories" xlink:href="fonr-20160930.xsd#Note4-Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-StockholdersEquity" xlink:href="fonr-20160930.xsd#Note8-StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation" xlink:href="fonr-20160930.xsd#Note11-SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies" xlink:href="fonr-20160930.xsd#Note12-CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-IncomeTaxes" xlink:href="fonr-20160930.xsd#Note13-IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note14-SubsequentEvents" xlink:href="fonr-20160930.xsd#Note14-SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesTables" xlink:href="fonr-20160930.xsd#Note4-InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinationsTables" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformationTables" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note4-InventoriesDetails" xlink:href="fonr-20160930.xsd#Note4-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:href="fonr-20160930.xsd#Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:href="fonr-20160930.xsd#Note7-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails" xlink:href="fonr-20160930.xsd#Note9-BusinessCombinations-ProformaResultsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:href="fonr-20160930.xsd#Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note6-OtherIntangibleAssets-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note8-StockholdersEquity-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative" xlink:href="fonr-20160930.xsd#Note13-IncomeTaxes-DetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_DocumentAndEntityInformationAbstract" xlink:label="loc_FONRDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDocumentAndEntityInformationAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheets" xlink:title="00000002 - Statement - Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsNet" xlink:label="loc_us-gaapAssetsNet" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherDeferredCreditsCurrent" xlink:label="loc_us-gaapOtherDeferredCreditsCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherDeferredCreditsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesCurrent" xlink:label="loc_us-gaapCustomerAdvancesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapCustomerAdvancesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NotesReceivableFairValueDisclosure" xlink:label="loc_us-gaapNotesReceivableFairValueDisclosure" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapNotesReceivableFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:label="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAttributableToParentNotAllowableForNetCapital" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfIncome" xlink:title="00000004 - Statement - Consolidated Statements of Income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PreferredStockClassAMember" xlink:label="loc_FONRPreferredStockClassAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRPreferredStockClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceRevenue" xlink:label="loc_us-gaapMaintenanceRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapMaintenanceRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ManagementFeesRevenue" xlink:label="loc_us-gaapManagementFeesRevenue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapManagementFeesRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaintenanceCosts" xlink:label="loc_us-gaapMaintenanceCosts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapMaintenanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ServiceManagementCosts" xlink:label="loc_us-gaapServiceManagementCosts" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapServiceManagementCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherIncomeAbstract" xlink:label="loc_us-gaapOtherIncomeAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherIncomeAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInCustomerAdvances" xlink:label="loc_us-gaapIncreaseDecreaseInCustomerAdvances" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInCustomerAdvances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ProceedsReceivedFromAcquisitionNet" xlink:label="loc_FONRProceedsReceivedFromAcquisitionNet" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_FONRProceedsReceivedFromAcquisitionNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepaymentsOfOtherDebt" xlink:label="loc_us-gaapRepaymentsOfOtherDebt" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfOtherDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" xlink:title="00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" xlink:title="00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" xlink:title="00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-Inventories" xlink:title="00000009 - Disclosure - NOTE 4 - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" xlink:title="00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:label="loc_FONRCostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRCostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets" xlink:title="00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities" xlink:title="00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-StockholdersEquity" xlink:title="00000013 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations" xlink:title="00000014 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformation" xlink:title="00000015 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-SupplementalCashFlowInformation" xlink:title="00000016 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-IncomeTaxes" xlink:title="00000018 - Disclosure - NOTE 13 - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note14-SubsequentEvents" xlink:title="00000019 - Disclosure - NOTE 14 - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:label="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRSummaryOfSignificantAccountingPoliciesPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" xlink:title="00000022 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesTables" xlink:title="00000023 - Disclosure - NOTE 4 - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" xlink:title="00000024 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CustomerAdvancesTableTextBlock" xlink:label="loc_FONRCustomerAdvancesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRCustomerAdvancesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:label="loc_FONRIncludedInAccompanyingCondensedConsolidatedBalanceSheets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRIncludedInAccompanyingCondensedConsolidatedBalanceSheets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" xlink:title="00000025 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" xlink:title="00000026 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinationsTables" xlink:title="00000027 - Disclosure - NOTE 9 - Business Combinations (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformationTables" xlink:title="00000028 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" xlink:title="00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" xlink:title="00000030 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivablesReceivablesNetDetailsAbstract" xlink:label="loc_FONRAccountsReceivablesReceivablesNetDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRAccountsReceivablesReceivablesNetDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsCurrentMember" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsCurrentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" xlink:title="00000031 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Note2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" xlink:label="loc_FONRNote2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenue" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueProvisionforBadDebts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:label="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapHealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note4-InventoriesDetails" xlink:title="00000032 - Disclosure - NOTE 4 - INVENTORIES (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" xlink:title="00000033 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CostsIncurredOnUncompletedContracts" xlink:label="loc_FONRCostsIncurredOnUncompletedContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRCostsIncurredOnUncompletedContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_EstimatedEarnings" xlink:label="loc_FONREstimatedEarnings" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONREstimatedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:label="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_FONRSubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerAdvancesAndDeposits" xlink:label="loc_us-gaapCustomerAdvancesAndDeposits" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCustomerAdvancesAndDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" xlink:title="00000034 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NotesToFinancialStatementsAbstract" xlink:label="loc_FONRNotesToFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrPrograms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BillingsInExcessOfCostCurrent" xlink:label="loc_us-gaapBillingsInExcessOfCostCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapBillingsInExcessOfCostCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:label="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNotesToFinancialStatementsAbstract" xlink:to="loc_us-gaapCostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" xlink:title="00000035 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" xlink:title="00000036 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails" xlink:title="00000037 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - Radwell (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_BusinessCombinationsAcquisitionRadwellDetailsAbstract" xlink:label="loc_FONRBusinessCombinationsAcquisitionRadwellDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRBusinessCombinationsAcquisitionRadwellDetailsAbstract" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_StockIssued" xlink:label="loc_FONRStockIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:to="loc_FONRStockIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AdditionalCashConsiderationlessCashReceived" xlink:label="loc_FONRAdditionalCashConsiderationlessCashReceived" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:to="loc_FONRAdditionalCashConsiderationlessCashReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationConsiderationTransferredAbstract" xlink:to="loc_us-gaapBusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRBusinessCombinationsAcquisitionRadwellDetailsAbstract" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_DiagnosticEquipment" xlink:label="loc_FONRDiagnosticEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="loc_FONRDiagnosticEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_LeaseholdImprovements" xlink:label="loc_FONRLeaseholdImprovements" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="loc_FONRLeaseholdImprovements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:label="loc_us-gaapBusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="loc_us-gaapBusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" xlink:title="00000038 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - TK2 + Turnkey - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_TK2EquipmentManagemenMember" xlink:label="loc_FONRTK2EquipmentManagemenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRTK2EquipmentManagemenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_CashPaid" xlink:label="loc_FONRCashPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRCashPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetAssetsAtFairValue" xlink:label="loc_FONRNetAssetsAtFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetAssetsAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails" xlink:title="00000039 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Proforma Results (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaapBusinessAcquisitionAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapBusinessAcquisitionAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaapBusinessAcquisitionAcquireeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAxis" xlink:to="loc_us-gaapBusinessAcquisitionAcquireeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" xlink:label="loc_FONRRadwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessAcquisitionAcquireeDomain" xlink:to="loc_FONRRadwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:label="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetIncome" xlink:label="loc_FONRNetIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="loc_FONRNetIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details" xlink:title="00000040 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" xlink:title="00000041 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Note9ControllingAndNoncontrollingInterestsAbstract" xlink:label="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote9ControllingAndNoncontrollingInterestsAbstract" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" xlink:title="00000042 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" xlink:title="00000043 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:label="loc_FONRAccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRNetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRAccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:to="loc_FONRNetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:label="loc_FONRNetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRAccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" xlink:to="loc_FONRNetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" xlink:title="00000044 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative" xlink:title="00000045 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:label="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue." xlink:label="loc_FONRValueOfSharesIssuedToEmployeesAsCompensationValue." />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_FONRValueOfSharesIssuedToEmployeesAsCompensationValue." xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." xlink:label="loc_FONRSharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_FONRSharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue." xlink:label="loc_FONRValueOfSharesIssuedInSettlementOfLiabilitiesValue." />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_FONRValueOfSharesIssuedInSettlementOfLiabilitiesValue." xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueEmployeeStockOwnershipPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_SharesOfCommonStockIssuedForAcquisitionShares" xlink:label="loc_FONRSharesOfCommonStockIssuedForAcquisitionShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_FONRSharesOfCommonStockIssuedForAcquisitionShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_ValueOfSharesIssuedForAcquisitionValue." xlink:label="loc_FONRValueOfSharesIssuedForAcquisitionValue." />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="loc_FONRValueOfSharesIssuedForAcquisitionValue." xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative" xlink:title="00000046 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:label="loc_FONRNote11SupplementalCashFlowInformationDetailsNarrativeAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRNote11SupplementalCashFlowInformationDetailsNarrativeAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative" xlink:title="00000047 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:label="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20160930.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative" xlink:title="00000048 - Disclosure - NOTE 13 - INCOME TAXES - (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredOtherTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredOtherTaxExpenseBenefit" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredOtherTaxExpenseBenefit" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>fonr-20160930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.18c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: xfr%2D3Qf17%2Dfinal.xfr; Date: 2017%2D05%2D10T18:49:42Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x802C0000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 9a45o7xRiXhun8uGbHdcOaGDGaP9wZ93WekhsGRzbblqvycqw+vVmyY68OOmkaAP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:FONR="http://fonar.com/20160930" elementFormDefault="qualified" targetNamespace="http://fonar.com/20160930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://fonar.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/StatementsOfIncome" id="StatementsOfIncome">
	  <link:definition>00000004 - Statement - Consolidated Statements of Income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000005 - Statement - Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd" id="Note1-DescriptionOfBusinessAndBasisOfPresentationUsd">
	  <link:definition>00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd" id="Note2-SummaryOfSignificantAccountingPoliciesUsd">
	  <link:definition>00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd">
	  <link:definition>00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-Inventories" id="Note4-Inventories">
	  <link:definition>00000009 - Disclosure - NOTE 4 - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts" id="Note5-CostsAndEstimatedEarningsOnUncompletedContracts">
	  <link:definition>00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets" id="Note6-OtherIntangibleAssets">
	  <link:definition>00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities" id="Note7-OtherCurrentLiabilities">
	  <link:definition>00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-StockholdersEquity" id="Note8-StockholdersEquity">
	  <link:definition>00000013 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-BusinessCombinations" id="Note9-BusinessCombinations">
	  <link:definition>00000014 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation" id="Note10-SegmentAndRelatedInformation">
	  <link:definition>00000015 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation" id="Note11-SupplementalCashFlowInformation">
	  <link:definition>00000016 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies" id="Note12-CommitmentsAndContingencies">
	  <link:definition>00000017 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13-IncomeTaxes" id="Note13-IncomeTaxes">
	  <link:definition>00000018 - Disclosure - NOTE 13 - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note14-SubsequentEvents" id="Note14-SubsequentEvents">
	  <link:definition>00000019 - Disclosure - NOTE 14 - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies" id="Note2-SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000020 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables" id="Note2-SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables">
	  <link:definition>00000022 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-InventoriesTables" id="Note4-InventoriesTables">
	  <link:definition>00000023 - Disclosure - NOTE 4 - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables" id="Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables">
	  <link:definition>00000024 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssetsTables" id="Note6-OtherIntangibleAssetsTables">
	  <link:definition>00000025 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables" id="Note7-OtherCurrentLiabilitiesTables">
	  <link:definition>00000026 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-BusinessCombinationsTables" id="Note9-BusinessCombinationsTables">
	  <link:definition>00000027 - Disclosure - NOTE 9 - Business Combinations (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformationTables" id="Note10-SegmentAndRelatedInformationTables">
	  <link:definition>00000028 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails" id="Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails">
	  <link:definition>00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details">
	  <link:definition>00000030 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details">
	  <link:definition>00000031 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note4-InventoriesDetails" id="Note4-InventoriesDetails">
	  <link:definition>00000032 - Disclosure - NOTE 4 - INVENTORIES (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details" id="Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details">
	  <link:definition>00000033 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details" id="Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details">
	  <link:definition>00000034 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-Details" id="Note6-OtherIntangibleAssets-Details">
	  <link:definition>00000035 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note7-OtherCurrentLiabilities-Details" id="Note7-OtherCurrentLiabilities-Details">
	  <link:definition>00000036 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails" id="Note9-BusinessCombinations-Acquisition-RadwellDetails">
	  <link:definition>00000037 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - Radwell (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details" id="Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details">
	  <link:definition>00000038 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - TK2 + Turnkey - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails" id="Note9-BusinessCombinations-ProformaResultsDetails">
	  <link:definition>00000039 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Proforma Results (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details" id="Note10-SegmentAndRelatedInformation-SegmentInformation-Details">
	  <link:definition>00000040 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative" id="Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative">
	  <link:definition>00000041 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative" id="Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative">
	  <link:definition>00000042 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative" id="Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative">
	  <link:definition>00000043 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative" id="Note6-OtherIntangibleAssets-DetailsNarrative">
	  <link:definition>00000044 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative" id="Note8-StockholdersEquity-DetailsNarrative">
	  <link:definition>00000045 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative" id="Note11-SupplementalCashFlowInformation-DetailsNarrative">
	  <link:definition>00000046 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative" id="Note12-CommitmentsAndContingencies-DetailsNarrative">
	  <link:definition>00000047 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative" id="Note13-IncomeTaxes-DetailsNarrative">
	  <link:definition>00000048 - Disclosure - NOTE 13 - INCOME TAXES - (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20160930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" name="NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" name="MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees_NonRelatedParties" name="ManagementAndOtherFees_NonRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetRelatedParty" name="AccountsReceivableNetRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsIncurredOnUncompletedContracts" name="CostsIncurredOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EstimatedEarnings" name="EstimatedEarnings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" name="SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." name="SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares." nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue." name="ValueOfSharesIssuedToEmployeesAsCompensationValue." nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue." name="ValueOfSharesIssuedInSettlementOfLiabilitiesValue." nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetAssetsAtFairValue" name="NetAssetsAtFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CashPaid" name="CashPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" name="CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerAdvancesTableTextBlock" name="CustomerAdvancesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets" name="IncludedInAccompanyingCondensedConsolidatedBalanceSheets" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetIncome" name="NetIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SharesOfCommonStockIssuedForAcquisitionShares" name="SharesOfCommonStockIssuedForAcquisitionShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ValueOfSharesIssuedForAcquisitionValue." name="ValueOfSharesIssuedForAcquisitionValue." nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProceedsReceivedFromAcquisitionNet" name="ProceedsReceivedFromAcquisitionNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StockIssued" name="StockIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AdditionalCashConsiderationlessCashReceived" name="AdditionalCashConsiderationlessCashReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DiagnosticEquipment" name="DiagnosticEquipment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LeaseholdImprovements" name="LeaseholdImprovements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PreferredStockClassAMember" name="PreferredStockClassAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalEquipmentMember" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TK2EquipmentManagemenMember" name="TK2EquipmentManagemenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TK2_Equip._Mgmt_Turnkey_Svc_of_NY_acquisitionMember" name="TK2_Equip._Mgmt_Turnkey_Svc_of_NY_acquisitionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" name="Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NotesToFinancialStatementsAbstract" name="NotesToFinancialStatementsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract" name="SummaryOfSignificantAccountingPoliciesPoliciesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivablesReceivablesNetDetailsAbstract" name="AccountsReceivablesReceivablesNetDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Note2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" name="Note2SummaryOfSignificantAccountingPoliciesPatientFeeRevenueRecognitionDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_BusinessCombinationsAcquisitionRadwellDetailsAbstract" name="BusinessCombinationsAcquisitionRadwellDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" name="ProFormaResultsOfOperationsForTk2Equip.MgmtTurnkeySvcOfNyAcquisition" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Note9ControllingAndNoncontrollingInterestsAbstract" name="Note9ControllingAndNoncontrollingInterestsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" name="AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" name="Note11SupplementalCashFlowInformationDetailsNarrativeAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798687072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Fonar Corporation<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Is Entity a Well-known Seasoned Issuer?</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Is Entity a Voluntary Filer?</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Is Entity's Reporting Status Current?</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,202,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember', window );">Preferred Stock Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6799286096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 7,750<span></span>
</td>
<td class="nump">$ 8,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable - net</a></td>
<td class="nump">3,614<span></span>
</td>
<td class="nump">4,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical receivables -net</a></td>
<td class="nump">11,332<span></span>
</td>
<td class="nump">10,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable -net</a></td>
<td class="nump">18,480<span></span>
</td>
<td class="nump">15,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable - related medical practices -net</a></td>
<td class="nump">5,255<span></span>
</td>
<td class="nump">4,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms', window );">Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Inventories</a></td>
<td class="nump">2,670<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">759<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">50,839<span></span>
</td>
<td class="nump">45,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">14,942<span></span>
</td>
<td class="nump">13,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment - net</a></td>
<td class="nump">15,292<span></span>
</td>
<td class="nump">14,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,322<span></span>
</td>
<td class="nump">3,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets - net</a></td>
<td class="nump">6,920<span></span>
</td>
<td class="nump">7,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets</a></td>
<td class="nump">509<span></span>
</td>
<td class="nump">732<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNet', window );">Total Assets</a></td>
<td class="nump">91,824<span></span>
</td>
<td class="nump">84,888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt and capital leases</a></td>
<td class="nump">727<span></span>
</td>
<td class="nump">2,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,183<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">7,483<span></span>
</td>
<td class="nump">10,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Unearned revenue on service contracts</a></td>
<td class="nump">3,987<span></span>
</td>
<td class="nump">4,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherDeferredCreditsCurrent', window );">Unearned revenue on service contracts - related parties</a></td>
<td class="nump">28<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerAdvancesCurrent', window );">Customer advances</a></td>
<td class="nump">1,018<span></span>
</td>
<td class="nump">1,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BillingsInExcessOfCostCurrent', window );">Billings in excess of costs and estimated earnings on uncompleted contracts</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">14,451<span></span>
</td>
<td class="nump">20,614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">482<span></span>
</td>
<td class="nump">482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent', window );">Due to related medical practices</a></td>
<td class="nump">228<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt and capital leases, less current portion</a></td>
<td class="nump">348<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">890<span></span>
</td>
<td class="nump">712<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">1,948<span></span>
</td>
<td class="nump">3,498<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">16,399<span></span>
</td>
<td class="nump">24,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Paid-in capital in excess of par value</a></td>
<td class="nump">176,761<span></span>
</td>
<td class="nump">173,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(106,911)<span></span>
</td>
<td class="num">(120,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Notes receivable from employee stockholders</a></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost - 12 shares of common stock at March 31, 2017 and June 30, 2016</a></td>
<td class="num">(675)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital', window );">Total Fonar Corporation Stockholders' Equity</a></td>
<td class="nump">69,157<span></span>
</td>
<td class="nump">52,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non controlling interests</a></td>
<td class="nump">6,268<span></span>
</td>
<td class="nump">8,396<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1', window );">Total Stockholders' Equity</a></td>
<td class="nump">75,425<span></span>
</td>
<td class="nump">60,776<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 91,824<span></span>
</td>
<td class="nump">$ 84,888<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees_NonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by non-related parties, - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees_NonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by related medical practices - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical receivable from management of specific centers - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net assets (liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606914-122999<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e604008-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64830158&amp;loc=SL35686385-199418<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 225<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488393&amp;loc=d3e606914-122999<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BillingsInExcessOfCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method that are expected to be realized within one year or one operating cycle, whichever is longer, from the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57788-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BillingsInExcessOfCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054760&amp;loc=d3e55302-109406<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerAdvancesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion of prepayments received from customers for goods or services to be provided in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerAdvancesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and capital leases due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDeferredCreditsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unearned revenue or income classified as other, expected to be taken into income within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDeferredCreditsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity attributable to the parent entity not allowable for net capital computed in accordance and used for compliance with regulatory requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Rule 15c3-1<br> -Number 240<br> -Section 15c3-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAttributableToParentNotAllowableForNetCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity including the portion attributable to noncontrolling interests, after the cumulative effect adjustment of a new accounting principle applied in the period of adoption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6801677808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non-Voting Preferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Authorized</a></td>
<td class="nump">453,000<span></span>
</td>
<td class="nump">453,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Issued</a></td>
<td class="nump">313,000<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Outstanding</a></td>
<td class="nump">313,000<span></span>
</td>
<td class="nump">313,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par Value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Authorized</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="nump">8,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Issued</a></td>
<td class="nump">6,214,000<span></span>
</td>
<td class="nump">6,062,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Outstanding</a></td>
<td class="nump">6,202,000<span></span>
</td>
<td class="nump">6,051,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Authorized</a></td>
<td class="nump">227,000<span></span>
</td>
<td class="nump">227,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Authorized</a></td>
<td class="nump">567,000<span></span>
</td>
<td class="nump">567,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Issued</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798911760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product sales - net</a></td>
<td class="nump">$ 768<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 1,103<span></span>
</td>
<td class="nump">$ 780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaintenanceRevenue', window );">Service and repair fees - net</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,406<span></span>
</td>
<td class="nump">7,074<span></span>
</td>
<td class="nump">6,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees - related parties - net</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">83<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">9,028<span></span>
</td>
<td class="nump">8,695<span></span>
</td>
<td class="nump">26,509<span></span>
</td>
<td class="nump">24,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts', window );">Provision for bad debts and bad debt expense for patient fee</a></td>
<td class="num">(3,979)<span></span>
</td>
<td class="num">(3,830)<span></span>
</td>
<td class="num">(11,859)<span></span>
</td>
<td class="num">(10,608)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ManagementFeesRevenue', window );">Management and other fees - net</a></td>
<td class="nump">9,592<span></span>
</td>
<td class="nump">9,394<span></span>
</td>
<td class="nump">28,216<span></span>
</td>
<td class="nump">27,180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees - related medical practices - net</a></td>
<td class="nump">2,206<span></span>
</td>
<td class="nump">1,907<span></span>
</td>
<td class="nump">6,020<span></span>
</td>
<td class="nump">5,598<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenues - net</a></td>
<td class="nump">20,008<span></span>
</td>
<td class="nump">18,619<span></span>
</td>
<td class="nump">57,146<span></span>
</td>
<td class="nump">54,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Costs related to product sales</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="nump">543<span></span>
</td>
<td class="nump">939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaintenanceCosts', window );">Costs related to service and repair fees</a></td>
<td class="nump">829<span></span>
</td>
<td class="nump">552<span></span>
</td>
<td class="nump">2,168<span></span>
</td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees - related parties</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">1,744<span></span>
</td>
<td class="nump">2,549<span></span>
</td>
<td class="nump">6,481<span></span>
</td>
<td class="nump">7,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ServiceManagementCosts', window );">Costs related to management and other fees</a></td>
<td class="nump">5,122<span></span>
</td>
<td class="nump">5,649<span></span>
</td>
<td class="nump">15,641<span></span>
</td>
<td class="nump">16,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees - related medical practices</a></td>
<td class="nump">1,122<span></span>
</td>
<td class="nump">1,045<span></span>
</td>
<td class="nump">3,202<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">332<span></span>
</td>
<td class="nump">395<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">1,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">4,483<span></span>
</td>
<td class="nump">4,063<span></span>
</td>
<td class="nump">12,617<span></span>
</td>
<td class="nump">12,125<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">14,006<span></span>
</td>
<td class="nump">14,522<span></span>
</td>
<td class="nump">41,782<span></span>
</td>
<td class="nump">42,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income From Operations</a></td>
<td class="nump">6,002<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
<td class="nump">15,364<span></span>
</td>
<td class="nump">11,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
<td class="num">(416)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (Expense) Income</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">5,982<span></span>
</td>
<td class="nump">4,026<span></span>
</td>
<td class="nump">15,264<span></span>
</td>
<td class="nump">11,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Benefit/(Provision) for Income Taxes</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="num">(235)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">7,122<span></span>
</td>
<td class="nump">3,881<span></span>
</td>
<td class="nump">16,557<span></span>
</td>
<td class="nump">11,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income - Noncontrolling Interests</a></td>
<td class="num">(1,222)<span></span>
</td>
<td class="num">(876)<span></span>
</td>
<td class="num">(2,844)<span></span>
</td>
<td class="num">(2,091)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="nump">$ 3,005<span></span>
</td>
<td class="nump">$ 13,713<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,166,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,143,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 5,526<span></span>
</td>
<td class="nump">$ 2,810<span></span>
</td>
<td class="nump">$ 12,842<span></span>
</td>
<td class="nump">$ 8,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">6,166,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,143,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding</a></td>
<td class="nump">6,294,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,271,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember', window );">Preferred Stock Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 279<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAbstract', window );"><strong>INCOME</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income - Controlling Interests</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Basic Shares Outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs related to the management and other fees - related medical practices</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generatingmaintenance revenues. Also includes costs of maintenance on client contracts - for related parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations - for related medical practices - net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue derived from maintenance services provided under contracts or arrangements with clients for related parties - net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8184-115640<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8195-115640<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052803&amp;loc=SL9156464-115641<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the provision for bad debts related to patient service revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaintenanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred and are directly related to generating maintenance revenues. Also includes cost of maintenance on client contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaintenanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaintenanceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue derived from maintenance services provided under contracts or arrangements with clients. For example, it may include the maintenance of software, plant and equipment, and facilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaintenanceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeesRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue, comprised of base and incentive revenue derived from the management of joint ventures, managing third-party properties, or another entity's operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeesRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ServiceManagementCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to delivering management services during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ServiceManagementCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_PreferredStockClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6804716976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 16,557<span></span>
</td>
<td class="nump">$ 11,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,587<span></span>
</td>
<td class="nump">2,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax benefit- net</a></td>
<td class="num">(1,900)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for bad debts</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(300)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock issued for costs and expenses</a></td>
<td class="nump">2,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan', window );">Compensatory element of stock issuances</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Stock option exercised</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivable(s)</a></td>
<td class="num">$ (4,476)<span></span>
</td>
<td class="num">(3,674)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Costs and estimated earnings in excess of Billings on uncompleted contracts</a></td>
<td class="num">(649)<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(596)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(278)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">223<span></span>
</td>
<td class="num">(143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(437)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(4,008)<span></span>
</td>
<td class="nump">576<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInCustomerAdvances', window );">Customer advances</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Billings in excess of costs and estimated earnings on completed contracts</a></td>
<td class="num">(182)<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">178<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties', window );">Due to related medical practices</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">9,428<span></span>
</td>
<td class="nump">10,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,774)<span></span>
</td>
<td class="num">(534)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,896)<span></span>
</td>
<td class="num">(599)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(3,431)<span></span>
</td>
<td class="num">(1,871)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(4,972)<span></span>
</td>
<td class="num">(4,138)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ProceedsReceivedFromAcquisitionNet', window );">Proceeds received from acquisition - net</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Repayment of notes receivable from employee stockholders</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(8,310)<span></span>
</td>
<td class="num">(6,003)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net (Decrease) Increase in Cash and Cash Equivalents</a></td>
<td class="num">(778)<span></span>
</td>
<td class="nump">3,698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents - Beginning of Period</a></td>
<td class="nump">8,528<span></span>
</td>
<td class="nump">9,449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents - End of Period</a></td>
<td class="nump">$ 7,750<span></span>
</td>
<td class="nump">$ 13,147<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProceedsReceivedFromAcquisitionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional cash consideration received by Company during purchase from Radwell Leasing, LLC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProceedsReceivedFromAcquisitionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Provision for bad debts used for calculationof cash flow statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInCustomerAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of prepayments by customers for goods or services to be provided at a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInCustomerAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1757-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Treasury Stock Method<br> -URI http://asc.fasb.org/extlink&amp;oid=6527216<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Call Option<br> -URI http://asc.fasb.org/extlink&amp;oid=6506649<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Warrant<br> -URI http://asc.fasb.org/extlink&amp;oid=6528364<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=65897068&amp;loc=SL4591551-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=SL4573702-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794476656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Description
of Business</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our
business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America
and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America)
to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of
45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management
of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name &#8220;Health Management
Company of America&#8221;.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basis
of Presentation</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly,
they do not include all of the information and footnotes required by accounting principles generally accepted in the United States
of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been included. Operating results for the three and nine months ended March 31,
2017, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2017. For further
information, refer to the consolidated financial statements and footnotes thereto included in the Company's Annual Report on Form
10-K filed on September 28, 2016 for the fiscal year ended June 30, 2016.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786209008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">MARCH 31, 2017 and 2016</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(Amounts and shares in thousands, except per
share amounts)</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">&#160;</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned
subsidiaries and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions
have been eliminated in consolidation.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based on weighted average number of shares common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating
diluted earnings per share for the three and nine months ended March 31, 2017 and March 31, 2016.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the
average market price of common shares outstanding during the period. For the three and nine months ended March 31, 2017 and March
31, 2016, diluted EPS for common shareholders includes 128 shares upon conversion of Class C Common.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2016</font></p></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><u>Basic</u></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Class C Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Numerator:</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Net income available to common stockholders</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,900</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,526</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">95</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">3,005</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2,810</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">50</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Basic income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.96</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.90</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.25</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.46</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><p style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Diluted</u></font></p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt">Convertible Class C Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Total denominator for diluted earnings per share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,294</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,178</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Diluted income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.88</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.25</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.45</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2016</font></p></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><u>Basic</u></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Class C Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Numerator:</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Net income available to common stockholders</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,713</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">12,842</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">222</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">9,360</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">8,752</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">155</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Basic income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.23</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.09</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.58</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.55</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.45</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><p style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</font></p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt">Convertible Class C Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Total denominator for diluted earnings per share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,271</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,178</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Diluted income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.05</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.58</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.42</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Recent
Accounting Pronouncements</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
January 2017, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2017-04, Intangibles &#8211; Goodwill and Other
(Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment
test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets
and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed
in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill
impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on
our Consolidated Financial Statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments
in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as
acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual
periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting
this guidance on our Consolidated Financial Statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
March 2016, the FASB issued ASU No. 2016-09, &#8220;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based
Payment Accounting&#8221;. This update includes provisions intended to simplify various aspects of accounting for share-based
compensation. ASU No. 2016-09 will take effect for public companies for the annual periods beginning after December 15, 2016.
The Company is currently assessing the potential impact of ASU No. 2016-09 on the Company&#8217;s consolidated condensed financial
statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or
on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability
for all leases with a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less
will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for annual reporting
periods beginning after December 15, 2018, including interim periods within that reporting period and is applied retrospectively.
Early adoption is permitted. The Company is currently in the process of assessing the impact the adoption of this guidance will
have on the Company&#8217;s consolidated condensed financial statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supercedes the revenue recognition requirements
in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification.
The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an
amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This
ASU is effective for annual reporting periods beginning after December 15, 2017, as deferred including interim periods within
the reporting period and should be applied retrospectively to each prior reporting period presented or retrospectively with the
cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating
the effect that this ASU will have on its condensed consolidated financial statements and related disclosures. The Company has
not yet selected a transition method nor has it determined the effect of the standard on it ongoing financial reporting.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
July 2015, the FASB issued Accounting Standards Update No. 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221; (&#8220;ASU
2015-11&#8221;). ASU 2015-11 requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable
value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal,
and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (&#8220;LIFO&#8221;) or
the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should
be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March
31, 2017 that will become effective in subsequent periods; however, management does not believe that any of those updates would
have significantly affected our financial accounting measures or disclosures had they been in effect during 2017 or 2016, and
it does not believe that any of those pronouncements will have a significant impact on our condensed consolidated financial statements
at the time they become effective.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Reclassifications</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain
prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any
effect on reported consolidated net income for any periods presented.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794478256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">NOTE 3 - ACCOUNTS RECEIVABLE. MEDICAL RECEIVABLES AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at March 31, 2017:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivable</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance for</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">doubtful accounts</font></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%">Accounts receivable</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">3,879</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">265</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">3,614</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Accounts receivable - related party</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">30</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">30</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Medical receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">31,035</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">19,703</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">11,332</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">31,512</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,032</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">18,480</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable - related medical practices ("PC&#8217;s")</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,648</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">393</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,255</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at June 30, 2016:</font></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivable</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance for</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">doubtful accounts</font></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%">Accounts receivable</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,654</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">284</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,370</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Accounts receivable - related party</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Medical receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">27,579</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">17,452</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">10,127</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">29,584</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,946</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">15,638</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable -&#160;&#160;related medical practices ("PC&#8217;s")</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,457</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">393</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,064</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's customers are concentrated in the healthcare industry.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due
to the customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies
are completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing
these services if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from
service and repair fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection
terms. The Company performs ongoing credit authorizations before a product sales contract is entered into or service and repair
fees are provided.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
Receivable</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare
programs, patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing
in Florida. The carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate
of the amounts that will not be collected. The Company continuously monitors collections from its clients and maintains an allowance
for bad debts based upon the Company&#8217;s historical collection experience. The Company determines allowances for contractual
adjustments and uncollectible accounts based on specific agings, specific payor collection issues that have been identified and
based on payor classifications and historical experience at each site.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding
under management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical
reimbursement organizations, principally insurance companies and health management organizations.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely
manner their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers
compensation claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims.
Approximately 62% and 59% of the PCs&#8217; net revenues for the three months ended March 31, 2017 and 2016, respectively, were
derived from no-fault and personal injury protection claims. Approximately 62% and 60% of the PCs&#8217; net revenues for the
nine months ended March 31, 2017 and 2016, respectively, were derived from no-fault and personal injury protection claims. The
Company considers the aging of its accounts receivable in determining the amount of allowance for doubtful accounts. The Company
generally takes all legally available steps to collect its receivables. Credit losses associated with the receivables are provided
for in the condensed consolidated financial statements and have historically been within management's expectations.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately 11.0% and 10.2% of the consolidated
net revenues for the three months ended March 31, 2017 and 2016, respectively. Net revenues from management and other fees charged
to the related PCs accounted for approximately 10.5% and 10.3% of the consolidated net revenues for the nine months ended March
31, 2017 and 2016, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &#38; Diagnostic Center, PA (all related medical
practices) entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to
the Company, which have arisen under each individual management agreement.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the three
and nine months ended March 31, 2017 and 2016 are summarized in the following tables.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Three Months Ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,228</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,245</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Medicare/Medicaid</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">351</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">332</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Workers' Compensation/Personal Injury</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">5,688</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">5,453</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Other</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,761</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,665</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">9,028</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">8,695</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Provision for Bad Debts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(3,979</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(3,830</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Net Patient Fee for Revenue</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,049</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,865</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Nine Months Ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p></td></tr>
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">3,650</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">3,438</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Medicare/Medicaid</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">950</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">874</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Workers' Compensation/Personal Injury</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">16,772</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">15,649</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Other</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">5,137</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">4,635</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">26,509</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">24,596</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Provision for Bad Debts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(11,859</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(10,608</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Net Patient Fee for Revenue</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">14,650</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,988</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5066-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5162-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786140304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 - INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">NOTE 4 - INVENTORIES</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
4 - INVENTORIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheet consist of the following:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">June 30,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></p></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Purchased parts, components and supplies</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">2,391</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,862</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Work-in-process</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">279</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">212</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Inventories</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2,670</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2,074</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794513280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock', window );">NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">MARCH 31, 2017 and 2016</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(Amounts and shares in thousands, except per
share amounts)</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt">&#160;</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Information
relating to uncompleted contracts is as follows:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">June 30, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt">Costs incurred on uncompleted contracts</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,031</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">894</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Estimated earnings</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">999</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">491</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt">Subtotal</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,030</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">1,385</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Less: Billings to date</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,406</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,592</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">624</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">(207</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Included
in the accompanying condensed consolidated balance sheets under the following captions:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">June 30, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">649</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">25</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">207</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">624</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">(207</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs And EstimatedEarningsOn Uncompleted Contracts And Customer Advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsAndEstimatedEarningsOnUncompletedContractsAndCustomerAdvancesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786005280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">NOTE 6 - OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
6 - OTHER INTANGIBLE ASSETS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheet consist of the following:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">June 30,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></p></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Capitalized software development costs</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">7,005</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">7,005</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Patents and copyrights</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,694</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,571</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Non-compete</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,100</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,100</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt">Customer relationships</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">3,800</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">3,800</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Gross Other intangible assets</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">19,599</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">19,476</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt">Less: Accumulated amortization</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">12,679</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">11,757</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 8.85pt">Other Intangible Assets</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,920</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">7,719</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the three months ended March 31, 2017 and 2016 amounted to $49 and $47, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of capitalized software development costs for the three months ended March 31, 2017 and 2016 amounted to $65 and $65, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the three months ended March 31, 2017 and 2016 amounted to $146 and $146, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the three months ended March 31, 2017 and 2016 amounted to $48 and $47, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the nine months ended March 31, 2017 and 2016 amounted to $145 and $141, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of capitalized software development costs for the nine months ended March 31, 2017 and 2016 amounted to $195 and $227, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the nine months ended March 31, 2017 and 2016 amounted to $439 and $439, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the nine months ended March 31, 2017 and 2016 amounted to $143 and $142, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6626089584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">NOTE 7 - OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
7 - OTHER CURRENT LIABILITIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheet consist of the following:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">June 30, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.95pt; padding-left: 8.95pt">Accrued salaries, commissions and payroll taxes</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">891</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">3,189</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Accrued interest</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">45</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">45</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Litigation accruals</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">245</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">545</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Sales tax payable</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,287</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,402</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Legal and other professional fees</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">362</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">385</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Accounting fees</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">123</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">242</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Self-funded health insurance reserve</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">153</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">392</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Interest and penalty - sales tax</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,580</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,487</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Other</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">797</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,140</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Other Current Liabilities</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">10,827</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>
<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786106864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - STOCKHOLDERS EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">NOTE 8 - STOCKHOLDERS EQUITY</a></td>
<td class="text"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">MARCH 31, 2017 and 2016</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(Amounts and shares in thousands, except per
share amounts)</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
8 - STOCKHOLDERS EQUITY</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
Stock</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2017, the Company issued 1 shares of common stock to employees and consultants as compensation
valued at $27 under a stock bonus plan.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2017, the Company issued 107 shares of common stock for costs and expenses of $2,239.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2017, an option for .2 shares of common stock pursuant to a incentive stock option plan were exercised
for $2.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2017, the Company issued 42 shares of common stock valued at $791 for an acquisition (see note
9)</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6785995440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - BUSINESS COMBINATIONS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">NOTE 9 - BUSINESS COMBINATIONS</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: left"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
9 - BUSINESS COMBINATIONS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Acquisitions</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
March 20, 2017, the Company purchased 100% interest in Radwell Leasing LLC and Radwell LLC. The consideration and net assets acquired
is as follows:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: top">Consideration</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock Issued</td><td style="width: 10%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">791</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Additional Cash Consideration(Less: Cash Received)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(120</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total Consideration</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">671</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: top; border-bottom: Black 1pt solid">Net Assets Acquired</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="3" style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-left: 5.4pt">Diagnostic Equipment</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">545</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Leasehold Improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">126</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Total Net Assets Acquired</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">671</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;<font style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC. The
consideration and net assets acquired is as follows:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Cash Paid</td><td style="width: 10%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right">4,224</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net assets at Fair Value</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,862</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Goodwill</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,555</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Pro
forma Results</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
following unaudited pro forma results of operations for the three and nine months ended March 31, 2016 assumes that the above
acquisitions were made at the beginning of the year prior to acquisition. The unaudited pro forma information does not purport
to be indicative of the results that would have been obtained if the acquisitions had actually occurred at the beginning of the
year prior to acquisition, nor of the results that may be reported in the future.. The result of operations of Radwell Leasing
LLC and Radwell LLC were diminutive and did not affect the pro forma results of operations.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Three months ended March 31, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Total Revenues - Net</td><td style="width: 10%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right">18,619</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income - Controlling Interests</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">3,096</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,895</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class A Non-Voting&#160;Preferred Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">150</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class C Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">51</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.48</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Diluted Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.47</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic and Diluted Income Per Share - Common C</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,051</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Diluted Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,179</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic and Diluted Shares&#160;Outstanding - Class C Common</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>
<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Nine months ended March 31, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Total Revenues - Net</td><td style="width: 10%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right">54,599</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income - Controlling Interests</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">9,632</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">9,006</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class A Non-Voting&#160;&#160;&#160;Preferred Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">467</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class C Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">159</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">1.49</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Diluted Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">1.46</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic and Diluted Income Per Share - Common C</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.42</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,051</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Diluted Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,179</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic and Diluted Shares&#160;Outstanding - Class C Common</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794473072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 - SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">NOTE 10 - SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
10 - SEGMENT AND RELATED INFORMATION</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic
imaging centers.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
accounting policies of the segments are the same as those described in the summary of significant accounting policies as disclosed
in the Company&#8217;s 10-K as of June 30, 2017. All inter-segment sales are market-based. The Company evaluates performance based
on income or loss from operations.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Medical Equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Management of Diagnostic Imaging Centers</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Totals</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the three months ended March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="width: 5%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">3,162</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">16,846</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">20,008</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">218</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">218</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">104</td><td style="font-weight: normal; font-style: normal; text-align: left"></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">5,899</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">6,003</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">81</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">787</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">868</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">26</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">267</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">293</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the three months ended March 31, 2016</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,454</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">16,165</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">18,619</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">546</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">546</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">(Loss) income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">(207</td><td style="font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">4,304</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">4,097</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">79</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">751</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">830</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">31</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">117</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">148</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the nine months ended March 31, 2017</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">8,259</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">48,887</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">57,146</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">981</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">981</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">46</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">15,318</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">15,364</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">242</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,345</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,587</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">122</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,774</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,896</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the nine months ended March 31, 2016</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">7,833</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">46,766</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">54,599</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,594</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,594</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">18</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">11,919</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">11,937</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">242</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,265</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,507</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">390</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">209</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">599</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6620532944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
11-  SUPPLEMENTAL CASH FLOW INFORMATION</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2017 and March 31, 2016, the Company paid $147 and $280 for interest, respectively.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 6pt; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the nine months ended March 31, 2017 and March 31, 2016, the Company paid $740 and $235 for income taxes, respectively.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794523120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 12 - COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">NOTE 12 - COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">MARCH 31, 2017 and 2016</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(Amounts and shares in thousands, except per
share amounts)</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(UNAUDITED)</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
12 - COMMITMENTS AND CONTINGENCIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Litigation</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury,
customer contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions,
will not have a material adverse effect on the consolidated financial position or results of operations of the Company.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2016 and our form
10Q for the first and second quarters of fiscal 2017.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
Matters</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company is also delinquent in filing sales tax returns for certain states, for which the Company has transacted business. As of
March 31, 2017, the Company has recorded tax obligations of approximately $2,287 plus interest and penalties of approximately
$2,580. The Company is in the process of determining the regulatory requirements in order to become compliant.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit
the maximum potential liability for individual claims to $100 per person and for a maximum potential claim liability based on
member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when
estimating its health insurance program liability and related expense. As of March 31, 2017 and June 30, 2016, the Company had
approximately $153 and $392, respectively, in reserve for its self-funded health insurance programs. The reserves are included
in &#8220;Other current liabilities&#8221; in the condensed consolidated balance sheets.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to
its reinsurance and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment
is involved in assessing these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred
date, reported dates and paid dates, and the frequency and severity of claims. There may be differences between actual settlement
amounts and recorded reserves and any resulting adjustments are included in expense once a probable amount is known. There were
no significant adjustments recorded in the periods covered by this report.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73718637&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6620532944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 13 - INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">NOTE 13 - INCOME TAXES</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">MARCH
31, 2017 and 2016</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
13 - INCOME TAXES</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement
of tax positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position
must be more-likely-than-not to be sustained upon examination by taxing authorities. Differences between tax positions taken or
expected to be taken in a tax return and the benefit recognized and measured pursuant to the interpretation are referred to as
&#8220;unrecognized benefits&#8221;. A liability is recognized (or amount of net operating loss carryforward or amount of tax
refundable is reduced) for an unrecognized tax benefit because it represents an enterprise&#8217;s potential future obligation
to the taxing authority for a tax position that was not recognized as a result of applying the provisions of ASC topic 740.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable)
and would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most
instances, the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior
to 2010.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company has recorded a deferred tax asset of $14,942 and a deferred tax liability of $482 as of March 31, 2017, primarily relating
to net operating loss carryforwards of approximately $110,029 available to offset future taxable income through 2031. The net
operating losses begin to expire in 2021 for federal tax purposes and in 2016 for state income tax purposes.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the three and nine months ended March 31, the Company recorded an increase in its deferred tax asset of $1,900 and $800 for 2017
respectively and $0 and $0 for 2016 respectively, in its condensed consolidated balance sheets. During the three months ended
March 31, the Company recorded a net benefit of $1,140 for 2017 and a net provision of $145 for 2016, in its condensed consolidated
statements of income. During the nine months ended March 31, the Company recorded a net benefit of $1,293 ($1,900 benefit offset
by a $607 provision) for 2017 and a net provision of $235 for 2016, in its consolidated statements of income.</font></p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which
those temporary di</font><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">fferences
become deductible. The Company considers projected future taxable income and tax planning strategies in making this assessment.
At present, the Company does have a sufficient history of income and anticipates profitability in the coming years and has concluded
that it is more-likely-than-not that the Company will be able to realize a portion of its tax benefits in the near future and
therefore a valuation allowance was established for the partial value of the deferred tax asset.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">A
valuation allowance will be maintained until sufficient positive evidence exists to support the reversal of the remainder of the
valuation. Should the Company continue to remain profitable in future periods with supportable trends, the valuation allowance
will be reversed accordingly.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794478256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 14 - SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">NOTE 14 - SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">FONAR CORPORATION AND SUBSIDIARIES</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">MARCH 31, 2017 and 2016</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(Amounts and shares in thousands, except per
share amounts)</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center">(UNAUDITED)&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
14 - SUBSEQUENT EVENTS</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company has evaluated events that occurred subsequent to March 31, 2017 and through the date the condensed consolidated financial
statements were issued.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772243056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract', window );"><strong>Note 2 - Summary Of Significant Accounting Policies Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>



<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Principles
of Consolidation</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned
subsidiaries and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions
have been eliminated in consolidation.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based on weighted average number of shares common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic earnings per share and applied the if converted method in calculating
diluted earnings per share for the three and nine months ended March 31, 2017 and March 31, 2016.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the
average market price of common shares outstanding during the period. For the three and nine months ended March 31, 2017 and March
31, 2016, diluted EPS for common shareholders includes 128 shares upon conversion of Class C Common.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2016</font></p></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><u>Basic</u></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Class C Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Numerator:</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Net income available to common stockholders</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,900</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,526</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">95</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">3,005</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2,810</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">50</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Basic income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.96</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.90</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.25</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.46</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><p style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"><u>Diluted</u></font></p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt">Convertible Class C Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Total denominator for diluted earnings per share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,294</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,178</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Diluted income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.88</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.25</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.45</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2016</font></p></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><u>Basic</u></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Class C Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Numerator:</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Net income available to common stockholders</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,713</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">12,842</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">222</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">9,360</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">8,752</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">155</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Basic income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.23</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.09</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.58</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.55</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.45</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><p style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</font></p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt">Convertible Class C Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Total denominator for diluted earnings per share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,271</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,178</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Diluted income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.05</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.58</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.42</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Recent
Accounting Pronouncements</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
January 2017, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) 2017-04, Intangibles &#8211; Goodwill and Other
(Topic 350). The amendments in this update simplify the test for goodwill impairment by eliminating Step 2 from the impairment
test, which required the entity to perform procedures to determine the fair value at the impairment testing date of its assets
and liabilities following the procedure that would be required in determining fair value of assets acquired and liabilities assumed
in a business combination. The amendments in this update are effective for public companies for annual or any interim goodwill
impairment tests in fiscal years beginning after December 15, 2019. We are evaluating the impact of adopting this guidance on
our Consolidated Financial Statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
January 2017, the FASB issued ASU 2017-01, Business Combinations (Topic 805); Clarifying the Definition of a Business. The amendments
in this update clarify the definition of a business to help companies evaluate whether transactions should be accounted for as
acquisitions or disposals of assets or businesses. The amendments in this update are effective for public companies for annual
periods beginning after December 15, 2017, including interim periods within those periods. We are evaluating the impact of adopting
this guidance on our Consolidated Financial Statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
March 2016, the FASB issued ASU No. 2016-09, &#8220;Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based
Payment Accounting&#8221;. This update includes provisions intended to simplify various aspects of accounting for share-based
compensation. ASU No. 2016-09 will take effect for public companies for the annual periods beginning after December 15, 2016.
The Company is currently assessing the potential impact of ASU No. 2016-09 on the Company&#8217;s consolidated condensed financial
statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
February 2016, FAS issued ASU 2016-02, Leases (Topic 842). The new standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or
on a straight-line basis over the term of the lease. A lessee is also required to record a right-of-use asset and a lease liability
for all leases with a term of greater than 12 months regardless of their classification. Lease with a term of 12 months or less
will be accounted for similar to existing guidance for operating leases. The new guidance will be effective for annual reporting
periods beginning after December 15, 2018, including interim periods within that reporting period and is applied retrospectively.
Early adoption is permitted. The Company is currently in the process of assessing the impact the adoption of this guidance will
have on the Company&#8217;s consolidated condensed financial statements.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
FASB has issued ASU No. 2014-09, Revenue from Contracts with Customers. This ASU supercedes the revenue recognition requirements
in Accounting Standards Codification 605 - Revenue Recognition and most industry-specific guidance throughout the Codification.
The standard requires that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an
amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. This
ASU is effective for annual reporting periods beginning after December 15, 2017, as deferred including interim periods within
the reporting period and should be applied retrospectively to each prior reporting period presented or retrospectively with the
cumulative effect of initially applying the ASU recognized at the date of initial application. The Company is currently evaluating
the effect that this ASU will have on its condensed consolidated financial statements and related disclosures. The Company has
not yet selected a transition method nor has it determined the effect of the standard on it ongoing financial reporting.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
July 2015, the FASB issued Accounting Standards Update No. 2015-11, &#8220;Simplifying the Measurement of Inventory&#8221; (&#8220;ASU
2015-11&#8221;). ASU 2015-11 requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable
value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal,
and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (&#8220;LIFO&#8221;) or
the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should
be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of March
31, 2017 that will become effective in subsequent periods; however, management does not believe that any of those updates would
have significantly affected our financial accounting measures or disclosures had they been in effect during 2017 or 2016, and
it does not believe that any of those pronouncements will have a significant impact on our condensed consolidated financial statements
at the time they become effective.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><p style="font: 11pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Reclassifications</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain
prior year amounts have been reclassified to conform to the current year presentation. The reclassifications did not have any
effect on reported consolidated net income for any periods presented.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SummaryOfSignificantAccountingPoliciesPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=64809438&amp;loc=d3e5614-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794479856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"></p>

<p style="font: 10pt/normal Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"></p>



<p style="margin: 0; text-align: justify"></p>

<p style="margin: 0; text-align: justify"></p>

<p style="font: 14pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Earnings
Per Share</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2016</font></p></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><u>Basic</u></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Class C Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Numerator:</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Net income available to common stockholders</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,900</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,526</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">95</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">3,005</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2,810</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">50</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Basic income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.96</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.90</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.25</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.50</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.46</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><p style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</font></p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,166</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt">Convertible Class C Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Total denominator for diluted earnings per share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,294</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,178</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Diluted income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.88</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.25</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.45</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="11" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Nine months ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31, 2016</font></p></td></tr>
<tr style="text-align: center; vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><u>Basic</u></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Class C Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Total</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Common Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Class C Common Stock</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Numerator:</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Net income available to common stockholders</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,713</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">12,842</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">222</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">9,360</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">8,752</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 2%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 6%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">155</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Basic income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.23</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.09</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.58</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.55</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.45</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; vertical-align: bottom"><p style="font-weight: normal; font-style: normal"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</font></p></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; border-bottom: Black 1pt solid">Denominator:</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.75pt; padding-left: 8.75pt">Weighted average shares outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,143</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,050</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -8.75pt; padding-left: 8.75pt">Convertible Class C Stock</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">128</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt; vertical-align: bottom">Total denominator for diluted earnings per share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,271</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,178</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">383</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; text-indent: -8.75pt; padding-left: 8.75pt">Diluted income per common share</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2.05</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.58</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">1.42</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">0.40</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786180816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock', window );">Receivables - net</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at March 31, 2017:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivable</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance for</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">doubtful accounts</font></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%">Accounts receivable</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">3,879</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">265</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">3,614</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Accounts receivable - related party</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">30</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">30</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Medical receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">31,035</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">19,703</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">11,332</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">31,512</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,032</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">18,480</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable - related medical practices ("PC&#8217;s")</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,648</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">393</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,255</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at June 30, 2016:</font></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivable</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance for</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">doubtful accounts</font></p></td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">Net</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 46%">Accounts receivable</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,654</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">284</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="width: 1%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,370</td><td style="width: 1%; padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Accounts receivable - related party</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Medical receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">27,579</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">17,452</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">10,127</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">29,584</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,946</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">15,638</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Management and other fees receivable -&#160;&#160;related medical practices ("PC&#8217;s")</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,457</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">393</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,064</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock', window );">Patient fee revenue - net</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts less the provision for bad debts for the three
and nine months ended March 31, 2017 and 2016 are summarized in the following tables.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Three Months Ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p></td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,228</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,245</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Medicare/Medicaid</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">351</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">332</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Workers' Compensation/Personal Injury</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">5,688</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">5,453</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Other</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,761</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,665</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">9,028</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">8,695</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Provision for Bad Debts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(3,979</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(3,830</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Net Patient Fee for Revenue</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">5,049</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">4,865</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="7" style="text-align: center; border-bottom: Black 1pt solid; vertical-align: top"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">For the Nine Months Ended</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p></td></tr>
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom; width: 56%">Commercial Insurance/ Managed Care</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">3,650</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">3,438</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.1pt; padding-left: 8.1pt">Medicare/Medicaid</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">950</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">874</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Workers' Compensation/Personal Injury</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">16,772</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">15,649</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Other</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">5,137</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">4,635</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Patient Fee Revenue, net of contractual allowances and discounts</td><td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.1pt; padding-left: 8.1pt">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">26,509</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">24,596</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Provision for Bad Debts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(11,859</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">(10,608</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; text-indent: -8.1pt; padding-left: 8.1pt; vertical-align: bottom">Net Patient Fee for Revenue</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">14,650</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">13,988</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of credit losses for current financing receivables (such as trade and accounts receivable), including a rollforward of the balance.  An alternative caption includes allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66008989&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of patient service revenue (net of contractual allowances and discounts), by major payor source of revenue for health care organizations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 55<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68073389&amp;loc=SL9156489-173031<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052803&amp;loc=SL9156464-115641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueSourcesHealthCareOrganizationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794473072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 4 - INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheet consist of the following:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">June 30,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></p></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Purchased parts, components and supplies</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">2,391</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,862</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Work-in-process</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">279</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">212</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Inventories</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2,670</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">2,074</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794428208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CustomerAdvancesTableTextBlock', window );">Information relating to uncompleted contracts</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Information
relating to uncompleted contracts is as follows:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">June 30, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt">Costs incurred on uncompleted contracts</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">1,031</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">894</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Estimated earnings</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">999</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">491</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -9pt; padding-left: 9pt">Subtotal</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,030</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">1,385</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt">Less: Billings to date</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,406</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,592</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt; text-align: left; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">624</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">(207</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-indent: -9pt; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets', window );">Included in the accompanying condensed consolidated balance sheets</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Included
in the accompanying condensed consolidated balance sheets under the following captions:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0 0 0 9pt; text-align: justify; text-indent: -9pt"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: top">June 30, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: left; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">649</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">25</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">207</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 9pt; vertical-align: bottom">Total Costs and estimated earnings in excess of billings on uncompleted contracts</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">624</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">(207</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">)</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerAdvancesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table of total customer advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerAdvancesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Table of balance sheet items</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncludedInAccompanyingCondensedConsolidatedBalanceSheets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786017632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Other intangible assets - net</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheet consist of the following:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">March 31,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2017</font></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">June 30,</font></p> <p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">2016</font></p></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Capitalized software development costs</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">7,005</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">7,005</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Patents and copyrights</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,694</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,571</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Non-compete</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,100</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">4,100</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt">Customer relationships</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">3,800</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">3,800</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 8.85pt">Gross Other intangible assets</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">19,599</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">19,476</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 8.85pt">Less: Accumulated amortization</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">12,679</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">11,757</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 8.85pt">Other Intangible Assets</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">6,920</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">7,719</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798533744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 7 - OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Other current liabilities</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheet consist of the following:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="text-align: center; vertical-align: top">
    <td style="font-weight: normal; font-style: normal">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; border-bottom: Black 1pt solid">June 30, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 56%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.95pt; padding-left: 8.95pt">Accrued salaries, commissions and payroll taxes</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">891</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 8%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 12%; font-weight: normal; font-style: normal; text-align: right">3,189</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Accrued interest</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">45</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">45</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Litigation accruals</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">245</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">545</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Sales tax payable</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,287</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,402</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Legal and other professional fees</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">362</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">385</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Accounting fees</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">123</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">242</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Self-funded health insurance reserve</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">153</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">392</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Interest and penalty - sales tax</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,580</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,487</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 1pt; padding-left: 5.4pt">Other</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">797</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; font-weight: normal; font-style: normal; text-align: right">1,140</td><td style="padding-bottom: 1pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-bottom: 2.5pt; padding-left: 5.4pt">Total Other Current Liabilities</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">7,483</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: normal; font-style: normal; text-align: right">10,827</td><td style="padding-bottom: 2.5pt; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>
<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 6pt 0.9pt 0 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794530080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Consideration and Net Assets for TK2 Equip. Mgmt, Turnkey Service Of NY &amp; Radwell Acquisition</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Acquisitions</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
March 20, 2017, the Company purchased 100% interest in Radwell Leasing LLC and Radwell LLC. The consideration and net assets acquired
is as follows:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center; vertical-align: top">Consideration</td><td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Stock Issued</td><td style="width: 10%; padding-bottom: 1pt">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">791</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Additional Cash Consideration(Less: Cash Received)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">(120</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Total Consideration</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">671</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 80%; font: 11pt Calibri, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center; vertical-align: top; border-bottom: Black 1pt solid">Net Assets Acquired</td><td style="font-size: 10pt">&#160;</td>
    <td colspan="3" style="font-size: 10pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; text-align: left; padding-left: 5.4pt">Diagnostic Equipment</td><td style="width: 10%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">545</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Leasehold Improvements</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">126</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-left: 5.4pt">Total Net Assets Acquired</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">671</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0">&#160;<font style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC. The
consideration and net assets acquired is as follows:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 60%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Cash Paid</td><td style="width: 10%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right">4,224</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net assets at Fair Value</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,862</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Goodwill</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,555</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro Forma Results Of Operations For Radwell Leasing LLC and Radwell LLC Acquisition</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Pro
forma Results</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
following unaudited pro forma results of operations for the three and nine months ended March 31, 2016 assumes that the above
acquisitions were made at the beginning of the year prior to acquisition. The unaudited pro forma information does not purport
to be indicative of the results that would have been obtained if the acquisitions had actually occurred at the beginning of the
year prior to acquisition, nor of the results that may be reported in the future.. The result of operations of Radwell Leasing
LLC and Radwell LLC were diminutive and did not affect the pro forma results of operations.</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Three months ended March 31, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Total Revenues - Net</td><td style="width: 10%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right">18,619</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income - Controlling Interests</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">3,096</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">2,895</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class A Non-Voting&#160;Preferred Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">150</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class C Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">51</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.48</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Diluted Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.47</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic and Diluted Income Per Share - Common C</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.13</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,051</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Diluted Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,179</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic and Diluted Shares&#160;Outstanding - Class C Common</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>
<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: center; border-bottom: Black 1pt solid; vertical-align: bottom">Nine months ended March 31, 2016</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 70%; font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Total Revenues - Net</td><td style="width: 10%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 18%; font-weight: normal; font-style: normal; text-align: right">54,599</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income - Controlling Interests</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">9,632</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">9,006</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class A Non-Voting&#160;&#160;&#160;Preferred Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">467</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Net Income Available to Class C Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">159</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">1.49</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Diluted Net Income Per Common Share Available to Common Stockholders</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">1.46</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Basic and Diluted Income Per Share - Common C</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">0.42</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,051</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Diluted Shares Outstanding</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">6,179</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; text-indent: -8.85pt; padding-left: 8.85pt">Weighted Average Basic and Diluted Shares&#160;Outstanding - Class C Common</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">383</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790611440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 - SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Segment information</a></td>
<td class="text"><p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0">(Amounts and shares in thousands, except per share amounts)
(UNAUDITED)</p>



<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Arial, Helvetica, Sans-Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Medical Equipment</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Management of Diagnostic Imaging Centers</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Totals</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the three months ended March 31, 2017</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td><td style="font-weight: normal; font-style: normal; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="font-weight: normal; font-style: normal; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 46%; font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="width: 5%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">3,162</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">16,846</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="width: 5%; font-weight: normal; font-style: normal">&#160;</td>
    <td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">$</td><td style="width: 11%; font-weight: normal; font-style: normal; text-align: right">20,008</td><td style="width: 1%; font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">218</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">218</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">104</td><td style="font-weight: normal; font-style: normal; text-align: left"></td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">5,899</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">6,003</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">81</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">787</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">868</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">26</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">267</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">293</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the three months ended March 31, 2016</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,454</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">16,165</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">18,619</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">546</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">546</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">(Loss) income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">(207</td><td style="font-weight: normal; font-style: normal; text-align: left">)</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">4,304</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">4,097</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">79</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">751</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">830</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">31</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">117</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">148</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the nine months ended March 31, 2017</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">8,259</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">48,887</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">57,146</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">981</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">981</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">46</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">15,318</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">15,364</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">242</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,345</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,587</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">122</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,774</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,896</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-decoration: underline; text-align: justify; padding-left: 5.4pt">For the nine months ended March 31, 2016</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: right">&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Net revenues from external customers</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">7,833</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">46,766</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">54,599</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Inter-segment net revenues</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,594</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">&#8212;&#160;&#160;</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">1,594</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Income from operations</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">18</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">11,919</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">11,937</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Depreciation and amortization</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">242</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,265</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">2,507</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: normal; font-style: normal; text-align: justify; padding-left: 5.4pt">Capital expenditures</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">390</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">209</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td><td style="font-weight: normal; font-style: normal">&#160;</td>
    <td style="font-weight: normal; font-style: normal; text-align: left">$</td><td style="font-weight: normal; font-style: normal; text-align: right">599</td><td style="font-weight: normal; font-style: normal; text-align: left">&#160;</td></tr>
</table>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6798688032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="nump">$ 3,005<span></span>
</td>
<td class="nump">$ 13,713<span></span>
</td>
<td class="nump">$ 9,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,166,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,143,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Convertible Class C Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 5,526<span></span>
</td>
<td class="nump">$ 2,810<span></span>
</td>
<td class="nump">$ 12,842<span></span>
</td>
<td class="nump">$ 8,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,166,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,143,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Convertible Class C Stock</a></td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">6,294,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,271,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income Per Share</a></td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 95<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 222<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Income Per Common Share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Total Denominator for diluted earnings per share</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Income Per Share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6799284032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">$ 3,614<span></span>
</td>
<td class="nump">$ 4,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">11,332<span></span>
</td>
<td class="nump">10,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">18,480<span></span>
</td>
<td class="nump">15,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">5,255<span></span>
</td>
<td class="nump">4,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Gross Receivabe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">3,879<span></span>
</td>
<td class="nump">4,654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">31,035<span></span>
</td>
<td class="nump">27,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">31,512<span></span>
</td>
<td class="nump">29,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">5,648<span></span>
</td>
<td class="nump">4,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AllowanceForDoubtfulAccountsCurrentMember', window );">Allowance for Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">19,703<span></span>
</td>
<td class="nump">17,452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">13,032<span></span>
</td>
<td class="nump">13,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC's")</a></td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Non Related MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees_NonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by non-related parties, - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees_NonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management of, and other fees receivable from MRI Centers owned by related medical practices - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical receivable from management of specific centers - net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AllowanceForDoubtfulAccountsCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AllowanceForDoubtfulAccountsCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790174416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 9,028<span></span>
</td>
<td class="nump">$ 8,695<span></span>
</td>
<td class="nump">$ 26,509<span></span>
</td>
<td class="nump">$ 24,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts', window );">Provision for bad debts for patient fee and bad debt expense</a></td>
<td class="num">(3,979)<span></span>
</td>
<td class="num">(3,830)<span></span>
</td>
<td class="num">(11,859)<span></span>
</td>
<td class="num">(10,608)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts', window );">Net patient fee revenue</a></td>
<td class="nump">5,049<span></span>
</td>
<td class="nump">4,865<span></span>
</td>
<td class="nump">14,650<span></span>
</td>
<td class="nump">13,988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance / Managed Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">1,228<span></span>
</td>
<td class="nump">1,245<span></span>
</td>
<td class="nump">3,650<span></span>
</td>
<td class="nump">3,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare/Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">351<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="nump">950<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation/Personal Injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">5,688<span></span>
</td>
<td class="nump">5,453<span></span>
</td>
<td class="nump">16,772<span></span>
</td>
<td class="nump">15,649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationPatientServiceRevenue', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 1,761<span></span>
</td>
<td class="nump">$ 1,665<span></span>
</td>
<td class="nump">$ 5,137<span></span>
</td>
<td class="nump">$ 4,635<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8184-115640<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=d3e8195-115640<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052803&amp;loc=SL9156464-115641<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the provision for bad debts related to patient service revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 605<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68054470&amp;loc=SL9156442-115640<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationPatientServiceRevenueProvisionforBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6772196064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 4 - INVENTORIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,391<span></span>
</td>
<td class="nump">$ 1,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">279<span></span>
</td>
<td class="nump">212<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Total inventories</a></td>
<td class="nump">$ 2,670<span></span>
</td>
<td class="nump">$ 2,074<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1),(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Inventory<br> -URI http://asc.fasb.org/extlink&amp;oid=6516093<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786180816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CostsIncurredOnUncompletedContracts', window );">Costs incurred on uncompleted contracts</a></td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="nump">$ 894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_EstimatedEarnings', window );">Estimated earnings</a></td>
<td class="nump">999<span></span>
</td>
<td class="nump">491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts', window );">Subtotal</a></td>
<td class="nump">2,030<span></span>
</td>
<td class="nump">1,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerAdvancesAndDeposits', window );">Less: Billings to date</a></td>
<td class="nump">1,406<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear', window );">Total Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">$ 624<span></span>
</td>
<td class="num">$ (207)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsIncurredOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsIncurredOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EstimatedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EstimatedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The calculation of the subtotal of costs, estimated earnings, and billings on uncompleted contracts plus costs incurred on uncompleted contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SubtotalCostsEstimatedEarningsAndBillingsOnUncompletedContractsPlusCostsIncurredOnUncompletedContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings which is expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerAdvancesAndDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Refundable consideration, usually cash, held by the entity pending satisfactory completion of the entity's obligations or pending the closing of a contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerAdvancesAndDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6766903232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NotesToFinancialStatementsAbstract', window );"><strong>Notes to Financial Statements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms', window );">Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">$ 649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BillingsInExcessOfCostCurrent', window );">Less: Billings in excess of costs and estimated earnings on uncompleted contracts</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear', window );">Total Costs and estimated earnings in excess of billings on uncompleted contracts</a></td>
<td class="nump">$ 624<span></span>
</td>
<td class="num">$ (207)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NotesToFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NotesToFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BillingsInExcessOfCostCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liability attributable to (i) billings in excess of costs under the percentage of completion contract accounting method representing the difference between contractually invoiced amounts (billings) and revenue recognized based, for example, on costs incurred to estimated total costs at period end or (ii) contractually invoiced amounts (billings) in excess of costs incurred and accumulated under the completed contract accounting method that are expected to be realized within one year or one operating cycle, whichever is longer, from the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57788-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BillingsInExcessOfCostCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68054760&amp;loc=d3e55302-109406<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of receivable reflecting the cost incurred on uncompleted contracts in excess of related billings which is expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57795-111642<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 35<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68068069&amp;loc=d3e57807-111642<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790137360">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">$ 19,599<span></span>
</td>
<td class="nump">$ 19,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization</a></td>
<td class="nump">12,679<span></span>
</td>
<td class="nump">11,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other Intangible Assets - net</a></td>
<td class="nump">6,920<span></span>
</td>
<td class="nump">7,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">7,005<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">4,694<span></span>
</td>
<td class="nump">4,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">4,100<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Other intangible assets</a></td>
<td class="nump">$ 3,800<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790134288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 7 - OTHER CURRENT LIABILITIES -  (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 891<span></span>
</td>
<td class="nump">$ 3,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Litigation accruals</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">2,287<span></span>
</td>
<td class="nump">2,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">362<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Interest and penalty - sales tax</a></td>
<td class="nump">2,580<span></span>
</td>
<td class="nump">2,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">1,140<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Total Other current liabilities</a></td>
<td class="nump">$ 7,483<span></span>
</td>
<td class="nump">$ 10,827<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e7018-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=28361426&amp;loc=d3e1243-112600<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786245936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 9 - BUSINESS COMBINATIONS - Acquisition - Radwell (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 20, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_StockIssued', window );">Stock Issued</a></td>
<td class="nump">$ 791<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AdditionalCashConsiderationlessCashReceived', window );">Additional Cash Consideration(Less: Cash Received)</a></td>
<td class="num">(120)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Total Consideration</a></td>
<td class="nump">671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Net Assets Acquired</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_DiagnosticEquipment', window );">Diagnostic Equipment</a></td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_LeaseholdImprovements', window );">Leasehold Improvements</a></td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized', window );">Total Net Assets Acquired</a></td>
<td class="nump">$ 671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AdditionalCashConsiderationlessCashReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received as result of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AdditionalCashConsiderationlessCashReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DiagnosticEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>MRI scanner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DiagnosticEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leasehold improvements acquired as part of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StockIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>On March 20, 2017, the Company issued 42,000 shares of common stock valued at $791,000 for an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StockIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount, measured at acquisition-date fair value, of all the assets acquired and liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAssetsAndLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6741220864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 9 - BUSINESS COMBINATIONS - Acquisition - TK2 + Turnkey - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,322<span></span>
</td>
<td class="nump">$ 3,322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_TK2EquipmentManagemenMember', window );">TK2 Equipment Management</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_CashPaid', window );">Cash Paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetAssetsAtFairValue', window );">Net assets at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,555<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>On June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>On June 30, 2016, the Company purchased 100% interest in TK2 Equipment Management, LLC and Turnkey Services of New York, LLC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_TK2EquipmentManagemenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_TK2EquipmentManagemenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6799491408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 9 - BUSINESS COMBINATIONS - Proforma Results (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenues - Net</a></td>
<td class="nump">$ 20,008<span></span>
</td>
<td class="nump">$ 18,619<span></span>
</td>
<td class="nump">$ 57,146<span></span>
</td>
<td class="nump">$ 54,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 2.23<span></span>
</td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding - Basic</a></td>
<td class="nump">6,166,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,143,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 2.09<span></span>
</td>
<td class="nump">$ 1.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="nump">$ 0.88<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 2.05<span></span>
</td>
<td class="nump">$ 1.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding - Basic</a></td>
<td class="nump">6,166,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
<td class="nump">6,143,000<span></span>
</td>
<td class="nump">6,050,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares Outstanding - Diluted</a></td>
<td class="nump">6,294,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
<td class="nump">6,271,000<span></span>
</td>
<td class="nump">6,178,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="nump">$ 0.58<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding - Basic</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares Outstanding - Diluted</a></td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember', window );">Radwell LLC. and Radwell Leasing LLC. acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Total Revenues - Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 54,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetIncome', window );">Net Income (Proforma)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,096<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding - Basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,051,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,051,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares Outstanding - Diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,179,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,179,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember', window );">Radwell LLC. and Radwell Leasing LLC. acquisition | Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetIncome', window );">Net Income (Proforma)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember', window );">Radwell LLC. and Radwell Leasing LLC. acquisition | Class A Non-Voting Preferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetIncome', window );">Net Income (Proforma)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember', window );">Radwell LLC. and Radwell Leasing LLC. acquisition | Class C Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetIncome', window );">Net Income (Proforma)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted Average Shares Outstanding - Basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Shares Outstanding - Diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">383,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Weighted-Average Number of Common Shares Outstanding<br> -URI http://asc.fasb.org/extlink&amp;oid=6528421<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=FONR_Radwell_LLC._and_Radwell_Leasing_LLC._acquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790341440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 10 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenues from external customers</a></td>
<td class="nump">$ 20,008<span></span>
</td>
<td class="nump">$ 18,619<span></span>
</td>
<td class="nump">$ 57,146<span></span>
</td>
<td class="nump">$ 54,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Inter-segment net revenues</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">546<span></span>
</td>
<td class="nump">981<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from operations</a></td>
<td class="nump">6,003<span></span>
</td>
<td class="nump">4,097<span></span>
</td>
<td class="nump">15,364<span></span>
</td>
<td class="nump">11,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">868<span></span>
</td>
<td class="nump">830<span></span>
</td>
<td class="nump">2,587<span></span>
</td>
<td class="nump">2,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">1,896<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenues from external customers</a></td>
<td class="nump">3,162<span></span>
</td>
<td class="nump">2,454<span></span>
</td>
<td class="nump">8,259<span></span>
</td>
<td class="nump">7,833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Inter-segment net revenues</a></td>
<td class="nump">218<span></span>
</td>
<td class="nump">546<span></span>
</td>
<td class="nump">981<span></span>
</td>
<td class="nump">1,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from operations</a></td>
<td class="nump">104<span></span>
</td>
<td class="num">(207)<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">81<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net revenues from external customers</a></td>
<td class="nump">16,846<span></span>
</td>
<td class="nump">16,165<span></span>
</td>
<td class="nump">48,887<span></span>
</td>
<td class="nump">46,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from operations</a></td>
<td class="nump">5,899<span></span>
</td>
<td class="nump">4,304<span></span>
</td>
<td class="nump">15,318<span></span>
</td>
<td class="nump">11,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">787<span></span>
</td>
<td class="nump">751<span></span>
</td>
<td class="nump">2,345<span></span>
</td>
<td class="nump">2,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">$ 267<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
<td class="nump">$ 1,774<span></span>
</td>
<td class="nump">$ 209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=68079674&amp;loc=SL4613673-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786223456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)<br></strong></div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_Note9ControllingAndNoncontrollingInterestsAbstract', window );"><strong>Note 1 - Description Of Business And Basis Of Presentation - Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM (percent).</a></td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM (percent).</a></td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent', window );">The ownership interest of the original investors of HDM after reorganization of newly expanded HDM (percent).</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Note9ControllingAndNoncontrollingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Note9ControllingAndNoncontrollingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHdmOriginalInvestorsOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business. The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a 24.2% interest in HDM. Health Management Corporation of America retained a direct ownership interest of 45.8% in HDM, and the original investors in HDM retained a 30.0% ownership interest in the newly expanded HDM. The entire management of diagnostic imaging centers business segment is now being conducted by HDM, operating under the name, &amp;#8221;Health Management Company of America&amp;#8221;.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6794455168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
<td class="nump">128,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795192464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract', window );"><strong>Note 3 - Accounts Receivable Medical Receivable And Management And Other Fees Receivable - Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Net revenues derived from no-fault and personal injury protection claims</a></td>
<td class="nump">62.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">62.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs', window );">Net revenues from management and other fees charged to related PCs</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
<td class="nump">10.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableManagementAndOtherFeesReceivableDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Approximate per cent ofthePCs net revenues derived from no-fault and personal injury protection claims</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenuesDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net revenues from Management and other fees charged to related PCs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenuesFromManagementAndOtherFeesChargedToRelatedPcs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6740479344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6790037952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 8 - STOCKHOLDERS EQUITY - (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2017 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares of common stock issued to employees as compensation (shares). | shares</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue.', window );">Value of Shares Issued to employees as compensation (value). | $</a></td>
<td class="nump">$ 27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares.', window );">Shares of common stock issued in settlement of liabilities (shares). | shares</a></td>
<td class="nump">107,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue.', window );">Value of Shares Issued in Settlement of Liabilities (value). | $</a></td>
<td class="nump">$ 2,239<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross', window );">Shares issued pursuant to incentive stock option plan (shares). | shares</a></td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan', window );">Value of shares issued pursuant to incentive stock option plan (value). | $</a></td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_SharesOfCommonStockIssuedForAcquisitionShares', window );">Shares of common stock issued for acquisition (shares) | shares</a></td>
<td class="nump">42,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_ValueOfSharesIssuedForAcquisitionValue.', window );">Value of shares issued for acquisition (value). | $</a></td>
<td class="nump">$ 791<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SharesOfCommonStockIssuedForAcquisitionShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>During the nine months ended March 31, 2017, the Company issued 42,000 shares of common stock valued at $791,000 for an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SharesOfCommonStockIssuedForAcquisitionShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>During the six months ended December 31, 2016, the Company issued 107,000 shares of common stock for costs and expenses valued at $2,239,000.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_SharesOfCommonStockIssuedInSettlementOfLiabilitiesShares.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ValueOfSharesIssuedForAcquisitionValue.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>During the nine months ended March 31, 2017, the Company issued 42,000 shares of common stock valued at $791,000 for an acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ValueOfSharesIssuedForAcquisitionValue.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>During the six months ended December 31, 2016, the Company issued 107,000 shares of common stock for costs and expenses valued at $2,239,000.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ValueOfSharesIssuedInSettlementOfLiabilitiesValue.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>During the six months ended December 31, 2016, the Company issued 1,000 shares of common stock to employees and consultants as compensation valued at $27,000 under a stock bonus plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ValueOfSharesIssuedToEmployeesAsCompensationValue.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP). Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=65888597&amp;loc=d3e16649-113920<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786013616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract', window );"><strong>Note 11 - Supplemental Cash Flow Information - Details Narrative</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income Taxes Paid</a></td>
<td class="nump">$ 740<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Note11SupplementalCashFlowInformationDetailsNarrativeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6786035760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NOTE 12 - COMMITMENTS AND CONTINGENCIES - (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent', window );">Recorded tax obligations</a></td>
<td class="nump">$ 2,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Tax interest and penalties</a></td>
<td class="nump">2,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance', window );">Maximum limit for individual claims under stop-loss umbrella policy for health insurance</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6792934112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NOTE 13 - INCOME TAXES - (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Mar. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred income tax asset</a></td>
<td class="nump">$ 14,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent', window );">Deferred income tax liability</a></td>
<td class="nump">482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net deferred operating loss carryforwards</a></td>
<td class="nump">110,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in deferred tax asset</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Deferred tax asset net benefit</a></td>
<td class="nump">1,140<span></span>
</td>
<td class="nump">145<span></span>
</td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOtherTaxExpenseBenefit', window );">Deferred tax benefit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other tax liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=63044130<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68052875&amp;loc=d3e28680-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32621-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e32123-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>58
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O*NQ[Z_;N'QM?!%4#O^Y"?0%02P,$%     @ KGFJ2IE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M+GAM;(696V^K1A2%_XKE]QR8/3>('$L-5=5*K12=JNTSL2>Q=<"X0.+3?U_
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M<;*PWZQ3IM%@!/L*<O<=H(ECTUH>:G22"8?#[IX#-#;)0XU. ML<MGV.3&6
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M2H>P))9W):(X47,>Q$P:2H=M;H'-2=I\A.+)D)./KSF@K)'KJP)09&,Y)94
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MVO[/N/M[=W@W[?"A;;;C>W>+X\M_M_\#4$L#!!0    ( *YYJDHNM1:<9P0
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M9+I;B3T3WH1XV8; CY'K-E23D3RC9SQT,, -23=&Y^/Q @'Q8DC/>&:/"4P
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M%V7XI9O@!Y?O;B^%>V_[QZ1[KL?KO_&EK<[3U69PNU]=_0=02P,$%     @
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M_!#.=ARST?#833^(S=^X^ U02P,$%     @ KGFJ2DC7M?RT 0  T@,  !D
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M-BYX;6Q]4]MNW" 0_17$!X1=]I+5RK:4312E4BNM$K5]9NWQ10'& ;Q._SZ
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M96/_2T0'7LKJQH]0[3_89$@H73C>^K,9QFPP'+;C#V+3-\X^ %!+ P04
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M<\!H+OX;W( 9N,W$:!2"*?=%Q:"TX#.+2873UVEM.[>.TTD<S6'^@' .")>
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M!;4+QWM_-M.838;#?OY!;/G&Q5]02P,$%     @ KGFJ2L$0ZW[! 0  -P0
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MNV\(W8/@Q_[[B'/]2+/\#U!+ P04    " "N>:I*C8<.EL@"  #Y"@  &0
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M<5+RG3+#6(]EW_CU$R6:H:D-QLYZ^1]02P,$%     @ KGFJ2BHPA-;@ 0
MY@0  !D   !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL?53;;IPP%/P5Y ^(
MN9.L "G9J&JE5EJE:OOLA;,+BHVI[5W2OZ\O!!'6[0OV.9X99HQQ.7'Q*CL
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M.['S:RG[+4+B5$-+Q!/KH5-?+HRW1*J07Y'H.9"S26HIPD&0HI8TG5\69NW
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M_K7F5K&>*P(\2I &&"E\D,*W]<$-!9E0]!IB-8W5X#1*TPD)I I)#,,$($P
MP"03F%X37F^CB:<P@ J3B, P(0@3 C"3;5;A;)LX];T)RUQ$"$YAE A$B>8H
MQ(,-8M @?N(MQW-,SXLF61Z(;E (B$* +'>^V 0T2)[(DLPPPS@-)UD 470/
M)0514B"+#QM@#VX"WA-I!M$-*?:FG]DCU2W.G9Z$@43!'0NXH>!G.@J>-XL@
MF2=ZH.IQT%7#-2?@#RJ.92.=+5>Z=]L.>^!<,>WHO>A_4J$/W7%2L8,R0Z+'
MHC]Y^HGB[7"JHO%HS_\!4$L#!!0    ( *YYJDH;RL 5=P(  +4(   9
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M?(.IGM!UIN)_P 6HDNM,%*-@5)BG4YR%9.WDHE)IR><X-IT9A\G_&F8/P%,
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MJU*DOW!8%$?1C#R^:P)MF\P.I:U,JB3!ZB@5!G@CIPQE7PAP'=MR&"0PTVR
M[Y] &RBS46E3B_%<;SA(DE7-].(@E%@90XF[-3 5QK=1X/HHV:R*OF]'1!B%
M $A99: XQN]P7#P?/S#O[O15ZOK8'X4;9V<N5=L)NAN]';>?17=Z0^-K>-H
M,YYVQ_/^M/?3_7"V_SNKCWG5.*^FM6?&_F1W,*;5-G?_D]U+)YWM;S>%/K3=
M96ROZ^%,/=RTYCS^7^#=_K18_0]02P,$%     @ KGFJ2MI'KUNR 0  ) 0
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M:6$E KEGC(A_,Z"\+\(X/"9>FEVM3 *5>4=V\ O4:[<2.D*#RJ9AT,J&MX&
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MJQF.6VKBY?RL_FR\*R];+&#)R)]F)^LBG(7!#O;X2.0+Z[^"]9.%@37_'4Y
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M?EP0V$L]?51S/G2\82%99YLY&O\HY3]02P,$%     @ KGFJ2N,9X<=\ @
MPP@  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N>&ULC5;MCILP$'P5Q ,<
MWX%$!.D"J5JIE:*KVOYVB!/0&4QM)US?OK9Q.&)\N?P!>YF9W5FP3=IC\DHK
M")GUUJ"6KNV*L6[E.+2L8 /H$^Y@RY\<,6D XU-R<FA'(#A(4H,<WW473@/J
MULY2&=N1+,5GANH6[HA%STT#R+\-1+A?VYY]#;S4IXJ)@).E'3C!GY#]ZG:$
MSYQ1Y5 WL*4U;BT"CVO[V5MM/5<0).)W#7LZ&5O"RA[C5S'Y=EC;KJ@((E@R
M(0'X[0)SB)!0XG7\5:+VF%,0I^.K^A=IGIO9 PISC/[4!U:M[<2V#O (SHB]
MX/XK5(8BVU+NO\,+1!PN*N$Y2HRHO%KEF3+<*!5>2@/>AGO=RGNO]*\T,\%7
M!'\D\-SW"($B!.^$\"XA5(3PT0R1(D1:!F?P+IM9  :RE.#>(L/WT 'QV7FK
MB+^N4@3EVY'/>#\ICUZR(%BDSD4(*<QFP/@33)+<0HHYQ!L1#B]@K,(W5;'Q
M9W3_-D$^1R1+K89/1;9W16[*#(S-"B0_F&:(/_ 9&@7"F4 0Q%JW!TPL,:W$
MA)K3W #15(HYQ LCK1TFS =V(J.=R- /URRP, HL'NC'@ DG52XT(_GGD&(.
M\99Z/^88WX_-=F*CG=C0#]\LD!@%D@?ZD<R=A-J*S1_ %'-,&&@?VO8^YL;0
MTFAH:>A(8!;@QXUQ@W(?Z(D"W:P(;8O*31A]U1@P7AAH33&"]-?L3#;@!I*3
M/ VI5>)SRX2;270\<9]]L8%K\8VWRCU#O! GM-SPW^6'X_T'(*>ZI=8>,WYL
MR,W]B#&#O';WB2_9BO]1C!,$CTP,8SXFP[$Z3!CNU"^#,_ZW9/\!4$L#!!0
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M    >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;'U4VVZ<,!3\%>0/B+EF-RM
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M8<P0%^Z_\*_VP&\]_:1".R:&*1\3=?:K"<-M=ZWQ^KO5Y#]02P,$%     @
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MDS^]37_XTUN\A^\;V>=1F#XD<,_27Q:_/??BIMUQ';O=<@?%+\<;_+)5_:6
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M#)KBA>]#I"'8@M@'&MCZ2#.)'W\$,JRGEX-N,@@<3V'YV:CC?)=LO(7_W]^
M$H,+^-_\8)?1E:1 '+ ;RX_(KDK0O%/DGCL$BUW'Y="#D2?BLWHTGN$&WN &
M[MKY*GI7>U/67 "O:53/)"I!V$5##OP$W"SRY%=-.3LHAG%2^<(UE]9?,+^Y
MG/SEI\NSD^GU_%M[^M?WLYM?R^=EEZ0#WM2 ?5=OFB,!(#L;Q,NV=#K@]&S7
M6\;KTK\+%D&) 5Q$:9Y=W\71VO:!8J(GW[<3!.8A6BW]N/S6H) G6U"7$I;[
M7DK$".?!;8NRS01*KT47X36@4"X>M$Y-^P>2UJ^5M(S<DJ+,>!+0 *? +,NT
M=0'7$=%'='20*_H 5MT!.&3)TE[3&QQR9T$-.;KRD#X?_!3I_1C0]L9^6V.D
MB&)CP_LT?HY([]2ZSQZER+'A.?;/5>11NG*\31] .O[C@$5)P]Y_V0XEL'#M
MKM.PXQWRE]6_0/ZZ:NCSU^S27Z,PB5;!D@X6&@"D Q&USYCC':IC=@ZV/DOG
MXGKZ\_3B_71>H4,LMXO43CS2]ZJD_EQD&%(NZ3VBM3WSXH+8J[[]"DXKLF&X
M1XE1!Z]CUL#R: LGRENMHD>2>_2D)=@E)/DK7N]CD" # -O>OO66) ;X)O67
MTN+HDDT&P.'Z:^6K[+I\AXY;M11SD6O&1\TUD\OYS=P>7YS8T[]=32_FY:UF
M55D]&H3HQMS[O5<GU3O[TOOV*D(5\):)8^\]Z[I=>/F=N_:O=.Q @2,)1E0*
M,*\B4M++QX9$CF/?^Z&/KAN\WENN@Y#\06GPL?2JHH5IA6XJMDC)C+F87)Y/
MR\8-<9Y3E-^7&Y^E9(4)Q!)0+5YE(B4IX8@7K-:;CN3VXYJK!)AW/IQ W\Z?
M6?GNQOLD9QVDFBFD9W5"^AU@\BY(WQ[I]8Y+"Y8T +_N1;)O8/L/!2%WT^0@
MH+TD6-C&?5?H]3&<*L4;?O&#^P<DQ?%'V,1[0"*ML-^K<A*LMGC?YSQ+K;'_
M:7FQ1_Z.4^#@A[M7C%ON#)H%7([AY'VLMBSPW8+*[1PO?]LRX29L3L!^+@)0
M:$-]"WZ.?Y%/9H,T!#+7OGVR(_UHK_[1)SX8;XN E4\ZS&NT+/Y1Z;:MLH!N
MF7RKI62U5"LC'97H@+07NM*P_FJ8!6P_?N&E$6CJ_HK9'^Q8HI>J-#;Y2=&&
MWM;_Y,>+("DK*$= 9V@% !]8^OP;[KF!3_(>D, O(539]HYFNO@>!I-FJ: L
MDZ/D>)_Q\G)7TKOGNY+D=8_4BQ_GW]RP+*M?_V7F_ &@71Q*XOM.),N"/2?R
M:@O"$,UNLD0K_5=5V\)V:UKE$M7P;Q,Z0/!/P7$X[*=!"'2]!_9K4%Z>U(&X
MC>(X>B0\EWP*=G2["NZK)>H)RO/@=DM?$HO)RY):FQ/._,+WEXJ \40CY-X"
M\)8$$K2JX!4YJ,.7V^\E/-]IG-7C&6\Z.M$DKX\!W*Y]WO3+M-[G77LAO.\[
M_SX(D=KQY3BF\9S;,8Y4>^/%Y<W4=N&JD^E\<CV[NIE=7MB7I_:[]_/9Q73.
MNO:[\7PVQT^OKJ?SZ<7-F*XZ0IGVIL2 A(61/0X&X0*MH/\]ODWH8/Z?UWM^
M<:73RXOQM36YO+ZZO&8 \=;Y^W?SV<EL?#V;SFU\V-RZN;0GEQ<G:#V<X&_S
MR[/9R?@&_CB=78PO)K/QF3V'9TS/X5%S^WQ\/?G)ROEFT/2TC\9K8M46?B*N
M'=CQ5,EVASC8)K7A]//W*!WQCF- W<7X_<D,GGE,0%DOVX$3/UG$ <DC"QGV
M-@E"Y)G3NSL?J=6W_KQ=/=D,>L\!V'Q4?39>^&3C\8O!+MJB1,8O%N)'@H,=
MWWNA"'&D'/S6$$'PR3+P[D/@6*"# 3^^Q[U>^'BF$S"$[M55T3:V;@6F)B@]
M*+ER:S]Z<+T!!9@CJ!HK?@Z@(Z.X)Z 0B$BK\+C\3[ZW2A]LPP(U76%PP7@-
M)+_P:(-^.CEOVC,0^W$ #(QX$?(G>"H8V7AQ@"*&HP)'CP\!&#./P*)L8&$K
M])WPUOJV>I_G '!LP9L! &(<"F/S[':WV?Z#YH7X!(+RT&5AJ=0+0EIJ&<"Z
M@/1'L*N2AV"3K1K=6=U><_@'6=XA( B9<0 ;1WY3%"51G,@EYKJ=5K/UAZIE
M!1VA_PB[!'J6A[X:AA\W&J &B RJL793C4:K(I\@ 3;^"/HA716%:,*SU*:7
MR$3W%AX<,RP>*)5__!_#=KOU?0F'EJ+[#']TJ?M]DXR)! &\PDA$F#*BX34L
M;['@V_A)WG89B)JQ1,62?LN\7B(K *5)9@@\>!^!:GP_!$4 A!3KOS8N'"_)
M]?D8 *!B$ ,NX1M@&HA\S4>M30PJ<[!!WQ4JN+0)P=IX7F D=>#^TIJ(DR#D
M\Z7D\"E<9F/J UTV!EU] ?+1;2%:KOU[](N3'[GQMZ8])ACA^:LGQX+%GNPE
M"G*R'%;;I:].#C\G#\!=%*5*#(,PBGGKLE>RC5>J>'>AKO=AH+V)M$&*\EG-
M9RY1B78XZZ&PC""48Y,1HT.@>X9U=(0;&;!"11H$O P%B;=QS,)_$6^]57)L
MT85 <@!7Z*.&BLD1" ] A5Z?C4E#V>8+SI9-PZ:#*[>KE/<484T?8I\]2"#L
MX?"P%]2GDZ4C!!9*(7@!.%VX%PJ&@)@EF@S(]]6VJ">D#UX*[_\$L)!11&=)
M/?:.TQV>,-W!)[LV%WP8-)%J[+MMC%X.R]AIQR9W-=(5"Y!]9R%/&;B<#_<J
MU*A=EY/Z;6*/PW!++D&,5Z&FC^1K ?G^!=9?P1U(JD@QZUL HSUDIW#=B_F%
MH$JS4A=I@R2>OS\'J?\KRMOY[,>+V>EL,KZXL<>3R>7[BYO9Q8_V%>@,$U0I
M:I2@%RQ5J<_8^_49^R7ZC%VOS]@'Z#/6/GWFF5B\TMP 3WD62E!\^&6L5_$I
MI 5/!<UA?<%L)E0=DOYK[S>0B6*H/8*!L'IJH.1;6LGV%LY\X,4JM(6^7!&)
MQ#M6*]:WX!#BPT0("2&+G#D&C@I<)PGNP^ .SBD*.63D(F$R"$E QUZ8>,RW
MK8R+^*M@#6\J+')AXJEI3\4DMM##1<XJ=I-9VE;.--$C 7%Z-5?@H<A%6$@I
MNO42/EZ/RAOFB3<LW-)A0V\)TT@^EHFT0[\9^3U6E+G,C#A'=AMQZZ)(',\G
MP%DVH"RT^ZV&"X=68+Y"1SI0"S/1.?+H+.B(Z+]YC!H<'5S[0+Y+>4,28EK_
M)0.OZFH6+MYJ0<(0GG!+OL8*))+#:[-9!;)20-$;P!,[S6DQBD_KM:RE^!(K
M5GN6%,C.;NZC?E-Y*RW8663/2)C$:NU-A)X%/"($!/G5T"[&[Y0SRR:YBJ^0
MB-!$0<G7 PTF&:Z!=*/\UFN225%Q$FI9>_$'V&^0]@O?W'6)A&=T82^W)&@)
M4K)46>R\%"/*8.L[ML(Y8D04!PV#N $4JTALMSU4T&TW'"DWL)%/P&M:-P39
M+H#V7=&WV)6MXAQ9M-6NRO8[]#KK8KM&-2.*O[,R_S <8B]8D4NDL'L*#V_L
MGC-JM>AGK]V'GZ,>_-=Q6BW\V7:&+GW9LD[\,")>A(_XI<@E*C:X[[C]OOS?
M&7;@MU:O)?_#WX(' 12/A;E/\,Q6<]3G'RWZT>[1CQ[_U>7OW(ZE#L + <Q
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M]]H+MW<HH#DG6(IWN(9#!+/*/<Y&<'-=0/5<$*LPX:&IYRFH 0!J-HQJZ*"
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M8:,SLY_37$X<0[H6<"MB3&@VZ^[I$%=;>[^QY446R4.T F89/88HWF&'@V5
MM7WB&XM3$%]<0WJDFG/R$"1XF#$)4G*G9(H-G-?<0 HT;*1&,8.02,88[VEE
MN>-J1BY[I!8FGDJ$,57M('0&Y$$A476;E25./N?,%?P_EGGF*/O1JABBK,;/
M3*_F>OJ,M)W?LD(HS6,?BX.@PRT%!C"YC>'*E2T1O/0;6J-PBFF8A]%LU6@7
ME=U&YE6]6=SNMQI@+:A-OJ(&HBBF:3*2#TQ!IO6*N^3F,6IP0B</SI$W=,P^
M</867[#J:@Z8B?6,3[BE%-(*))+*()-RR.U"3;!P_C4%.&@Q))IL+6O'7.MG
MUVA490\T59JK!3MKYX:I91X1 L((>6:5;3;W,$;A)LH']MCCZ[$N+L,UM>_+
M;;TF&933BEHX#9%G-YF[7IXF7M(\E5_O91BQLGP*A7/$"!<:9C"HC&8]R15'
MDPMTY/7+8R.?)KR_9F)@[Z^J^!>;:=\C8P=_]BA9<,0C.[B]2-L9NO1EZT7C
MXOM]^?\E\^Q;S5&??[3H1UOFN?-?7?[.[7S6//L<:%]NGOVH^^QY]JWF<&BB
MH=M3[[^G?F)@[RVP^!>C2+?C#%RJ1P?RX\P[2C\<.9U^B](I!SQ I-=[T:9W
M._+_2ZBRW6QWZ =E^ $Y4CYALT>YKVI7NJW/HLH<:%^.*@?NLZD2T- ST4"[
MA>]?BM-AI6E!N\V-%*N^WJJ]_H#Q\SNF*1J3$+4ZQ*/JNX[1D(C]XZ[[O9UK
MNL6I.C)SNM-K'>^;Z*[G@I-T0S\[[L:]6I-[LU, [?9):Z ,N+\!8T'+[>Q*
M*Z5,1$[JR4(!#[XQL%'R_<W9'S3"54V*IB@>5J6R)T!\%08T^ R2U6K>9YJ(
MPXEB"F9#$".17Z7G+,G;DQ5HWAHQBT)G;@,*F1)L%MH6G\6EJI0WX>FL)21-
M5<R^;S]HJGUNJF+E/'696R@SV]1 0[5M5@%1"6=EZ42Q_1,91TW[%P%&CT;5
M6\ #1GDNLG* Z?&^V'%G&QMF'&"IJKUD\X!CPG,_@?1!'%1W!E#3U5N]X^^1
M_\3&S-$3_RZ0@"^"JU<H;H%5V((%+Z-\3[DU])8"M3[XJXVQ+<I1H*><FV:<
M.4 WWYL[R=<Q\\Q$F@":& 2'+9CET7[I!3Z+A@X>X3TX:(0W363D#P\G(:M(
M0O;A)*3:(*CDJ2(!R73:/HW/-FQSU7.D(7J".<%!J&K@#H^_RS<)@&V?2C<3
MMH\;[ZA:28WTR#B[#E'>&#NC=7LC,(NH)-4''9"*&ZM0H)?P3.GHSBS:HM 0
M/9UKI<P>*LWB6[-7%*/Z*K>UEB+(5\*<Y?#1K58A#3*;JIP?J9X9?1D!%$%]
MX1QUPUVF V.G_FVL> N0!I!%@:W  ]L.E;/[&1_IMH]5/.^Q8A Y=D?W6591
MG!U#EUN>,AU'WN+!43%L9$+6BM=&)V) '($!)M/6B!7R586Q0!OE%*,19L)1
MX#[VW?M\5VX$+T$C3UCJ7A26#%5AR(4:\P-XF$ RV:N>QH]0257YK MM87MA
M;A2MQ.K%XQ#%%HU 0_<QJI>-%:[/L\\PB4J4#M #Q,E.CZ1L#P)7YQ>;"04<
M)<.<!UHRNFM@(@8'*CG6Q8#K,#*UR.&I&(1IE?$JS[V/?<S&1G4 NT J<P03
MS./E2C)Y4YHLD\=;DXFGN%ZV!!8NPOW:59_G_'#6P=R(.3P<L#:C6>!=!8ED
MA*DO4ROOGL-\,(L?'L3B=5IZD)\1CYM5/1R^:4TYO7,IC8R")!O4O&,L>SFC
M.L]2A)$0VU)+TV:9TH04(C6W_27<Q3:Y"SJD2<30_/62F.F2F%'-X$DYGNA>
MNT0HJJMI(F<1;TZV@ TXM7ZB0T\\72U+63/SQ5%AJ30A)M$R.]7]%K:W5J!<
M%]/?(FI,PT7.#3W?2V--PA8X'YQQEJW,'+_,'&4TL]+R-;=(] N1B@]\5@8J
MHWYTQPY<V.(US1A%%38QIN\5IC*B7AU*TJB=GP6GRC6R[CCFS Y;>=HYVTVE
MY1&L*Y4^RM48(@I1DRE!PYMFX::]WOAS;!-FY%WL.X(RF+WB!!I*9O5!)&:#
MPT6X;TQI$3WTF0M;TO+,=?2H2@=="J)*M0S&K@,U)-#,0$-,F5E8:18(RVXR
M)[CO8 >9'DDH\%5'&5I4CE(V_CO:F692.Y!();D9D\OS(,'!MU */X&\27R>
M'HCL'ZF9SY=(/^S"0UPBS82KV,$::ZEYD@AB/<<R@U!O$]M,VQ4I-;WG^16$
M0?4:KJOUX+FHFVJSSHVL6@!.3Z%0^6^&;\*2M8SX%JM5^&'&$S)V )0G2:*8
M]"[3+80<<)Q9K)JCZZ96DEN"GB6RO]5T)/4I=PM$$B&<ZE;H"2?TL:=?IRA4
ME*YE96LDYHW!HQN<A;7@0#SG/G+  -NG4\A0V6B.I0-V%+F7?( L*&PF*J,=
M$#*/64I1@T*$SI_=DG #/2-M!/ <*M)J(!=6N#^;G5YJQQ"FX!$S2+U@E5L.
M*1#()7U%-M4OV9W,;RR#WVS*',,'T1_XL7G&,^$OJ7V<66PTN**\-&9^]2 W
MB?@YEC8%\4 M%V8\D/+&2SY@U$8*._"2^73"G$%.2WZNGF%>J0,)A,%VFQ1!
M2/D6]W7-4A*SI/ELO*CD()FJL9DJ("C_WGY0!2)&BQ#=:4PJ3)1@E7F(*)<$
M+/9>L7)CA):1!].#?2G]TYS$>$FA..5Q4+R.FI"E...*!WDJ]5X%Q>@]==88
MYOH$!T&\R;M(,S;MY8/B8AJR!^ 9O-L25H(#(17\^2THQ<A!)<H/(MU[@3UA
MDK%8?%+-I2I@R>+TL6\D,E,H@5J2Z/G44D(E_=M(X!J2+RX]5'508W2%3U96
MHIH5016GMZEN%>(A5&=<"_C7226YH1;5Q422FE$Q_[SD@J_!SZ_!SZ_!SZ_!
MSZ_!SV<'/XGM8U6>\/>Y?3V=3&<_C]^=31W[?'H"W/_,^(PR/,_'%^,?I[JW
M&G?I/YU.S9OMH_?S$_O-<9V0^.':F";;0)EUD!0Q[G)H^*JDBL7D/2BV[D<#
M(W_JOGLUF<.S9XS)X^/=4WMI8NVX8A0PLO4A=8/B)CX=I^]V*Z]L:.N4"_7A
MVI;17ZC3TCW*\LOCI# Z""-GT.IP<R&<=7E>.UNV>'_/;3,':'7:W$JK.VP=
M=G\&M"JTUR-8[:-OLMG>WQR3M.MWA]2KJ$-_M>$ /W_+<S7UW[WF3N%L1VSJ
MU!YRHZ_.H'7@3JEMRK9+\83*/6L/G![1A#MPNLQ66X[;'ARZ9^V1TR,8<0JE
MZL'5Q[F<K[YG70!PH/>LZ[3ZY;F%:ERF,9?V&8?^YM]UTNVK,:.O$W._3LS]
MCYJ8^SS;\PN-CWVUX_SO/8:V5B4TIJK:>Z>J'KCQ+Y_3^F5V\S]GWFM%YY//
M.XB'DL _=\SLER235]N7_\AQM<^3&?]*HUF_$(U]'?%:,>+U^:,<7T)G7V:2
MX9>AHZ\3$?\_3T2D(6(U^=+5FE=^K!9";@S!0FU=#[!JVN?WZ]0ISJO"6N&+
M7^T_>NO-]WHFD#&R[*"C\'L8<?9J1^CKJ+1_P5%IK[>[GSURK5PF'U'[WVP$
M&QRYRZSC,/HG#J#\9Q_*\NBWURH)O_DZ0N[K"+FO(^2^CI"C7?XZ0N[K"+FO
M(^3^273X\A%RM2:#FB5G2+B#](DO.[7K]2S>K]._OD[_^CK]Z^OTKW^/Z5_5
M N&9^;\-N]QGS#XZH6H$.#,-&U/ CM[@Z7AK\%YL@PQ\]PU9^XH/%^$1%4$G
M*]K/2%:L7LM,^;,/2/FK7J5&S:APJ%6G!A8O9/WOY.",P.+]=>K*ETOT:^0R
MM&B?&C54L&O#*]*HBI<H&6P\KW3) >E-+[F'3^SNK*AODV]*6E(^]ZSTZ'PF
MVHG*1%.X^)*;:.1G)#HYXR4;>;4CG\K,VD)<JV]5F7GIA;%C6SG3JVI$7#';
MQLZGVU33DI%M4[Q DFYVYMP4[R''_6'I*\]'ZX%I'U7O861]5/.?($O^>.5<
M#WCMYV1UP/4OP,V!212E+IFE>'1%-UQ*IBA^7IU/48W;5XQ_O_K>O).XX9SB
MAK/47[]P!UX]A^#9P?V7L*J=P>4* 5495ZYD A6!Y:I\UQ\.B[E7I--6A-S+
M_7QUU+WTV,K ^PM"W2\BEF<&B.MN5U&C$BV60\6E<UV,&)?I>4_0N$9]4;'C
MLK=D?PBYG""U.Y)<S6YJ![75AXK?SV<7T_D<YXF^FUV0VP=WUH@4H9(G7OIL
MNW=O,AA;31V[%;K8&78NH<P(B9:P_>S8:!UOW@% 17"SK'V78Z=E4JH*HE;#
M<\ CG[EM&$[]GSID^A(F61>0+;,R"7E6X;$J\OGL-P/-LA")?!U;L\H'7U*C
MBK[82L\KV8@ONU4,N5*9E)FTD(N693'>IAF[J\*^&(='"H'E8JSG/L7^OSGS
MMUP[_9(%=\0>7F_]?%3BY7YQN$)</Z:"^Y(#=H@?JE(V5#J?:@8,%CQ.-7I(
MSFM49W[7<CK#D+[<Y1&O1CJ>@>E\<CV[(OQ>GF9\ /?@W7@^F^.G5]?3.<Y;
MEUU0^+8OO)C'=96H^\_;5=-NL=NO5SGU@!Y.LP>YBQ2 KQ.HQD!=[ZAG&7QZ
M913LTSV%9Y=8"[8>>91Q 5F>"W9766]X!K2!-9W1PATX8C^*[[W0&+ 3^H\K
MZF'DD2;QT\FY?42]H\+TN%32W^XVVZT_' [13ZR7&/ 88Q*H71]0(E# ZT#7
M[36'SX&.F[@$0$=BK^+8'+(O\#FO E*GU6R507J99[2"+%%WJV26<R6N)"%^
M;[MW\GNJJ7K8A##K*_\E748''#TZ7?1XY=XSZC#+_CPZ; 8!CE5/8^66,DH4
M]YZ]'%\%)0_U0.:#8=2X\S!'A37KW*1Z5/53?\&A2!IL6URWWZXBD]ZHZM-^
M-4F5./ZZU@>Y .*X]Z7U(5N?5Y,23*Y;]1RW5<4!7.S64/5IIX;X#S.[\Y1^
MH"5HQC.H(=@>(YS@&>)AO+F<_.6GR[.3Z?7<GO[U_>SFUQI8#C!35.!,@*XY
MI4:$X5L2@NF3@Q$*&4+"I]@!%5AE]NF.W,9HWUWSE(0/%$:2J'Y%V+M->L]2
MSJ+9]=4^8IB/FZ#G5(/_L^IA+4^9';(JM=BB1=\\#UCL=Z2G/.-%9F+[BX&%
M5>>Y5<W<Z . %>#,(;7 =+%#&790(OBEC23.?'L.G,G+'O!B_%)C'T.[5: ^
M%]+2.CL@8C7-)4EX=75&\@%DQV0\_\D^/;O\)9\V\N;X\U@#ZV7T-/1LTY8K
M<_]T%3T6U.Z]TD![4S85)FHVA1M04VG#TKNWR=5Z?CZ[X4%E*!S1G0JR?WJQ
M4_ ?]L[7:@(D>J:R,<%E@Q6^#LK>H0HGS[GW*5AOUS9V[D^EZ=PR^!A0VV(6
M;U+>!N2U:="\5.!H(&E6./EO%2QX&''19U6-G])X[\\D 3_-VF+N&NI:L9UZ
MIFEY?&#)B5.>>&K,W]QY=>F:MTF2_O#_ %!+ P04    " "N>:I*&U4%$UL"
M  "!#   #0   'AL+W-T>6QE<RYX;6SMEUMKVS 4Q[^*4,9H8=27+NFVVH&M
M4!BLH] \[*THMFP+=/%D.7/ZZ:>++XG'LB5;1@/+0W1TCO0[?UD2/HXJM:;X
MH<!8@8917L6P4*I\YWE54F"&J@M18JXCF9 ,*=V5N5>5$J.T,I,8]4+?GWD,
M$0[G$:_9+5,52$3-50RGO0NX^3<BQ3%\/'OYM1;J^@5P[>359.(_GE^/_6<V
M< Z!8WQ,8QC,7D/O]Z$7OO[]E&RC(_QT7_Q.^@@^VQ.^BSU"7^V'WD$>@=\8
ML-=N[#S*!!_V]Q(ZA\Z,& 8K1&-X@RA92F)F98@1NG;NT#@2084$2A\LK2PP
MGNK)A0/7,V>NY3#"A;2Y70;WOVR'CP)=SP@DE/8"0^@<\ZA$2F');W7'#K;.
M'T*@M1?K4BO,)5H'X10.$VRCDRR%3+'LTP2P<\TCBC,C1Y*\,*T2I6>"2@FF
MC92@7'!D-70S6D-C$TSI@[F07[(M=I,!-\9LB0^!4=&9>M6M.>R:;R5OTAQ[
M$QL>Q 4E60GUH=;+X;9OC@Z^ES@CC>TW62] TU%9TO5[2G+.L%O,+Q,&!R:<
M1ZC+ PHAR9/FF:.2: >6$*RP5"39]'R3J%S@1G7'J<D.U1S^UPQSS+%$=%.T
M/OM'4WQY]>>2[1T="WY>3_4($O_V!?O'&V\J@.?X6,-Q'7$"(F>G(/($+KJI
MDHXKTFM?WQLUPE:%T'O!LB94$=[*+4B:8J?'E&@Q_&QJ0[KUGAX*!8U7:*F_
M![;X>FZ*,U13=6^6:(,Q'.Q/1G@PZT<M>D0,!_L.IZ1F;VW"X:-C_AU02P,$
M%     @ KGFJ2B+1;_X,!   ZA\   \   !X;"]W;W)K8F]O:RYX;6S%F5N/
MHS84@/^*Q=-6:IOXDLQ%,R,1XIFQ2B -9-1]9 AIT!(8 ;/3_OO:9+,]:>NC
MOL1Y H.!3S8^W[%]]]&T7UZ;Y@OY8U_5W;VWZ_NWV]&HRW?%/NM^;MZ*6M_9
M-NT^ZW6Q_7W4O;5%MNEV1='OJQ$;CZ>C?5;6WL/=\5W+=O1P9TY>RN*C^_NZ
M*9(L[\NO19J]WGMC3]<;@8K#2X_' ]%M^W^8FNVVS(MYD[_OB[H_0+5%E?5E
M4W>[\JWS2)WMBWOO6(5D]8;(NB_[/XFJ#Z_2=3TR?%IM[CVJS_NLU\]\+;OR
MM2H\TMZ6^D:K-M2 GP]REE59G1<D&9H#,#&$B;ED(I^66:L?V!5]F6?5#X"1
M(XS\O(R!+C=5N=%?WY#$0)@'.M)L=1_G#8 4"*0X+^0I5Y!U._)8-1^PFR<(
MW>2\=%&<2D+)3V0NDV"EEJF*(Q(_DMDZ49%, .04@9PZ@&0:,EDO%O[JLP%,
MU%.D'E7@1RF O$(@KQQ <@WI!T&\CM*$K&0@U8L_"^6/9 $@KQ'(:P>00D.J
MZ$5&:;Q2)WU\@Y#=."";:+(@3G3;^=&<R"15"S^5^LR'@7J,1>JQ \RIQHS3
M9[G2S9CZT9/274S\))'P5Z2H4,YLE 'SZCMFL%ZM='>34/DS%:H33,PQ],R2
M&3"OS<!.X^"7YSB<RU5"Y*]KE7Z&C)ACZ)DE,S#>:,9O(3'1?^ABIB+?A$HX
M>"@F&7IFRQSB^-@TI7Q:F+XV(V@EPV'\*(B)V88ZT0T=0OER&4I#ZH<D\)-G
M\AC&$!/S#74A',J&:+18J-1@'F)2$$?I26MBQJ$NE$/Y$,XUJ"2I_]M)/*>8
M:J@+UU Q]/4LT8/:_)72:.<$$7,.=2$=6V+!QC 3QZ3#7$C'BDDA)B8=YD(Z
MM@R(,8B)3FQ<2.<?.1#YI">H5='!B0W#K,-<6,>6#C$!,3'M,!?:L:5#; (Q
M,>TP%]JQI4-L"C$Q[3 7VAE2C?>NK(NN(T&S?RWK0TT",3'M,"?:L>0:[!IB
M8OYA+OQCC9HW$!-S$'/A(%O4Y-!!'',0=^$@*R9T$,<<Q%TXZ%_!?5[T65F=
M1'>.*8B[4) MNG,.,='EM4M*B$,)<4Q"_)(2XE!"'),0OZ2$.)00QR3$G4GH
M/^:[_ IB8A+B+B1DQ802XIB$N L)63&AA#@F(>Y"0C:E"R@A@4E(N)"0;;5:
M0 D)3$+"A81LF8> $R&!64BXL)!-Z0):2& 6$BXL9 OO EI(H-L\+BQD6<O4
M5R$F9B%QR14X 2TD, N)2Z[ "6@A@5E(7&0%3A</*2?$Q"PD!@N-CMOAFV*K
MIW^;2'^BT]?SK,J7+3&'PXJ]F)A5L^U[507Z6ER'339L8)MW'/?>'_X"4$L#
M!!0    ( *YYJDIKUWPKSP$  '4=   :    >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'/%V<U.PD 4AN%;(;T A_,#_D1<N6&KWD # R5 VW3&J'=O96--
MM)\+\K&A(6W.>5=/FNG]4SR4>=?4J=JU:?)^/-1I450YMW<AI%45CV6Z:MI8
M]W<V37<L<_^WVX:V7.W+;0PZG<Y#-YQ1/-P/9TZ6ZT71+==23%[*;AOSH@CO
MA_#6=/M4Q9A3.%WDJE_0/_+1QO^L;S:;W2H^-JO78ZSS+Q7?"XKP>Y".!RD]
MR,:#C![DXT%.#YJ-!\WH0?/QH#D]Z'H\Z)H>=#,>=$,/NAT/NJ4'R13(..4G
M(:SY6@O@6OA>"P!;^&(+(%OX9@M 6_AJ"V!;^&X+@%OX<@N@6_AV"\!;^'HK
MT%OY>BO06R_PKHU>MOEZ*]!;^7HKT%OY>BO06_EZ*]!;^7HKT%OY>BO06_EZ
M*]!;^7H;T-OX>AO0V_AZ&]#;+G!6@@Y+^'H;T-OX>AO0V_AZ&]#;^'H;T-OX
M>AO0V_AZ&]#;^'H[T-OY>CO0V_EZ.]#;^7H[T-LO<-:-#KOY>CO0V_EZ.]#;
M^7H[T-OY>CO0V_EZ^T#O5)5=7#_G;E=OT[E+?@S_\SO. .Z4/P[Q_!FGJ7_N
M'RB=^RTQG'[/;O-IZE=$^/&5]>$34$L#!!0    ( *YYJDH9>](.P0$  '8=
M   3    6T-O;G1E;G1?5'EP97-=+GAM;,W9RV[",! %T%]!V5;$^%'Z$+!I
MNVV1VA]PDX%$)+%E&PI_7R= I2(J40'2W1"2<69N@G4VC#XVEGQO75>-'R=%
M"/:1,9\55&N?&DM-K,R,JW6(IV[.K,X6>DY,# 9#EIDF4!/ZH>V13$;/--/+
M*O2>MM?;UN-$6UN5F0ZE:=BJR0^:]G<-4T=5M\87I?4W<4'2>UG'+CY>&R>Q
MZA-VPH3#&]OS>-_;BIPK<_I7-#.;E1GE)EO6\9;46T<Z]P51J*O4%]I1_AY<
MV<QW>:?:A5==Q\9L7;%?"]+KY0B;BHX'Z"J7G!SBMJ!CH[K"]I.?-7"_&S+C
MJ&]=K+I0'GF\&&D:JYZU"R_YB-1NG9SRDX;'UM?[8;^,6W3?C[WPGZ)GW>&\
MMWZY' (DAP3)H4!RW(+D&(+DN /)<0^2XP$D!Q^@!$$1E:.0RE%,Y2BH<A15
M.0JK',55C@(K1Y%5H,@J4&05*+(*%%D%BJP"15:!(JM D56@R"I09)4HLDH4
M626*K!)%5HDBJT215:+(*E%DE2BR2A19%8JL"D56A2*K0I%5H<BJ4&15*+(J
M%%G5%67MCFFMR^:O))_&+/;S6?=WZ^0;4$L! A0#%     @ KGFJ2A\CSP/
M    $P(   L              ( !     %]R96QS+RYR96QS4$L! A0#%
M  @ KGFJ2F;S"V""    L0   !               ( !Z0   &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " "N>:I*3>H>.^\    K @  $0
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M=#(N>&UL4$L! A0#%     @ KGFJ2NN^)=PB P  A \  !@
M ( !"A$  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( *YY
MJDKY@BK][ 8   @H   8              "  6(4  !X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"% ,4    " "N>:I*+K46G&<$  !K%0  &
M        @ &$&P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%
M  @ KGFJ2I9)ZR2V 0  T@,  !@              ( !(2   'AL+W=O<FMS
M:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( *YYJDIQ)J]!M@$  -(#   8
M              "  0TB  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"
M% ,4    " "N>:I*QC%LH[(!  #2 P  &               @ 'Y(P  >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ KGFJ2L,[)<NT 0
MT@,  !@              ( !X24  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM
M;%!+ 0(4 Q0    ( *YYJDI(U[7\M $  -(#   9              "  <LG
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ KGFJ2EO+
M(SVS 0  T@,  !D              ( !MBD  'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"% ,4    " "N>:I*#/+D)+4!  #2 P  &0
M    @ &@*P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (
M *YYJDJI][=.M0$  -(#   9              "  8PM  !X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L! A0#%     @ KGFJ2J:7OI:U 0  T@,  !D
M             ( !>"\  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M% ,4    " "N>:I*?8F=-;0!  #2 P  &0              @ %D,0  >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( *YYJDHQ).G.M0$
M -(#   9              "  4\S  !X;"]W;W)K<VAE971S+W-H965T,38N
M>&UL4$L! A0#%     @ KGFJ2E-XPC>U 0  T@,  !D              ( !
M.S4  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "N>:I*
MH-J%4+0!  #2 P  &0              @ $G-P  >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;%!+ 0(4 Q0    ( *YYJDI-Y3(4M $  -(#   9
M      "  1(Y  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%
M  @ KGFJ2J EIJ'A 0   04  !D              ( !_3H  'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "N>:I*8W)ZOK8!  #2 P
M&0              @ $5/0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+
M 0(4 Q0    ( *YYJDK!$.M^P0$  #<$   9              "  0(_  !X
M;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ KGFJ2BPZ5GVW
M 0  T0,  !D              ( !^D   'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"% ,4    " "N>:I*V-7^(<8!   W!   &0
M@ 'H0@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( *YY
MJDJ),:7+N $  -$#   9              "  >5$  !X;"]W;W)K<VAE971S
M+W-H965T,C4N>&UL4$L! A0#%     @ KGFJ2A -0_2W 0  T0,  !D
M         ( !U$8  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
M    " "N>:I*?N8"7\(!   W!   &0              @ '"2   >&PO=V]R
M:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( *YYJDK3T E0MP$  -(#
M   9              "  ;M*  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL
M4$L! A0#%     @ KGFJ2HQ]P02R P  L!$  !D              ( !J4P
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "N>:I*C8<.
MEL@"  #Y"@  &0              @ &24   >&PO=V]R:W-H965T<R]S:&5E
M=#,P+GAM;%!+ 0(4 Q0    ( *YYJDK8RS$!^ (  &4+   9
M  "  9%3  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @
MKGFJ2BHPA-;@ 0  Y@0  !D              ( !P%8  'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6Q02P$"% ,4    " "N>:I*M=4 Z!("  #Z!0  &0
M            @ '76   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4
M Q0    ( *YYJDH[?6]TV@$  +T$   9              "  2!;  !X;"]W
M;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ KGFJ2F)?:FI' @
MY@<  !D              ( !,5T  'AL+W=O<FMS:&5E=',O<VAE970S-2YX
M;6Q02P$"% ,4    " "N>:I*&\K %7<"  "U"   &0              @ &O
M7P  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( *YYJDKX
M\.B$]P$  )4%   9              "  5UB  !X;"]W;W)K<VAE971S+W-H
M965T,S<N>&UL4$L! A0#%     @ KGFJ2J59]?7B 0   @4  !D
M     ( !BV0  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *YYJDK7N@O^&P(  %T&   9              "
M 5YS  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ KGFJ
M2N,9X<=\ @  PP@  !D              ( !L'4  'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6Q02P$"% ,4    " "N>:I*8)I)DBH"  "B!@  &0
M        @ %C>   >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0
M   ( *YYJDJ1  /O\P$  .L$   9              "  <1Z  !X;"]W;W)K
M<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ KGFJ2F"L)Y#D 0   04
M !D              ( ![GP  'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q0
M2P$"% ,4    " "N>:I*SS*"-)T"  !G"0  &0              @ $)?P
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( *YYJDJ\,H9;
MA3X  +,4 0 4              "  =V!  !X;"]S:&%R9613=')I;F=S+GAM
M;%!+ 0(4 Q0    ( *YYJDH;50436P(  ($,   -              "  93
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ KGFJ2B+1;_X,!   ZA\   \
M             ( !&L,  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *YY
MJDIKUWPKSP$  '4=   :              "  5/'  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( *YYJDH9>](.P0$  '8=   3
M          "  5K)  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     Y #D
*@0\  $S+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>97</ContextCount>
  <ElementCount>204</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>20</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/BalanceSheets</Role>
      <ShortName>Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/StatementsOfIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/StatementsOfCashFlows</Role>
      <ShortName>Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd</Role>
      <ShortName>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (USD $)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (USD $)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - NOTE 4 - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-Inventories</Role>
      <ShortName>NOTE 4 - INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssets</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OtherCurrentLiabilities</Role>
      <ShortName>NOTE 7 - OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-StockholdersEquity</Role>
      <ShortName>NOTE 8 - STOCKHOLDERS EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-BusinessCombinations</Role>
      <ShortName>NOTE 9 - BUSINESS COMBINATIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10-SegmentAndRelatedInformation</Role>
      <ShortName>NOTE 10 - SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note11-SupplementalCashFlowInformation</Role>
      <ShortName>NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-CommitmentsAndContingencies</Role>
      <ShortName>NOTE 12 - COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - NOTE 13 - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13-IncomeTaxes</Role>
      <ShortName>NOTE 13 - INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - NOTE 14 - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note14-SubsequentEvents</Role>
      <ShortName>NOTE 14 - SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesUsd</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (USD $) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsd</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - NOTE 4 - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-InventoriesTables</Role>
      <ShortName>NOTE 4 - INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note4-Inventories</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContractsTables</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssetsTables</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-OtherIntangibleAssets</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables</Role>
      <ShortName>NOTE 7 - OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7-OtherCurrentLiabilities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - NOTE 9 - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-BusinessCombinationsTables</Role>
      <ShortName>NOTE 9 - Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10-SegmentAndRelatedInformationTables</Role>
      <ShortName>NOTE 10 - SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Note10-SegmentAndRelatedInformation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-EarningsPerShareDetails</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-ReceivablesNet-Details</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Receivables, Net - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-PatientFeesRevenue-Details</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Patient Fees Revenue - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - NOTE 4 - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note4-InventoriesDetails</Role>
      <ShortName>NOTE 4 - INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note4-InventoriesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-InformationRelatingToUncompletedContracts-Details</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Information relating to uncompleted contracts -  (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note5-CostsAndEstimatedEarningsOnUncompletedContracts-BalanceSheetItems-Details</Role>
      <ShortName>NOTE 5 - COSTS AND ESTIMATED EARNINGS ON UNCOMPLETED CONTRACTS - Balance Sheet Items -  (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssets-Details</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-OtherIntangibleAssetsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note7-OtherCurrentLiabilities-Details</Role>
      <ShortName>NOTE 7 - OTHER CURRENT LIABILITIES -  (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note7-OtherCurrentLiabilitiesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - Radwell (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-BusinessCombinations-Acquisition-RadwellDetails</Role>
      <ShortName>NOTE 9 - BUSINESS COMBINATIONS - Acquisition - Radwell (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Acquisition - TK2 + Turnkey - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-BusinessCombinations-Acquisition-Tk2Turnkey-Details</Role>
      <ShortName>NOTE 9 - BUSINESS COMBINATIONS - Acquisition - TK2 + Turnkey - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - NOTE 9 - BUSINESS COMBINATIONS - Proforma Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note9-BusinessCombinations-ProformaResultsDetails</Role>
      <ShortName>NOTE 9 - BUSINESS COMBINATIONS - Proforma Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - NOTE 10 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note10-SegmentAndRelatedInformation-SegmentInformation-Details</Role>
      <ShortName>NOTE 10 - SEGMENT AND RELATED INFORMATION - Segment Information - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentation-DetailsNarrative</Role>
      <ShortName>NOTE 1 - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note1-DescriptionOfBusinessAndBasisOfPresentationUsd</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPolicies-DetailsNarrative</Role>
      <ShortName>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note2-SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-DetailsNarrative</Role>
      <ShortName>NOTE 3 - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note3-AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableUsdTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note6-OtherIntangibleAssets-DetailsNarrative</Role>
      <ShortName>NOTE 6 - OTHER INTANGIBLE ASSETS - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note6-OtherIntangibleAssetsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - NOTE 8 - STOCKHOLDERS EQUITY - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note8-StockholdersEquity-DetailsNarrative</Role>
      <ShortName>NOTE 8 - STOCKHOLDERS EQUITY - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note8-StockholdersEquity</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note11-SupplementalCashFlowInformation-DetailsNarrative</Role>
      <ShortName>NOTE 11 - SUPPLEMENTAL CASH FLOW INFORMATION ($)- (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note11-SupplementalCashFlowInformation</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - NOTE 12 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note12-CommitmentsAndContingencies-DetailsNarrative</Role>
      <ShortName>NOTE 12 - COMMITMENTS AND CONTINGENCIES - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note12-CommitmentsAndContingencies</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="fonr-20160930.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - NOTE 13 - INCOME TAXES - (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Note13-IncomeTaxes-DetailsNarrative</Role>
      <ShortName>NOTE 13 - INCOME TAXES - (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/Note13-IncomeTaxes</ParentRole>
      <Position>48</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>fonr-20160930.xml</File>
    <File>fonr-20160930.xsd</File>
    <File>fonr-20160930_cal.xml</File>
    <File>fonr-20160930_def.xml</File>
    <File>fonr-20160930_lab.xml</File>
    <File>fonr-20160930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0000355019-17-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-17-000011-xbrl.zip
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MI-NPZFH?P3CE89SR:9PMP9Z!JEJ>Z3H/5*7ZJ_)DT/-@F0"OL>52Y[.EF,[
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MGP_Y"@ BH6DH=B%36HN$QKC*.!3(EBE=FP,AT:C^X<9T=7>1P6MI'>9GPZY
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M[:O>]_X4-08((ZQ_*0-^\&]E^(]$QVXVKAK?;QK:)XN)USC 1O-['!P'7'2
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M)YP5/L'0;Y9G:.2)+H$%0@6PX#L12& J/@U15/_A^%SPNS>C&H,#!E+(D^<
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M-9OY%1N8^:@X.F>S+M>>#2XR S1)K8P:NRPXY'<-B>XXF&4N!9H::W&P=0:
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M[=:[J]O?EN_T=V^85.>NQKXX\+-[[.CSV;*TJK]C?W==\]&R;08/9=]A64]
M\_JGN[ FK--KO;E@/P$8 T3>%&(/&W@ S_)9*)?WK?G"!GH(F /N!Z(,>!\_
M%_YJ6![^DMT],6Y;HE@H$>$+UF93L$#BMZMO"A#P41I[G%F3&?/X?T++ SK@
M]^ +5@#+N9A#@+7F;.&Y$VZ&>"P%/C5YP#U8A8MO3^&9[,&P0\ AV%A'@(N@
M"$3<*;, /</W.2@W@H TL2WCSK*MP(*'3UW;=A_Q!_B<Y:KP#A[]Z(:VR>[X
M"E@@5 P+_B8!"2PEEV'&)/KRYEKP]W#.30$'/,A@=Z$/./D^9DWN! U=YR7>
M@/-@?#KED\!ZX((O"W"HP%AXQL)P)$X>K VR9S/QZ@F> 3!;\R4+)0CK1!,K
M32U_ C][XH;G ^*@*P)/8PJ_9Q_!@L[OX(7>TU ,1Q?L]P@@I($4@9@=DT"0
MQ'07T<> PGUHF0;86N9*!7%#CXU=1W07&)A(^@Q$<":@7:@2@;3)%S4W!HTQ
MROFLVNUOD872-?8AEN_Q2KY]%AFB8:OWYAWV(L/SGV+)^<BGH%GX/2$]RR=L
M:D6L0TG-F,A'B>>8&\]9:AH8DQFW%PEMB627@UWB:"Q9X '>(+\"6'\6VP!#
MVFO 4>A79$Y0UWU+?E>T2O@+US=L/V$/X.-X>?X,D8/46X  %M-RS9>U%9AE
M.1,[Q,AX:1#B'S]:  1"XOH\_C"_=DOCOJ'AC+2[3HA$VOW-\, YX_9ANVY?
MNQ=,;BY&&DM$*:#A"PYJ@YIP+@X6L.1'L=(/].&;2_9E#H[V00H :N0G"#?<
M)\Z9V!N=?S#\R$O>&$_"/ZUBI40HA*JT4APIVZ >^&A0251(E'+'Q!C#7<4T
M#V EW!"]\0*T3"KJ*A1#Y1+%B_.[)123!"(7FU1@(B0*C#]BO4U76J1GY)?S
M*FW_0D" -F,LG@6^',*%T/. +/:3,#&^OPQ?W  C*<-.Z.@FN*XCOAH];1DW
M#MYA%))05GAC M)H[F*U%:#XI+JJ(?(Q]&(C_)G?>;%W!@T&[=UPS" #;8U]
MY2#<*T_<;4=; H<_,C_:C,1!K\]L]%PR$#<6"Y0Z9J(0PQO/-28S#5TO2*%P
MXP(,6S[? .]J"9\J98BC+W1!]J4SB;XE% W4.)+,!2 SL1:V"*ECGPR_<UP9
MZXM?H18LW:2 *%K!!-4#"P9?$8#</46_00PB@Q$!"Y04EDGH[VJ#$:\HE^%_
MHN:+Y3P^<>\=ZR]80D(,OS6<A+,6/A4W2W-X@@M_E_LN_!H0U3,P[W1NXQKP
M>W@@6$ OVF'!A@>076('1B8"&1>&:,)-;)=< 0GPQY#IL'-W>AX"B"+:$'L.
M(P(^WGL\"3A$V "H1E1'CP_?C->^][@1"'@ )[W-YB"&,T3Z'D0!88D A/W.
M.OTNI#!M/F_U"-<3N @8!*V?Q5)@FBV(W1 U_J<EMV_+0&*Z1616PKK\6OSD
M]=@ILK8>7[C>,E#):WN'N0(FV"8N'Q_]53 !&0?*8G%4I,!SA;<1PBI-^B?#
M0[D5$12(B"6Z:N=6 $21Z&VU]Y:SVJ?ZRR!SY0$BNR\\3?QHP;AD;+;< <Z,
M!WZ(0V *.8-ZF>S&^)Z:@P^*)OTFAKG@-;:$NET1ZO[@#]P)N4QMP:X&[#D&
MC\+JC0$F=\X]/W(P^&,_!'4&=X1N<X8))/GSR(D(O8Q,^MI^=FM2<.R:*W?5
M;_78^1*<'XGGH=69N^!_+,<$B+RG<[0Y^,N5Z@<SSPWO84\;1$J_>O(JTGP>
M 0@SA\Y.YNF6KM!?(B:2=!!,R.>*+?04_?84;=7<0K.!R2?A#GSN/5@3&5!,
M8MJA:3/D'L28(PUBVSJU19B.CT5[9)G"%Z#5<J-4HOR3M);HL"=R5W$7Y15M
MF;?C?T)8X-SS*!3'C>XSB"0#98T F)@,,K;ZD]QQ/&R^0;A,#C21:<1LOQ)M
MJ/EVUY+(26SW,,*30F"&L11 _>PA"^ I%^Y7_'7]MT*D@T@O)N$\M V!?[2[
MP90J"AR$$D\R'(Q]#U(L$21%J=EE'E;^2((\2:0ZM_JY5<IA28IH?2$50:QF
MPNW';@Q3O2LOM>:\MKDL04N/V^(+IN5/;-?'A/,Z6+,HTX/AYQ,$6#Y'>43\
MI)1+W8M"/K ]THH$JX@RRG OJ1<D-4Q #?^]=\7F<PGEDF5']ZODZ-:SGZ$M
M-E>]W0HZD2_IG>OZ6MKD-LI*Q#KT#>+;4/H$E)4O#EC7P/6>$FF/9\4A!"MZ
M=K)0=!%O^? /*U.^LN)@).9R.5#.:)U8:VWW45KO"3H45!2'HS$&VOZ%U6U9
M]+A@UVN?"E!D.<22%AN+,7.A8* WMC!!GC#]42 +^QB0>5@72.?YPE#$N5)-
M;!OPZ;[KP-.?T&R9X&'$^@B7+P$$"G)40FV9?=66I1ZAHJA*D<&Y#>]\H 22
M=YX@-::1'.D>Y)9D19#H:[!!%4$V['VP0U8#7?7@%3K2)#^^?OG\?:U:%VT"
MI2T/#,M>>S0:C0OV)2C0T_2?99BENY#;X97+6#PW^ARV)!8\*6&B5YL2]%^1
M]5J!@/L/9^G#TL$F*Z8((FBOM*5$?H+ ZQZY] 4MF,]^&OX?[+,+<:M0>?S*
M[:>Q]*^1D9MPT"507E<D21*)T]BE@=[*C"R\D [V7D00F(^5(B12S *&CBZ#
MHZC:*K?PHI4\F56!6'JIM)$6O&,S,% /W-. ;HYQ+[78= $']--W'.3X@<=A
MZY,47(SX(M!D97>U!_:!UB(0EDE5L3A&1Z&7\,D)9".C$)=\XL@!*"6H]@00
M<$<$G=+MFR)#)W&%G\CD'%!'AOVY(%^L-:HD A\C"?TR\2O++SM$0])D1N&[
M-><Q'NOL2%/D5:?3KJU+FZU/-QBRW@@VP^9F+=5T9:(VX*,^<G_B63*]<6#K
MT]M(?]30STV4J2-)$43&TN[)!*+856&/!)-;55]JHE!Z;\E!F:P%\10-+?!2
M[%/E%D?^.MJ')39#WB;_P;R8PC)(77=D+C?>33B1I]U4< S6HD,YTZ@%)(X?
MEGN_EU5Y5U7<5.7;R8R;H<V_3S?;'S\8OC6Y<LSH -%/#.F*:69LK30Z9W]A
M6KOG#NV,Y2VX?>DB4J(%IE6[N;7T/' 78LGH;=R@NP$$-FIRK_:IW5CJ92D;
MPJ7;Y:FX^AI"=2RZ@LOMU=O\^BIR(C*W)T9QRUZ<T(>/(([F?T[X(EB-78G=
MSAO9V/G;]=5O'[_\_/3Q3;D]V.N<SV>JJN%#E!/@MAVU_K\_:YV)]SZ$P_'[
M]<,)$]>VC87/P=Q$K]Y!5&T&,Z1/ZY4\&7"95RN6D"R/_3XW:,]'[X Y+.",
M[P$3TO(?*@$B 2V=]V>ZODG)K N$#A:&XBH]'N=Q35IT!:78+Z8,R+(7*]XD
MIYE;XG8#N=W/Q^U=APZ4-)3LA9MF0WPA0GX!<Y@IMGL?DM/39YNE1Y<[Z4+G
M["!:Q4[@I2E[+\UG(]+M0[JQ'$Q1WLSKYE,P&AM.E"0U)C6N+P5?5N-ZS3+*
M$9=>AW/L&BK@$M,#)_T6)0=KFV)5QA@3<H0<(==@Y"H9CAWEX+IQ"D[)0=G7
MJP*;\6!8ML@_BFJ?''^'3G7FVN"7_%0!B1!M[X)G,9-AXC3GJQ3G6<V0F B*
M?HE0K.;%]+11*WU@3((@QQH.1-)0J33TVGV2!I(& <8H?2PCB<)IB4)':V4,
MZ21I."UI:&M#G8(&DH8H:%!0%!J7J?NXNGOHX%S=SD)=NKX>*(%EK4"W%!/M
M50"<:$^T)]H3[4^;]NI>05GP]3&_B^7Q:"D@9MSSN/G9#0-QFA!/_Q=>75%T
MEKH2MRGU-;V?GA:EL?G$:F)U_5BMSAUIQ.B2=;J5D:,B5A.KB=7U8[4ZYKM>
MR>9B]BCBV(KJ%UPV_*:G$06J#6<PN;)F,[A-%Y\VF\$4C#:<P5WRP<UFL'ZJ
MNXS,S8/<#_0NNID"0P4S*E82[8GV1'NB/=%>/12(]DI%9^4TI^0:1;382W+L
MPZ]HDX-.!07QYTMR9L_P(ODFVT*T)]HKB +1GFA/M"?:URC35WA822?:ZBM\
M1'NB/=&>:$^T)]H3[=4/]$H^T:;>T362/]+]PFB??=Q+%>@;1_:LWGU58&\<
MT<G.'-/.9)U+4@7ZQI']"':F%LF[U,- ^AY'@<:N(U##4;_Q$/WR[B%HG(SF
M6&$KE]3!JP@NO71Q0^G8E@+ BLMZ>TCL;2Y[)03#MMY. D.:3?:W)EQJNH*2
M_6TT>^M@?]7-]E9Q,XBXVXV9JZ(_0.4Q4_9_,AY=";ZZR[EXO=GO>)LZ=J P
M]T4'$:LU<P5/N&F/NL3J4V"U.A-NR/J2]265E/7"0?Z-!+&ZQJQ6Q_K6NZ2P
MWWRQZ&"8ZA/&U%%M\D]'-EK''5,R)*_4; ;3J#!U\"%;>]*JV#UY56PX@Y6=
M^?4VP NU5Q_%GZ^-;[AD.A96QK#*G6>E3%]XQ^:&=V\!%"W6NAC!]^'?K1']
M60P,/GM]'8E4SE$/&TCB$Y9H+DX")<$\-N&V'4G1^[/6F7CO+XQ)_'Y=SF'[
M9AL+'R0H?O6.Q;<JMN*KX"_SPOM\!YFDS@3V9MQ[7L4)W$4!V\4#BNWY[1,0
M"6CIO#_3]4U*9IU%/5C@BI*H:\OA#':YP<QG'#;+:9-1F#(0?S.\R8QU=(VU
M6_H@30^(V<UC=C\?L].S5WEL3W).4=5#D4)\(0;="SS"3$G>.P+;3^0[9SLO
MG$,U1)&^V2B.9191A0;ELC&->K%/!V,2WR9A^K+XUJLPD@/GZW#.O4(FHAR1
MMZD;+E5Z(@DY0HZ0:S!RE73:1EF8;IR$4;+K]IH'<0G=># L6V2@ G=92T>G
M.G-M\$M^JH!$B+9WP;.8-'.<Z'J5XCRKR3A'4/1+A")Q3J&C#3+2SPF*'*O4
M0.)0I3BTM6&W3>) XB# :+=)%D@6)!@CK=-/'RE!TG!:TC#4!CVR#20-4=C0
M2V]1.9HL-"Y;1Q.,,T20IDT1[8GV1'NB/=%>,12(]DK%="5/,"[F/-KO8OE2
M!QO7ICE;B>.9?4WOJM*F3:PF5A.KFW7HFAA=LDYG#40F5A.KB=7U8[4ZYKM>
MR>9B]BCBJ(+J$S,:?72T?=%610&(P>4PN#4B!C>8P:V+'DU2:3*#]8N,VC@Q
MN D,IOD<C69PZZ*KRG:RZEU&YN9![@=Z%]U,@:&"&14KB?9$>Z(]T9YHKQX*
M1'NEHK,R+UQY8?S,8B_)L0\>\A.-7A84Q)\OR9D]RHGDFVP+T9YHKR *1'NB
M/=&>:%^C3-]>:-#AM=K+&=&>:$^T)]H3[8GV1'OU8[J2#Z^I=TJ-Y(]TOS#:
M9Y_L4@7ZQI$]JTU?%=@;1W2R,\>T,UE'D%2!OG%D/X*=J5>>;LM(Y9UCOK'K
M"-1PLF\\,U^%ZP%J(J,Y5MC*)77P*H)+V0GC"K M!8#D'-W\ISJ(O;5CKX1@
MV-;;26!(L\G^UH1+35=0LK^-9F\=[*^ZV=XJ+@(15Z,Q<U7T!Z@\9LI63\8-
MSX''^6)J@%+C M2Q X6Y+SIS6*V9*WB837N@$ZM/@=7J#+,AZTO6EU12U@L'
M-)[C)%BMCO6M=TEAOU%BT1DPU8>)J:/:Y)^.;+2./!6,1LXTF<$T%8QL;7TX
MU6A5U"\R[D,E!M>?P0J/]WH;X/W9JX_BS]<F-5PR'0LK8UCESK-2!BV\8W/#
MN[< BM;6./XL!@&?N/YTB4K.60X;J.$3ELB)<0Z_O W]\WO#6%S>3F;<#&W^
M??HIJ@;<<.\6HWTQ5_C*,:--P4\DPD^ ^8/M3O[X]6__A0+ZR_/'C#UN6L%7
MU_>Y_]GU/EN.X4S@N3_XA%L/^!!_''H>[$C6GP@[#0=)\H-/WY]]]MQYNZ7W
MSUN#\Y8>N/ :7G3.._K9KXJ3?CO!ZR(Y"2YI EP'KY+W<1NX\"P?]H;NE 4S
M#FIFV^XC\)49 ?MF>),9Z^@:0T9=UIP&+VI/;1#9!WQX\EM=[[W*?'P" ['2
MZZNY&SJ!SPS'C$^?6 X(BAOZ\)&O,?[GA /,RTHC,^0OW@A 7O]V??7;QR\_
M/WU\LQ7.NA"\,9*S&R+"0;()M^W(4[\_:YV)]_["F,3OUV.)"1@08^&#EXY?
MO6/Q);6M5G1?\&5>>)]GZ9+4F8"WX5[VZ*6#MC\']#3E#P.!3D!.Y_U99Y.6
M62?^#Q:THF3J[Q[$!"GBQ)2!<N4 TR2?>/N<:E<8#$"<AW&!ISR/<<L23$.;
M&9.)<$*[LGKOC=^A,I%[X1S"<\V#.I8\9-O49F%#WU;7T-.[HY:^IMM_)24X
M$@7FK1N ;>R/?MH[\4OM]3+!2)0$M>$@_?:-H]UK3^)P''%H]].++B0,)R8,
M':VO=]43!]6;C@_UGFD>DYW#&]O %H*%X05/E#FOHF5&E;QY<]FK1&M44:<M
M2 A(QYO=%5>@D_O&3?Q+GETAR7N!\JYKK0XU5S69Q?I(&[14:?8E%I?"8EWK
M=%1IVSF)/=DWPS'N^1R>(2JQ;C#C'IMRGBNM2:)?J /KZ:J(/K&X%.O6@1B%
M6-QH%@^U[I"V7NKZLD3"<1[MU!:>,8%'PM=>G]V,ETF3P3O_[ TI305*T]/Z
MW9,_-M%H#G=&M&]K,G][Z!L4X? )-.,3(K5H<O]'Z'#6:8D>]_Z./>X2K_/
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M^%4+YIZ1^[),L+Z![UUT(T&\@9AY9OC1K<+@G#'R<QV^=.#A8F%CG)@FX=1
MN)D?USJC]"D7U-MYU(EZPWYZ:PWU=CYMS2>G&P_L\#J';?O"<V'C376*2K+9
M[6H/DE.#1\7LU?-?OWKR[1VI9BO*=J89KI]N(#I05VDPREA7</VFUA]03:+9
M'&YE]-4K7I*H7^9M6S$DNX 1%SX^?[_^<3D&<-TY]Z[,!]&O=JQ:A_C_:!&D
MV/;U@O0HUKDBRB!3_#J6AX0TB!LJQ65'+@L=W C;/)!U#]'=YS,+-L5^5-WP
M*ZAM'(LR52:OCX8C5434X07)6UVJ)VH. ZEF"UKMU2_I5:GU2_R(*&OE!J;
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MHM.B^QT2]<$M@<ZM'Q!E$V.!#1C435%S'/?!C+HIU.%%/3!KVEE4ZJ8X?N,
M=5,TO9MBVV"C/7;D5>S%J=:_N4W.&,I,31A'9(S$;-C6VTDD<Q/R)!LTMF<,
M<U= ,JW31F5DS1Y-LBQ7=?E"RKD_5Z.V&M.<B;OE<'>''"#54ZB>0EETJI)4
MSM]]S2252XH^,-JPR7!1"6;?NDK6E,[ <.XM8,^5[\,WKQSS[ZYK/H+);N3
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M=/5$[]53HX_DDV\-F_L8G&.@+M*3)$\;2JRUAP5L94F-=R5[MY5^;X#"BJR
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M!%Y8=1/(VP X\L7W0VY^##W@V0V(AVM*K,5_/Q@^-X$6^!2Y!2F&Z/H:V'O
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M"SY8$^XS=PI&_I']/]?[0UL6'P0(N0H0K.KB0QV%G$H*Y?FA.LJ#2M:[W%Q
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MJ!WUT^KD)PO_BZ?* NH=M18"T@?"OQ</XH]SY%[@X7S$%-3M:CS_R7>0]1A
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M]CP!YR*0M2(!/X2U# )"_<7(,J\MV_(%FT-NYHJ$_*@8OCN_NW7M!82PZK<
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M#US/;$1W;+-LV:YSNG9"EBDWHV5)+<K5W?NBH"5(YA1%N'GXF%^_ $A*E 2
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M:7&?2N<D6)I(+\\]*>/NNS2CQY9#+C(#].<.W>#%!\X"; *'\(#'1&BBQWB
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M>+S=2^*RF[<%=U:BWJ64\AA"'W34:^#-7>L1CS9:7@6>Y0 />ZGP4D(LC)'
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MLKL^O-&&G "($KF]4,,8NZGY(LP=O:I,!QMS=5RS7E.FW3_XS$2K%/]W;WH
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MZKZ-0C9=I\04"8I\/WR&<[&K,+H,=_?)>N>G=HUW;'8($C.L[/E[Q5E;LTK
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MAQBD6F5K&YV2\"S+;P5N<2$?ED@<F$IY'7^)%:2YJ4;?0<\S+"P5ZIOQ6&!
M#,2ZEK4SL3"A<0%B6/'%[W)6!G_[24/)//"\;3"H8=)6<"+&H$%==69 OC,0
M)]Z&)_ZC,G84YFWZPM96,:RW+CP>K\Y^#\@.MD6W/@7JM" 7IA58Z6W !?>
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MSL.E6@*" =-D6IN]S:$&S4,V.)O'RVSOLK2CN3+M?88!^8SV."NKQ<[XUHA
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MY4!7_^)B%WL!C>-+&J\B;YOF5*Z9NJ0OR073XU?-R^D@IT\P=C:SB-'60M!
MMZOF-4=NMIR0]VR@O)PLQG?3^7(ZNR6S*W+Q:3&]G2P69'1[22Y&B^D"/IW?
M31:3V^4(J'"@?>$]!-[:6T'01VN(VS+WFA>TE4&E=*!6G&@0W$I=)6P_,-@N
M/MW<C.Y^ G NIM_>3J^FX]'MDHS&X]FGV^7T]ELRGUU/Q]/) @=>"VF@&F9]
M)66_FXQ:5<M;C#4R-!C3ZU;?7LPHT<WHUZ$3Q/RP<1DY+F7C/-\L+:A\Z<4K
M/XQW$6T:\CK*ZA-W!YE;1&8G06BP>XCVRN'R(QLNY;BX('>3\63ZP^CB>O*&
MW$PNV:AY7?A,3/LWH]O1MY.;"8RG[,_9\KO)';F:3(K<Y/6GQ27Y5S3)$$5.
MJ'W^:AISB1@X^KTEU*AZ^4:0EAP-@IMUU.7TVI.<!=UPK#"K:=0ULPP,,^,8
M:J+'##2K$?$K-B).;W]@ ]SL[@@>HB; 08SAH3P<<ORLD*;. [3FZBW P=Z$
M+,"AF65P^+334YVN-0E)QDIRWA-!B6?EA,L-Z;WTM)S[+/B4I]X<I[?284NU
MDJ]!-U(=7WQOX#S!2\E0?$39..!^?(.4(^L?V<@ZGBV6PI&<+);3F]%RPGX;
MW=VR1?F"S&[)I]OQ[&9^/8'/Q[/;Y=UHO$2R2O\V#-UGS_>9^=5['-:>94L9
M?3H!G<PK>@6M! P._$.TKJ([E<'/FW(I1(C![+9:6=_DR+85@@[51F>WG83/
M"]=6P_:?V+ MEOG3V^7H]MLIK/!'B\4$R\ LH^UC<=81[1R_:1O5R-%S$'J3
MZI7@<QTY&N UZUB+"I8<?/A,>= -E97L)%Q/ZA;3F,K-N,)'>4^3V?J:AM)C
M/V2 2( COR!%],"1GH"FQYS$+.50_N=L*!]_NKN#/=SKZ>AB>CU=HCD+RY;+
MLJ:EC-B& )YDWS"L6_+V6]&QA3GE.HX6C&@@W$;;>IDZR0LQ647N+XC@1S<5
MU$V$?1][A[D%?^_51]N85:L[:L.,"+/M-%:.J'^!<(/E;/S]=[/KR\G=@DS^
M\6FZ_ D'3M-XH'&XN?<"<8^T80@ULPP1RV527A6VI:)'@SD+)6OI2"4+*?*@
M&Q(5AMF/A[;, \//<B2TX\0,R99CX-<0*)^&!HYG-Q?36QX,B,6CI _@7=S1
M;1CQS"8-3J26O->YN$'ITM2KH44#L08%:PZA("<9/;K1KFI0"]?/AG-(H-FZ
M>\UL:.'7<GA[_PY\O,FW6<S3W>2:GUM-;Z]F=S>8XIYWVZV?UA!WXD?(7S/Q
MC6$%[5A[!68+8TK(M.## TU[96NC9(&59.F*2,J-;LQ,S2OJG??$QK!\>_:^
M;UJV,:IZ,<^&%PU86RJL'DS?\_C\^?R:QY".KLEXM/B.7%W/?L0WGC*7>.,E
MHC,&//Z!S1XT6)7V7QL&UI8R>@5O%_-*"&XC  ^,.VA=S]"9R1"73(M2,!_X
M6QG?.!:W%((.U.9QN96$SPO6=F/T!QZH=7,S7<(8+<*U(!AK>OOMY!;/M:DI
MQ*;1I?/2(K#?P-%S^8\FU2NE/G3D:/#7K*.BL"?C((P%\XBIL*LYLM_$,C#.
M&B+[]?28D68WKGWDH?UL9)N0Y>@_L0QCB]U]3/][QP;NR9/52EU'WN_JW*QT
M>46NID4#J 8%ZROOE)P(>G1C5M6@QEU)/?V0H#+O0.J(T<+*;I#ZBB^0+Q:3
M?WR"#<<)W$0ZU2VDQ6ZS<:+];&V\=]^0D>8@2;U="#G,U.SN1S<Q@T/R<-U5
M-YU$L@4AE<S6I""7J++BI+_@&"39$BEF"KG\R).KMF]>^)I8^EWF-BM?7M3J
MZ0='9PLEZQF%/;;$W?JB9$])  Z4I5>IYC1:/#H1M0-:(U>?6+,TH0BW!A8T
MB+/3LPJZE LRR!'.AP-KM_2Y,)Y'8<!^78GC(&&8'?C:B^DWN7 W(\LIAMO)
M0(/7CHJK$MM4YNB2+!QP9F-[&(DDC4QAWXEC[ESPM&;N+[N8;W86<IUIWEE[
M,;W> .IH9.E:4$L9:.#<47$%G$N\2/"[6#U2=^?3V;HZS5PXL;<:!>ZEY^\2
MZB[AVD?C&KVKM%Y7\(>97%K?=Q.%K<SU869\+IY';N4XHJZ77(=Q3..K,,JR
MWQ=25*4WEMJAOKO@83K H2]"W1>Z2D4SY!_-%%.R/D1%9')[[^@3#79TP5]G
M_!UU_.1QS'KP+'IP N\W/G.U[!-=1 [3&[H;K^X'[>4A[ &=C:C?H$X\<.C7
ME))(",79![*D7-WF@";V8;!M9Y0:QV9>O,Z,E=ZZ3'Y'V +6Y<*JYB4RX<N*
MH[^,55:JYTFHC.2##W;V.M9!L@ZC#1_[V%CF.WQ[(@G)+L]$159I*JH3P6@:
MK/R="]6;8(MDLW4"*#@Q#@.7!C'/A"6WF:E[X?A@V^*1UJNN'RBK-^@=:FX&
MRJZ"<,#U0.T5X4U<'-0_2AXI<0I" <%"*OR6B27W0BZ)N6!\LW<YD1!;O*9I
MAEI/Y-:2AIK36YJJF]XMQ6">Z=N94.T&/',)%(Q-LZ(Y(BL:2O^TFHI%YC J
M96-I"?4N(H?!?'?CU>!O+P]O+^ALB[H[K(373/R<&UM72.^%%PK[QA?[PE]9
MB'D",Z/GTD@L6*U[QA&>,$Q'.=JK4?>;@\4/[DZ=SJ;Z19P",;^* U4H9>)-
MMI @R^\_\#1"VS?DYF&3G)'E+@I^I7NRH-&3QURMV9K<_D3^S=EL_TKN'/>9
M^CXIZ(6C6RI>WSP*KV"A5%@OV>;9L)8R1,*-EB:J,F]8BD#33;KIK2BN3C@/
MN:/QCH$*H#W;RKX1PW<9P*^I$\,RY/IZS#M-]CG[&QWX:QNF%_L;YY<P2K<7
MV$"2W>V7=_W;.FG=!0^ZG=[Y11@WU5M+1=.1CF:*+B6)EW?'@>K LNE-W'^!
M@S-U;%.!H.>ZKN;0)95>M6Q7<"A.;G<;&+;"Z!L^G7OBHICSY'@^M!9L![)/
M-FS&CPM)W 9JD1^I]_"84'?$%A3. V6ZW]-HMN:G\_%LE\1LY>LRP''35"W6
M2D#/+6JQ2.JFOKKA+VD0;B +%31]*I@U/)=,8BZ2A+G,@9I<&<IA$P>+M G-
M:JJ;2M[>A$"4L>B+B.)1>.UYF5:%*R?0.$J2R+O?)7S(#]G:@;V;F(WEL_6<
M/9RR-;G+LT)J7M/!4GN^^GF,5U"Y'7J(2#13T7'L4"Q%&4/"]SC'$(](QB*=
M+:YY28:;U8;G%C.33@2^@:VK =6V78:09:DP._&]!5>((32-RF.++3%)(9F7
MI)TV,Y,DQ=>$38I6FTI^7YR?&B>F$S9)NG',*X/Q\IVCP%7$NL'*)/U]R=[G
MZ,53NO>'R,/7N$>Q1A\)2("6_!.HC3>S3W6PGIJ7:R1W'9F5;"'J>-$5I?5C
M=#LV/*W91>EJHZ7L),KXAVBQ&^IZ*\?/C:@U3HT"63OH]:N^<DE)"I&S@[QR
M)V!3,[AC:9T+#I3;,+B#\!_JSIT(#LCJ+6')B*V!VJI=:[=, -^[#?F)XIK)
M&+KO@%Y5NW)P2>LDZN80O\5&A_B6)B/?#Y]YA)BZC0^3B;'YCV11%V00:#$1
M6<>\I(T< [;I@\CK5_/Q%_$K8_'N$_I+ZBAH&> L9Q2YN3N/PB</%FC,%[]P
MW$MZGRA=I@-%XL'/L0U2G" )8KZZN7=<X@(]_VM;"#$';*7?$OJRA4 V'/L^
M+=[,-8WCS."K.H*ZOW.]Y#[W?X[X*CIV)IW87KM3 BOW(W6F!H-J*5)H4NHV
M\F8&CI["IYXLBI^G]"WX6)5WI"/N$\]FA8L055.BV7TTJE<;DMF3'QV($]XR
MKS ^@W.O;1ADB6=CR8X#5)E5/X;1KU,(8F >A0Y4.N)^-\E-"I?WOE64:$!E
M5*\**J Y]X+SK: :R-/+5+[R B]^I#RL&/9_[-O"R-FSW]8XT;346KT%[9W^
M"A44@Y\&/$+551> 5RUKK-CZNTQE;T1^HZJ99_#NWE+1^A$5XX1P"LY*F*/?
MYZVJ29QX&UAUIEOZ*N,41+VA1JM@AI$:!0Y$Z-2JI8](Z;(CJY,EEKSGXR$'
M7$T[-N9=>+X/OZKA._=W<<=QJ*\G]YBXLL]764ATV<=C<<S0_1NL2"G,'X[#
MC:_>VX4D-70;QIYV=\3(T6M>S&;52VDQ]>2#C^SV.E;1!/L4WY 4KQ M";=+
MD6!+])')"SB[L[6Y4\TBYA4_1,XFGKQLZ0JR)(47=!SZ/O_C1R]Y]()90']B
MTYGN[9WN>?WF>SWQ:RLGBSW1PW ,]WV9J5[!"1\<]FYHS1N#J^*4JP/9;._3
M#MS%3S\A%M,7E;\ZL$DF E'AR<B [WC%3MV&0;?4DBM3FY]J%7:<\1HV*Q)Z
M[3U!7H3R3?!OHU"[N=?,UN?H:6M$$;1-/&C\ TM%JWCEWQ'-[7STV!NM5KO-
MCI]ACS9PH4<<V[1_15I!2/#98*@E8C52/@<,FU57A)&EU,0ID ^VQUTVYI8F
M;$[Q=Q!LG&;14.]P-_/AFSA;::U.C)"+2"]Q(\H3(E,^+!S?@0WXBL=3#VU5
M$O<YKI@5KH05*RC1C ]&]11C !"36%+S0].-%\?\&C1X85MGSQ[ID\1YP7-T
MFE#VUA*98,2,+1UQOT>G)H4K@YF"$@VVC.KIL.5))AS@X6-G/2&-&41-3+T'
M=S0:4 ORT'*@ 9>5FK6E)*-YD!E-@-7QD0Q2;/SE^X]L5O=BJ,!H-5HU<O6:
M0\'.A%*"!#,+&JS9Z5D[>@ NF EA5FP*'>_=UYI'X9KRF=OQ(5#:RN?2,@W@
M>S48H/#!-!QH8&:E9GUW[,'Q"T'IVP(WCU#_'%#'^M9M&*P.@&!% AX\*DVS
M!V>)_3-!JDIGS:TT2)6$!Z0+ZJ^G0;R+X#CPCL8T>J*Z*4%)VNM\:U"V-,DJ
MZ-  R:!</5.0OSY?[P)(_/O(0\O96D%RDDBPXH"1QC5M'.$L^! L'<RC62,3
M&NC9:EK//BT6J&*_@[*A+]F3<]@3$=X>(@PN6&^)]NW6K7J>WK'7I'X-=SH&
M;-NY-LHJ=W$'VFSGSV[1#@JCD(6,-ZFICC X68IA3;!GFKYR'&[N(3L*;+,6
MDDC*W)*7-'$\WUA$O*.@WD(Q#S(TBZSL)&7P^>A@U94%Q+]F4U(JE!2ELL\+
M@ME?:892*1S']*5X'^7LQ<SMBT7F* WN#Y(T1'K>#J:J4O2V$#,X] _7W9BU
M^E0A^)!Z;!K'NSS_4RG<N?AU?\'L=:7RB//\N\&;7*-0;;$'%$20G*@91Z[+
MAT#''SOQ8PDX/F"1?2B21ZB;N15[;S#H8%2>',F>%P>,VBM<VX7*)!"@)B49
MKT7@(?\BE6-,WC%HUGJ(I(1J&NP#-DQ.@L1+]GS<A/0CXFM=2&%G:0-GL6]C
M<D,V>QM1N%8PAQFABZ ^XNQY,D>0]<7P(?!^H^[49>LP;^TYA9@V87P:%#4*
MBGL[C&:WH2ZD_&GM-![WJ0,[F*=XA0W.Z#$?.?CTTZ^=JO0G,H8OE7@B'^G2
M<QX"-FQX*U[I95/?.]23]>;S&)3,?!L%S> @:E"LGGXUI209Z8F:'8J84,C]
M/]ULH_")YSU3W@G6$/;6]$9%L\974N%H?I-J]9-^24N*Q&BGZ:RH87&(BSRH
MCG/%6C K2[6"SS=P&)P/G?;#[6%/&7@:/L8K:IAV#WD$3H?WN,:I'>'^9EA8
M7<X=3[G%D'_77WJ7BCIY#A?Y!8YALZ)-;1<0ENSP_8D:#5PT ;WDRO&B'QQ_
M5XT3,=#UUI@F-;.&51'A:&2#9BJ/6%:_=1("U(23GZC]TQIRLAS<;)T7@V.?
M+W_](.HB0EE$611Q\;2:K6^+91E5%A]';F_X.N9KR/!X#*$X\'M$2U05"7F]
M- A\XA4)PS4)\XJ$ZWI%PC-E24+'KB3A*</8(&Y&I@%EW5@9P58F051Z3:>9
MVJN0A' $>WOXS3O]W"0*=&B&U/3+/F>ALD+%J4=\,WA[*M5133*R]LEKB'R%
M_C=4,N^>2^-]['<I0*-C%L;[J&G/K J>%".JV<2D( ""*$ &KE8^9:&ISZ.E
M&]7OUM92[% S8>(D?$]'^@G!PVB5>$]\52O+I.IJ%UFRXKO8WE;Q6E1DRD9R
MOF'*$AW@S_3;YVQ:1:.@:D:,4J>&5[^@+ZQ+PW'Z*BT,C&-_,G6]- ;G7_>Y
M(UA5JHB1]+O!72.-0LJH^/-85G,."L#  8"\0G*^,[ACXT:^)M/8;</8<_51
M2T,J!48;N-  S5K5.@2Y;\['H7PMC -^EW0;T97'56*_^Y1O7P<V*9;L6/N$
M8!MCBB"TX<,V%;;0N79@6V#E&R^V:9-ZS!GJ;+W$\2'Q(O.!DQU[B6F6W8M=
M<ALF/]%$<3K1GKW7C)XMC2HEZ+3D13-:ME2X?E+"V46M*<E_JHVI,*%?\ZR?
M(<_D*&\)YQ^D%^N,-UFZ2.EOJZNSB?F>6&L1@T/Q,+V5MU?>PV*<QJO(V_+1
M<[;.+[,PR7Q3)H9/YW#Q-T@<>9=%WF$AMTX$T__A%X(U6/YNLW)FSP%;WCQZ
MVX7W&YVMIQOF<GB.GU<*E"6NH+[R2A,XU4U.;W@^Q,P,T5V$X,#T 9K7#@ >
M*0E345F.*SBU22620HG)5"9QUHR0K:3"0@$U8 KHL[^'0=OAU^&_N[PAK[="
M@2_?G CSV9M(>_((E+LKZ7851J+J6V[,.(RVH?#%9^O1AMG*7NKZ%@R82/V_
M<S>&/M+/<WOK4WV^QJP/]O%0''VV1TOM^[AX6K&'%YX'!/*)GV5_=S>SR'OP
M L>'.EPQ$Q^?I'^W>PZZ_MSE-;7NOVT>\GGUUPZ6V??/!+Z1XGDA."Z?]US6
MTX[>*4^[.QCQ$0;*[6PV82#.N49)$GGWNP2N(BQ#YJ8_L;? QSKF0(N+M?S&
MI6;K\!"1^,Z<CF50[<ZJ.%+T DC,S "QVS*<K#(Y )FQ[\!U?"*>"_5C5HZ_
MXEFUB4-<<?Q()O/%J>Z\BJQ;A:KH^9RDKIHN5U39@LJT-C^F]/YNS![]E>07
M:H\F&L=8?71[E&O_CSQ#A7@2R461&^HR%\DO?@1; 06G"OX4*5I BR)A?SL#
MMS1)3\HNF4_W1%TXQ;@-U\[.AY?$IJ@XY+/8+[MH/X^8Q>)RIN]X&^4=FT,E
M]AGH=033B]%A!XC#T6..8H/QU-T58L6I5Q"><\DR-9F0S28D$ Z)0:5TLN+B
M3]\#P%CU$#%F<^4#5'JZH[RDQ'S5A/V6LH9 ?2=S57AO):@?I'\MD![0!WBL
MRKTZAA'- 2:;?+C/<]Y"!E&R$E+!J8J$7#(?(SG^+9X6SM;5:AX:/[6)J=<<
MMU8&E-+:&CD&'YY;J5E+&U)@ K<>:94GOER!"Z-L)H"[!LF^'"D[=\2EFK1O
M7GKQR@]C. -LR(]P%,F])LL]WJLHQUT>+!9-3SB>+<ID3E+R%T3(/B-".G0?
M(?^,L">(:UM\:!>>?.$IY)_I<XRQG3WW+Y&CZG(7><$#<^>\4$8E\W\OG!@J
M76ZV-(A-,3Z=)/7>?[J96NLO[<3@ZA^==-=L%/'RE7P?*.;9SCPN&_P7NMGZ
MX1Z<&B<&FDP@>1USWI-M^O/NE_9X8>PRG*3JC.*B=9SVC<H+["*E-X>]NXF9
MJ]Y>Q. H/DSO*H+%*)T-W3)17P-TGX#I9,B5=T'6<DLW[ZS38$&3Q!>W#-:%
M3 &"0PG@ X3UE_'Q4(/S_)!=)>% ]:'JMQN>/?9W)A6("FF@AQB>M4:V&IX;
MI0PY/%N::!J>&T3@ ')GO2V'9P;=10FZUT7H'FEX'LRU-A7-[BX.N9.M+;+=
M5=;@/>%(!N@.9T5/V.ZB>.>P3L \%B^ $WOOB<IQ/A0AIUO&?KSQ_*2]@G?W
MU(WC-%E4Q9Q9T>X%-PI#T",L#;;H#PV2L/<&._6UTT/<K5,,Y,A?A5$A,XH@
M:^4/J@4,[[";#&MVTE7<@^.VL\KMG''(<U-(89.-U_VYWV536OG<:M8A'6V3
M,2;O6L6' X+ME+4<*&NH.^V "%$Q[]\O=MNMGX:M.?'CE1\^3P.>A$;<3;2/
MTSI08*_7J0XVO'2SJK,T'&@^A@GJ^U9PX:HH5U0] ,FD(/H4<53'NMZ?EIK7
M7E8MD_1[9;^N7#G"-O]^<* 9E-)60MP>(=7F,=,\+)T7.*\T0*%"U7\"AYJ*
M]6P-&0DB3*CTTN1AX&1'R<)ZI,6SN8B[30GJ=B)Z72AW,*Z6DLB2'PT<.RA=
MQ2KD@XX@6#]Q7DAX[WL/F+*&9/UM\N)L9,[K.:\XZW'#LSLSHHIM4Z^UE3+(
M:-C.1.5H:2<"#7R[Z5V[U<2 Z]5+$I^N*.F-\^)M=IMK;^,E;"TU#5SOR7-W
MS!?E4<6? I=&;*V_]<,X_K2YCZCO._/0]U;[[-YE5O%;Y>0>5WYOBY53O)9L
M[7),X8/C_U0657N&? 3QX1E\T>YE3Y$A\ 3*R4>PI[0]AR>1G7P4V?)G<:YJ
ML7D<<\.EO)/&^K^(5<U2(4+JK#%;GNV9\L].Y.H.Q5I)Z#>_5&O3RFFFK-D'
M[PO==5:%RKM22IK^+'@@'-6K(C\.^,+6FJCAX?OA,W2KZBL8/S+SZ#00A3LT
M[ZV]F#Z!W-7((IK;RD #Z8Z**U:3$10^@NB%#-_@K?-(>QQ@SCPY6$X$*\\7
M2=]2^VJ=N_YJFES$ P0/XLT?_"*4#GYGJ6@ZQ=%,J2<;K'8-GH3UG@9T[2'I
M)JF./+*?KWL@=(->"!T;9D8=TQ".B=D E2^BYD #2RLUC9"S -JI5E[U:^G\
M%J*X6NA$R;ZVG&KD^-D-5[TU#'O6;I,FL5.ME6S5K5U32V_11_E->'Z),A;Y
MQ?AV042W4"Z)7Z$,U^0NO3H)<LG-W93$*R<(V"(IR^C]5SZR,%HG'9-$P1DW
MW-TGZYU/'/E<'&"0R=1&@7O'384;J!:(4+%AAX5!YV-@XS8,,GQ\?LC@N5=&
MS(8?0E@9E9.ZW%"XC%:#A04/+DS8*US+!,M3TXQ(QDLR9L*Y!VFS<,-PM?(@
M0X+<?1%7REVV)*:Z1K-@0M9J]AK7FBUC)1FOS(GB$N F@GV8UHMY=<Y)G'@;
M&#4F3A0P9,6SX!/XP9!-&R)X QZ? )1C.9*,W"<^>BSI2W+A5Q)3'5LV-BP<
MV[ Z9.)$I-%5/(,4'D*RIW#J]#DD?=!@F$HS7*M?B1HK9AZ$&+!26-VVGF0E
M;,+>%=ISE7+WG9XNMTKZ#\M0ESJ*?RUS/<U!64B$JV[2;K(0-O5!AJ@AD*9
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M+.M !87]!96=8?5B:;FUK"JEQN57W,.V8<C@45/.M!M+BE(YG+/+X02%4C^
MG8;:=^#&;$(J >_CP>'4#1A*%T3&EM8M.&^I"T1S,3=F0(AX;4@?8-^1GW!3
MI+X1"O0!\V%T<6G,.*&+2S7V7%H^3)/)%OAP!;!/@[J4JK6TDWV+M]FBTI"
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M"FO[5G#/J3*0_2V]=J"KBJ)1D/.T._.2RT-&EA=-0$*V]2RNMU18-.LAPOJ
M\>S':38"^<$2/M[R%E)DNKR5 ]F^!1]O>6O*U T%O<(A] 6C6/H.4'5$^Z&E
M#AWU6U)V>JXPF10G&FNS#IP8A;ZY.J@<S[8-YNCS1%/"QU88KA$NY0#,FIDJ
M"?PQK.75M*08R"1Y/&5@FPI3#8#?V[:][7C'ODQZ+MAWSL_;DW2U"@LO6#^^
MOP[1(R</I<+:\ST_FOR<!7J-1GWFJ=GIM[J=R=?6=7_X\U9.RK_\YU^/$D)^
M?J[@UM [\\ QK3J/9]&+\O0/VZULAXX?C-Z>^_>^#-Q0JK(<,U/_B>Y%<H!V
M&EH/U*X?)*XHG-@\+]KTT(;)<OW S6(10600(/N1OW'2"-GN\.;&F]*-,\N]
MT1VRN-C>P,F@6(DH3!P4#8>QG3B.T-A[FL&8SM"1_TQ]DKHTEPSSRZ4OJMDO
MDON.T2B6[=Z5,.8EHS,4FV.[<N_)7^9U@$<@\D-JQ\D</;., +,93F75(HP'
MLFT&KP/WBM)K+)WG$URFRSXD?!$EW8L"^ "#E)Q8+&#BEIP#F%P3R.TZCF^7
M=QB$H<]BS)_7.4*\B'#M1S-1\9UZO\*V6?R@*5"_.%S:%R8@G*])&Q-8\(/,
M7YW;VK8EO):=72(')_2U]^V2-JFIGWWBZV<T7-$;$ VMUYIV_NV@.K;FU$3Y
MDG:RFL,R"U@BE.4Q%/D'PNIG>4]E1\L*E09*>QDLM43AQLZX31M;=H5-C?Q2
M>@73T90K#69;<ZH.< 69N07Z>H:NTXC3I+E=LCD^SQ%^]'$@>3 T&L2V;E3#
M*E;+R UPJ0D[DVL8HD=ZT.^RTKWWB>;@19TEC885(VP^DFT=R1SFJM)R ^LU
MOV,P(WL-V788+P7)>W-XGUL-3>. L6V[!IC/A_HDZL8,*0@N3B>65#D&ER "
M<ZAQE(OZV7[,K[ZARR5A= O*_T+_<^?'@'SR/U!+ 0(4 Q0    ( *YYJDJG
MD(0OKJ0  (#9"P 1              "  0    !F;VYR+3(P,38P.3,P+GAM
M;%!+ 0(4 Q0    ( *YYJDHYJXK-M@\   V6   1              "  =VD
M  !F;VYR+3(P,38P.3,P+GAS9%!+ 0(4 Q0    ( *YYJDJ"H#[_81   $S#
M   5              "  <*T  !F;VYR+3(P,38P.3,P7V-A;"YX;6Q02P$"
M% ,4    " "N>:I**^4'+/,:    B@$ %0              @ %6Q0  9F]N
M<BTR,#$V,#DS,%]D968N>&UL4$L! A0#%     @ KGFJ2O#NB'JD2   DXX#
M !4              ( !?.   &9O;G(M,C Q-C Y,S!?;&%B+GAM;%!+ 0(4
M Q0    ( *YYJDI<(8XNX#   !'9 @ 5              "  5,I 0!F;VYR
G+3(P,38P.3,P7W!R92YX;6Q02P4&      8 !@"* 0  9EH!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
